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Abstract
It is well documented that temporarily abstinent smokers who undergo
an acute bout of moderate intensity exercise experience a reduction in
nicotine craving and withdrawal. Conversely, available research in
chronic exercise and smoking cessation does not reliably demonstrate
that combining exercise with well established treatments increases
smoking abstinence rates. The overall aim of this dissertation was to
investigate mechanisms underlying the beneficial effects of exercise in
a group of female smokers taking part in a 14 week exercise plus
nicotine replacement therapy (NRT) patch programme. Determining
how smokers may benefit from exercise has important implications for
designing effective interventions. Three independent yet related studies
were conducted. The specific aims of study one (Chapter two) were to
determine whether an acute bout of exercise would further reduce
craving and withdrawal symptoms in a group of female quitters using
NRT, and to explore whether the magnitude of this relief would relate to
quit success. It was demonstrated that exercise provided additional
craving and withdrawal benefit for these quitters. Magnitude of relief
was not found to be related to end of programme quit status. Study
two (Chapter three) sought to examine what bearing exercise
expectancy (EXP) and credibility (CRED) beliefs of recently quit smokers
had on self-reported craving and withdrawal following an acute bout
of exercise, and to compare participants’ beliefs regarding NRT and
exercise as quit smoking aids. Results showed that high exercise EXP
and/or exercise CRED were found to be related to craving relief.
Participants believed both NRT and exercise to be effective cessation
aids. Study three (Chapter four) examined whether participants
reported using exercise as a relapse prevention aid, and how readily
these

two

behaviours

can

be

concurrently

changed.

It

was

demonstrated that participants were able to simultaneously increase
their exercise behaviour and decrease their smoking behaviour.
iii

Exercise was not reportedly used as a relapse prevention strategy.
Overall, the results of these studies provide evidence that exercise is a
worthwhile adjunct smoking cessation treatment, and elucidate some
of the reasons as to how it may help individuals quit smoking. The
clinical implications of the findings are discussed throughout.
Keywords: Exercise, smoking cessation, withdrawal, craving, relapse,
coping, expectancy, credibility, nicotine replacement therapy.
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1 CHAPTER ONE: GENERAL INTRODUCTION

1.1 A short history of the tobacco problem
Nicotiana tabacum is native to the Western Hemisphere, and in Native
American culture tobacco was frequently used for religious and
recreational purposes. In the 16th and 17th centuries Spanish and
Portuguese travellers brought tobacco back from the Western
Hemisphere as a novelty. During this colonial era tobacco use spread,
as the Portuguese cultivated tobacco wherever they had trading
colonies. Interestingly, during this time tobacco was used as a form of
currency or an exchange medium. Indeed, George Washington, the
first president of the United States (U.S.) is said to have paid the rent on
his farm with tobacco (TTS, 2010).
A number of developments, when taken together, led to the
widespread cigarette use seen today. Around 1835, novel approaches
to tobacco processing taking place in North Carolina, led to the
development of the flue-cured process. This process chemically
changed the tobacco, making it less harsh and easier to inhale. By the
1870’s a market for flue-cured tobacco had developed, such that
factories making hand rolled cigarettes began to appear. In the 1880’s,
Buck Duke obtained the rights to a cigarette making machine, which
quickly replaced hand rollers. With this machine, Duke was able to
lower the costs of cigarette production and soon bought out all the
competition. The problem for Duke then became that he was able to
produce far more cigarettes than there was a market for. To expand
the existing market he did two things: (1) he advertised to get new
cigarette smokers (at this stage mostly young men); and (2) he sought
overseas markets. During this period, improvements in railroads were
made, safety matches were invented, and mass media began in the
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form of nationally circulated magazines; all of which contributed to the
rise of the cigarette (TTS, 2010).
From the early 1900’s until the 1950’s cigarette use rose rapidly with no
real serious opposition from medical or public health groups. In 1950,
U.S. and British case control studies began to emerge, linking cigarettes
to lung cancer. In the late 1950’s, British American Tobacco
commissioned a team of scientists to investigate the problem of lung
cancer and smoking. Without exception, these scientists concluded
that cigarettes were a cause of lung cancer. For the first time public
perception of tobacco began to change and people attempted to
quit smoking. From the 1950’s until present day the battle rages
between the public health system and the tobacco companies.
Despite tobacco companies actively opposing public health measures,
slowly the public health side seems to be gaining important ground
(TTS, 2010).
1.2 Damage caused by smoking and the benefits of quitting
Smoking is the leading preventable cause of death worldwide
(USDHHS, 2004). It is estimated that, in the United States alone, each
day more than 1200 people die from smoking cigarettes. No doubt
about it, smoking kills. Adults who smoke will on average lose 13 years
of their life, and half of all lifetime smokers will die early because they
started, and continued to smoke (USDHHS, 2004)
Lung cancer was one of the first diseases found to be caused by
smoking. Since the 1960’s, the number of cancers linked to smoking has
grown to include: mouth, throat, larynx, esophagus, pancreas, kidney,
bladder, stomach, cervix, and acute myeloid leukemia. Smokers are
about 20 times more likely to develop lung cancer than non-smokers
and the vast majority of lung cancer cases are a result of cigarette
smoking (USDHHS, 2004).
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Heart disease and stroke are cardiovascular diseases caused by
smoking. Coronary heart disease is the leading cause of death in
middle and high income countries (WHO, 2008). Compared to nonsmokers, smokers are four times more likely to die from heart disease.
Smoking harms lung health and causes injury to lung tissues. This tissue
damage leads to chronic obstructive pulmonary disease (COPD).
COPD is the third and fourth leading cause of death in middle and high
income countries and 90% of deaths related to COPD are caused by
smoking (USDHHS, 2010; WHO, 2008). Sudden respiratory illnesses, such
as bronchitis or pneumonia are cause by viral or bacterial infections.
Smokers have more upper (nose, throat, and larynx) and lower
respiratory (below the larynx) tract infections than non smokers. This is
because smoking damages the body’s defences against infection
(USDHHS, 2004).
In general, smokers are less healthy than non-smokers. As well as being
more likely to suffer from cancer, cardiovascular disease, and
respiratory illness, smokers are also more likely to experience: (1)
absence from work; (2) dental disease; (3) difficulty with wound
healing; (4) hip fractures; (5) reproductive difficulties; (6) an increased
risk of cataracts, a leading cause of blindness; and (7) peptic ulcers
(USDHHS, 2004). The economic costs of smoking to the health system
are astronomical. It is estimated that between 1995 – 1999, in the United
States each year, the cost of smoking was $157.7 billion (USDHHS, 2004).
It is considered never too late to quit smoking, and the benefits of
doing so are great. For example, a year or two after quitting, the excess
risk of developing heart disease as a result of smoking may be reduced
by 50% (USDHHS, 1990; USDHHS, 2001). In addition, people who quit
smoking after having a heart attack are less likely to die within the next
10 years compared to those who continue to smoke (USDHHS, 1990).
Five to 15 years post quit the chances of stroke are the same as those
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who have never smoked (USDHHS, 1990). Quitting reduces the risk of
lung cancer such that, ten years after quitting the risk of developing
lung cancer is 30 – 50% that of the risk of those who smoke (USDHHS,
1990). Quitting also increases life expectancy, and the sooner the
smoker quits the greater the number of years in life expectancy gained
(USDHHS, 1990).
1.3 How bad is the problem today?
Despite the morbidity and mortality risks, a proportion of the population
continue to smoke. It is estimated that 18% of the Canadian population
aged 15 years or older smoke. More males (20%) report smoking than
females (16%) (CTUMS, 2008). In the U.S., the prevalence rates are
comparable. In a recent U.S. National Health Interview Survey, 20.6% of
adults over 18 years of aged reported smoking (CDC, 2007). Twenty
three percent of men were smokers compared to 18.3% of women
(CDC, 2007). Increased tobacco use is associated with a number of
socio-demographic factors, such as: low socio-economic status,
ethnicity, and low education level (CDC, 2007; CTUMS, 2008).
1.4 What makes quitting smoking difficult?
In human nature there is a strong tendency to maintain a steady state
and to resist change, and change when it comes to smoking, takes a
great deal of work (TTS, 2010). Smoking behaviour is influenced by
biological, psychological, and social factors.
Nicotine is the addictive substance found in cigarettes. Once an
individual becomes dependent on nicotine physical cravings develop
in response to a decrease in the body’s level of nicotine (TTS, 2010). This
dependence also has a psychological component; a nicotine
deprived individual becomes pre-occupied with thoughts of smoking.
In addition, nicotine is a psychoactive substance and has various
effects on the central nervous system. Smokers will light another
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cigarette

to

reduce

the

nicotine

withdrawal

symptoms

that

accompany nicotine abstinence. These withdrawal symptoms are
many and varied and include: anxiety, depression, irritability, difficulty
concentrating, difficulty sleeping, decreased heart rate, increased
appetite and weight gain, and dizziness (American Psychiatric
Association, 1994).
Smokers continue to smoke for the immediate positive consequences
they come to expect. This positive expected benefit of smoking and
the learned habit of continual pairing smoking with positive outcomes
creates a psychological dependence on smoking (Abrams, Niaura,
Brown, Emmons, Goldstein, & Monti, 2003). Smoking becomes a form of
self-medication to cope with everyday life (Abrams et al., 2003).
Smokers may use smoking to accomplish specific goals, such as: to
relax, to control weight, to cope with boredom, or to feel less awkward
in a social situation (TTS, 2010).
For many smokers cigarettes become integrated into social aspects of
their lives. People smoke in a wide array of social settings (both positive
and negative), and as a consequence, smoking becomes ingrained
into many situations and events. In this way, smoking is associated with
family, friends and identity. For instance, people smoke with their
husbands or wives and it becomes part of their relationship. Smoking
becomes a way of being connected to others and a way of expressing
feelings toward others (e.g., light up a cigarette to express anger) (TTS,
2010). The complex interaction of the biopsychosocial pull of cigarettes
makes it incredibly difficult for nicotine dependent individuals to quit
smoking.
1.5

Smoking cessation interventions

For over 50 years health practitioners have been working to determine
how best to treat nicotine dependence (USDHHS, 2010). Much work has
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been done in this area and a good set of Clinical Practice Guidelines
exist, developed by The Public Health Service (PHS) in the U.S. (Fiore,
Jaen, & Baker, 2008). Smoking cessation is treated with interventions at
the individual level and policy level interventions. The research
contained with this dissertation concerns the individual. The best
practice evidence based information will be presented.
1.5.1 Evidence-based cessation interventions for the individual
Cognitive behavioural interventions such as individual, group, and
telephone counselling can dramatically increase the likelihood of quit
success over and above attempting to quit unassisted. The chances of
quitting successfully with these types of interventions increases with the
number of different types of counselling formats utilised, the intensity
and duration of the counselling sessions, as well as the number of
counselling sessions completed (Fiore et al., 2008). Pharmacotherapy
(e.g., nicotine replacement therapy, bupropion, varenicline) has been
shown to double a smokers’ chance of quit success. Combining
pharmacotherapy with cognitive behavioural therapy increases a
smokers’ chance of quitting successfully even further. Research
suggests that emerging technologies (e.g., web assisted interventions)
may provide a promising modality in which to offer cessation services
with a broad reach (Fiore et al., 2008) (Table 1.1).
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Table 1.1. Chances of quit success at six months compared to treatment strategy
(Fiore et al., 2008; West & Shiffman, 2007).
Cessation strategy
Unassisted
Physician advice
Tailored online intervention
Individual cognitive behavioural therapy (CBT)
Group CBT
Telephone support
Pharmacotherapy
Nicotine patch
Nicotine gum
Nicotine lozenge
Bupropion
Varenicline
Combined pharmacotherapy with CBT

Maintained abstinence
at six months (%)
4–7
10
7 – 10
9 – 12
9 – 12
11 – 14
15
19
16
20
23
25 – 33

1.5.2 Population-based interventions to promote cessation
Research has established that mass media campaigns can increase
smoking cessation rates, particularly when they are part of a
comprehensive tobacco control programme. For example, a study by
Biener et al. (2006) surveyed a group of smokers and recently quit
smokers. They found that most smokers reported an awareness of antitobacco advertisements on television and 30% of recent quitters
surveyed reported these advertisements contributed to their quitting
(Biener, Reimer, Wakefield, Szczypka, Rigotti, & Connolly, 2006).
A number of population level policy strategies have been implemented
in an attempt to control the tobacco problem. For example, numerous
studies have shown that tax increases and smoke-free policies (e.g.,
banning smoking in public places) reduce adults smoking rates and
indirectly impact smoking initiation by changing social norms. Tax
increases and smoke-free policies have been more effective at
reducing smoking rates than any other intervention (Farrelly, Pechacek,
Thomas, & Nelson, 2008; TTS, 2010).
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1.5.3 Alternative smoking cessation interventions
A number of alternative smoking cessation interventions exist including:
acupuncture, laser therapy, and hypnotherapy. A recent Cochrane
review concluded that there is not enough evidence to definitively
state that acupuncture or related techniques such as, electrostimulation or laser acupuncture therapy, successfully improve quit
smoking rates (White, Rampes, Liu, Stead, & Campbell, 2011). However,
these authors also state that there is not enough evidence to dismiss
the possibility that acupuncture may be a more effective quit smoking
strategy than a placebo (White et al., 2011). A Cochrane review of the
hypnotherapy literature found insufficient evidence to support its
effectiveness as a quit smoking aid (Barnes, Dong, McRobbie, Walker,
Mehta, & Stead, 2010).
1.5.4 Smoking cessation intervention summary
Population based indirect approaches that help smokers reduce or
eliminate their tobacco use are effective. However, population based
interventions can only do so much and it is essential that smokers are
also provided with individual tobacco treatment. Effective smoking
cessation programmes exist and have come a long way in the last 15
years (TTS, 2010). However, quit rates at six months, even with
comprehensive programmes that include both pharmacotherapy and
cognitive behavioural therapy have limited success (Table 1.1).
Currently, there is insufficient evidence for alternative smoking cessation
treatment strategies. Therefore, the importance of identifying adjunct
therapies that improve and sustain quit smoking rates should be
emphasised.
1.6

Exercise – a novel evidence based smoking cessation aid

Exercise has been proposed as an adjunct smoking cessation aid.
Overall, of all the quit smoking adjuncts, exercise stands out as being
the most evidence based. Two excellent reviews of the exercise and
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smoking cessation literature have been conducted: (1) on the acute
effects of exercise on craving, withdrawal, affect, and smoking
behaviour (Taylor, Ussher, & Faulkner, 2007); and (2) on the effects of
chronic exercise interventions on smoking cessation rates (Ussher,
Taylor, & Faulkner, 2008). The following two sections will outline the key
findings of these reviews and add to them.
1.6.1 Acute exercise evidence based studies
In a recent review of the acute exercise and smoking literature, Taylor
and colleagues (2007) found that nine out of ten studies showed
exercise to reduce cigarette cravings during temporary smoking
abstinence (moderate to large effect sizes [ES] between 0.50–4.6).
Significant reductions in desire to smoke have been observed for
different intensities and types of exercise. For example, isometric
exercise of a very low intensity and duration (five minutes) has been
shown to reduce the urge to smoke by 0.7 on a seven point scale (ES =
0.29)(Ussher, West, Doshi, & Sampuran, 2006); whereas 15-20 minutes of
self-paced walking reduced the urge to smoke by 4.6 on the same
scale (ES = 3.7) (Taylor, Katomeri, & Ussher, 2005). In addition, longer
periods of exercise (e.g., approximately 15 minutes of brisk walking) at
a light to moderate intensity have been shown to delay ad libitum
smoking by up to 50 minutes, even when the individual is presented
with a challenging mental task or a lit cigarette (Taylor & Katomeri,
2006; Taylor & Katomeri, 2007; Taylor et al., 2005).
The magnitude of the reduction in cravings is encouraging and
comparable with an acute response to oral nicotine replacement
therapy (NRT) (Taylor et al., 2007). In 2001, West and Shiffman
conducted a review of the acute effects of oral NRT on craving and
withdrawal. Although many of the studies included in this review did not
report effect sizes, it is possible to conclude that the reduction in desire
to smoke and withdrawal following an acute bout of exercise is
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comparable to that of oral NRT. In addition, the effect of exercise on
craving is faster than oral NRT. Temporarily abstinent smokers who
engage in a brief bout of exercise, even just five minutes of isometric
exercise (Ussher et al., 2006), experience some relief immediately
whereas it takes approximately 20 minutes for oral NRT to result in
craving relief (West & Shiffman, 2001).
In terms of the withdrawal symptoms related to nicotine abstinence,
Taylor and colleagues (2007) found eight out of nine studies reported a
significant reduction in at least two withdrawal symptoms when the
exercise group was compared to a control group. The withdrawal
symptoms shown to be reduced by an acute bout of exercise include:
stress, anxiety, tension, poor concentration, irritability, and restlessness
(Taylor et al., 2007). However, it should be noted that an acute bout of
exercise does not always successfully reduce all nicotine withdrawal
symptoms experienced by temporarily abstinent smokers (Taylor et al.,
2007).
Although results from the acute exercise and smoking paradigm are
promising, this body of research has two inherent flaws that are worth
mentioning. First, the majority of studies include temporarily abstinent
smokers rather than people undergoing a real quit attempt. Therefore,
the severity of symptoms experienced may not correspond entirely with
those felt when a smoker is fully invested in their quit attempt. Second,
acute studies often take place within a laboratory setting. Such an
artificial environment bears little resemblance to actual scenarios in
which a smoker attempting to quit may find themselves. These two
flaws raise questions about the ecological validity of these studies and
their findings.
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1.6.2 Chronic exercise evidence based studies
The results of the chronic exercise and smoking cessation literature are
not as promising or perhaps just not as clear cut as those obtained in
the acute exercise and smoking cessation research. The current
literature does not reliably show that chronic exercise interventions
improve smoking cessation rates long-term. However, there is also no
evidence to suggest that exercise interventions undermine smoking
cessation (Fiore et al., 2008; Ussher et al., 2008).
The study with perhaps the most promising results to date was
conducted in 1999 by Marcus and colleagues. In this study, participants
engaged in a cognitive behavioural support programme combined
with either: vigorous intensity exercise three times per week or equal
contact time health education lectures. At the end of the 12 week
programme, those in the exercise group had significantly higher levels
of continuous abstinence compared to the control group. This same
pattern of results was evident at three and 12 month follow-up. This led
the authors to conclude that vigorous exercise when combined with
cognitive behavioural smoking cessation support facilitates smoking
cessation (Marcus, Albrecht, King, Parisi, Pinto, Roberts, Niaura, &
Abrams, 1999). Following on from this work, studies that have
administered moderate intensity exercise rather than vigorous intensity
exercise have had mediocre results. Herein lies an intriguing disparity
between the chronic and acute literature. That is, intensive exercise
studies demonstrate that a vigorous programme of exercise yields
better results than those that use a moderate intensity paradigm
(Marcus et al., 1999; Prapavessis, Cameron, Baldi, Robinson, Borrie,
Harper, & Grove, 2007) whereas in an acute exercise paradigm
moderate intensity exercise appears to have an effect on craving and
withdrawal which is as good if not better than a bout of vigorous
intensity exercise (Taylor et al., 2007). It is possible that this disparity is
related to poor adherence in intensive exercise programmes (Marcus,
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Lewis, Hogan, King, Albrecht, Bock, Parisi, Niaura, & Abrams, 2005;
Ussher, West, McEwen, Taylor, & Steptoe, 2003). Recently, Williams et al.
(2010) sought to overcome the issue of poor adherence and determine
if moderate intensity exercise would produce positive smoking
cessation outcomes (Williams, Whiteley, Dunsiger, Jennings, Albrecht,
Ussher, Ciccolo, Parisi, & Marcus, 2010). The findings from this trial
indicate that if adherence is adequate, moderate intensity exercise
may enhance the efficacy of a programme that combines the nicotine
patch and cessation counselling. Although, the authors note that the
study findings are preliminary and a larger trial is needed. If these results
can be replicated it has important implications for chronic exercise
interventions. Namely, a moderate intensity exercise programme is
likely to be better tolerated amongst sedentary smokers than a
vigorous intensity exercise programme and thus, more likely to be
maintained.
Recently, Abrantes and colleagues (2009) compared the quit rates of
exercisers vs. non-exercisers following either 12 weeks of bupropion or
placebo. They found that at the end of a 12 week course of bupropion
abstinence rates were not significantly higher between regular
exercisers (43.1%) and non-exercisers (42.4%). However, smokers in the
placebo condition who exercised regularly (36.9%) were significantly
more likely to be smoke free at the end of the programme than their
non-exercising

counterparts

(24.1%)

(Abrantes,

Strong,

Lloyd-

Richardson, Niaura, Kahler, & Brown, 2009). From this the authors
concluded that exercise may a particularly useful smoking relapse
strategy, thereby providing another dimension to exercise effects on
smoking behaviour (Abrantes et al., 2009).
Looking at the chronic exercise and smoking cessation literature as a
whole, the results are mixed. However, it is important to mention that
studies that do not support exercise as an adjunct smoking cessation
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aid may be limited by: (1) small sample size; (2) poor adherence to the
exercise programme; (3) inadequate duration of the exercise
programme; (4) little instruction as to how exercise might be of benefit
during nicotine abstinence; and (5) lack of generalisability due to
recruitment of a predominantly white sedentary sample (Marcus et al.,
1999; Ussher et al., 2008). Considering the large number of studies that
report the utility of exercise to acutely reduce craving and withdrawal
and the studies that report some positive results in the chronic literature,
it is reasonable to suggest that some smokers may derive benefit from
exercise when combined with well established smoking cessation aids
(e.g., CBT and pharmacotherapy).
1.6.3 Summary of exercise as a smoking cessation aid
There is little doubt that in a laboratory setting, with temporarily
abstinent smokers (ranging from three hours to 18 hours) an acute bout
of moderate intensity exercise (ranging from ten minutes to 30 minutes)
can alleviate craving and withdrawal symptoms associated with
nicotine deprivation (Taylor et al., 2007). Conversely, available research
in

chronic

exercise

and

smoking

cessation

does

not

reliably

demonstrate that combining exercise with well established treatments
increases smoking abstinence rates (Ussher et al., 2008). To elucidate
why this contradiction between laboratory studies and exercise based
interventions exists, and to improve abstinence rates in an exercise
aided quit smoking programme, investigation of exercise mechanisms
of action on smoking cessation may be worthwhile. Determining why
and how exercise works may increase the effectiveness of exercise as a
smoking cessation aid.
1.7

Possible mechanisms and individual factors involved in the effects
of exercise as a smoking cessation aid

Although the literature is not extensive, studies researching the
mechanisms and individual differences involved in exercise effects on
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smoking cessation have been conducted, and are presented in the
following sections.
1.7.1 Shifts in attentional focus
Approximately 60% of smokers report poor concentration as a nicotine
withdrawal symptom (McEwen, Hajek, McRobbie, & West, 2006). There
is evidence to suggest that after a period of 12 hours without nicotine a
smoker will have difficulty concentrating on tasks that were previously
uncomplicated, which has been shown to lead to increased injury rates
(Waters, Jarvis, & Sutton, 1998). In the general population exercise has
been shown to enhance executive control processes, the same
processes

involved

in

concentration

(Kubesch,

Bretschneider,

Freudenmann, Weidenhammer, Lehmann, Spitzer, & Grön, 2003).
Exercise might work to improve concentration during nicotine
withdrawal by shifting attentional bias away from the urge to smoke. In
this way it may increase attentional capacity towards the task at hand
and ultimately reduce the withdrawal symptom of poor concentration
(Janse Van Rensburg & Taylor, 2008).
Janse Van Rensburg and Taylor (2008) sought to objectively measure
cognitive performance in terms of ‘poor concentration’ amongst
temporarily abstinent smokers. To do this, participants completed the
computerised version of the Stroop (1935) colour-word interference task
on two separate occasions. Following 15 hours of abstinence they
completed the Stroop (1935) task after either a passive control
condition where they sat for 15 minutes or an exercise condition where
they walked on a treadmill for 15 minutes at a self-pace. Contrary to
their hypothesis – exercise did not enhance cognitive functioning,
relative to the passive control condition (Janse Van Rensburg & Taylor,
2008). The authors offer a number of plausible explanations as to why
they believe exercise did not have a positive influence on cognitive
function in this instance (see Janse Van Rensburg and Taylor, 2008 for
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details). Ultimately, these researchers conclude that while exercise did
not affect cognitive functioning, given the limitations, future research in
this area is warranted.
Continuing on from this work, shifts in attentional focus have been
investigated as a possible mechanism underlying the effects of exercise
on craving and withdrawal (Janse Van Rensburg, Taylor, & Hodgson,
2009). Research has demonstrated that smokers show an enhanced
attentional bias towards smoking cues (Waters, Shiffman, Bradley, &
Mogg, 2003). For instance, a recently quit smoker may find themselves
inadvertently staring at a person smoking a cigarette. It is postulated
that when attentional bias toward smoking related cues increases so
too does craving. It is also suggested that this attentional bias-craving
relationship is associated with relapse. (Waters et al., 2003) Therefore,
attentional bias toward smoking related cues is implicated as a
mechanism for craving, and it was proposed by Janse Van Resburg et
al. (2009) that exercise may diminish this relationship. The aim was to
determine if 15 minutes of moderate intensity exercise (vs. passive
sitting) had the ability to shift attentional focus away from smoking
related images amongst temporarily abstinent smokers, as well as to
examine the relationship between attentional bias and cigarette
craving (Janse Van Rensburg et al., 2009). To measure attentional bias,
a randomised cross-over design was utilised, and participants were
shown matched paired smoking and neutral images (e.g., hand
holding a cigarette and hand holding a pen). Percentage of dwell
time and direction of initial fixation was measured through an eyetracking system. It was demonstrated that: (1) exercise significantly
reduced the amount of time spend looking at smoking images
(percent dwell time); (2) exercise significantly reduced the tendency
for participants to initially gravitate towards the smoking image; and (3)
a negative correlation existed between initial image fixation and
craving. This led the authors to conclude that exercise reduced
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abstinent smokers’ attentional bias towards environmental smoking
triggers, and may be one mechanism by which exercise alleviates
cigarette

craving

(Janse

Van

Rensburg,

Taylor,

Hodgson,

&

Benattayallah, 2009). Contrary to previous studies these researchers
found a negative relationship between craving and smoking salient
cues. They hypothesised that this was perhaps a limitation of the
images shown. That is, the images may have been too similar (i.e.,
hand holding a pen vs. hand holding a cigarette) and there may not
have been enough time for participants to quickly differentiate
between them. Also, perhaps this postulated mechanism is subject to
individual differences, whereby it is the mechanism of action for some
smokers but not others. As an example of this, McRobbie and
colleagues found that when attempting to quit, some smokers found
the smell of cigarettes pleasant and others did not, and this preference
was not related to relapse (McRobbie, Hajek, & Locker, 2008).
Additional work in this area by Janse Van Rensburg and colleagues
(2009) was conducted with the primary aim of assessing the effects of
10 minutes of moderate intensity exercise (cross-over design, exercise
vs. seated passive control condition) on regional brain activation
(functional Magnetic Resonance Imaging [fMRI]), amongst temporarily
abstinent smokers while being exposed to smoking cues (i.e., smoking
images). At baseline, this group of abstinent smokers showed an
increased activation in brain areas associated with cravings and
visuospatial attention (i.e., orbitofrontal cortex and caudate nucleaus).
Interestingly, following 10 minutes of exercise this same group had no
such brain activation when presented with the same images. These
researchers suggest that an acute bout of moderate intensity exercise
may reduce cravings by shifting brain activation away from areas
involved in the urge to smoke when in the presence of smoking triggers.
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1.7.2 Alleviates weight gain and weight gain fears
Nicotine has been found to have powerful effects on the regulation of
body weight. When a smoker quits it can lead to physiological pressure
to gain weight (Grunberg & Bowden, 1985). The weight gain associated
can have negative psychological consequences for the quitter and
result in resumption of smoking (Brownell, Marlatt, Lichtenstein, & Wilson,
1986; Schneider & Waters, 2007). A recent review of exercise
interventions for smoking cessation found that such programmes do not
consistently report an end of programme reduction in weight gain
(Ussher et al., 2008). For example, Prapavessis et al. (2007) found that
during and immediately following a 12 week quit smoking programme,
weight gain was attenuated to a greater extent in the exercise group
(vigorous intensity) when compared to those that received cognitive
behavioural therapy only (Prapavessis et al., 2007). In contrast, Ussher et
al. (2003) found no different in post intervention weight gain between a
brief exercise counselling group and a health counselling group.
However, perhaps Ussher et al. (2003) found no difference because the
exercise group were not exercising at a vigorous intensity (84% of
participants were exercising at a moderate intensity). In this instance,
the potential for exercise to moderate weight gain post smoking
cessation may have been mitigated (Ussher et al., 2003). Therefore, the
utility of exercise to reduce post cessation weight gain may be
dependent on the type of exercise engaged in. Regardless, the
general pattern of results seems to be that, at best, exercise
interventions may delay post cessation weight gain but at six month
and one year follow-up there will be no difference between exercise
and other groups (Ussher et al., 2008).
In addition to actual weight gain, smoking specific weight concern
(SSWC), the belief that smoking maintains weight and that quitting
smoking will result in weight gain, has been investigated as a factor that
may influence the success

of

an

exercise smoking cessation
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programme (Schneider & Waters, 2007). SSWC has been shown to be a
barrier to cessation, is implicated in relapse to smoking, and has been
shown to exacerbate negative affect during a quit attempt (Pinto,
Borrelli, King, Bock, Clark, Roberts, & Marcus, 1999; Schneider & Waters,
2007). In a cross-sectional study, Schneider et al. (2007) found that
women who were higher in SSWC, who were also exercising, had less of
an increase in negative affect one week post quit; whereas there was
no relationship between change in negative affect and exercise
amongst women who were low in SSWC. From this, these researchers
concluded that SSWC may be a moderating factor in determining who
gets the most affective benefit from exercise. As such, perhaps exercise
works as a mechanism to counter SSWC amongst abstaining smokers
who have high levels of SSWC thereby enabling them to better tolerate
and resist relapse when faced with typical post cessation weight gain.
1.7.3 Alleviates mood disturbance
There is much evidence to suggest that negative affect maintains
smoking behaviour and thwarts quit attempts (Tart, Leyro, Richter,
Zvolensky, Rosenfield, & Smitts, 2010). Smokers with a history of major
depression or those who are high in negative affect are very likely to
relapse (TTS, 2010). Accordingly, psychological and pharmacological
smoking cessation programmes that successfully reduce negative
affect show improved abstinence outcomes amongst their clients
(Haas, Munoz, Humfleet, Reus, & Hall, 2004; Richmond & Zwar, 2003).
Exercise has been shown to have affect regulatory effects in both the
general population and amongst those with major depression (Focht,
Knapp, Gavin, Raedeke, & Hickner, 2007; North, McCullagh, & Tran,
1990). There is also some evidence that exercise can reduce this
nicotine withdrawal side effect (negative affect) in nicotine deprived
smokers (Bock, Marcus, King, Borrelli, & Roberts, 1999; Schneider &
Waters, 2007; Taylor et al., 2007). In a recent cross-sectional study
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conducted by Tart and colleagues (2010) negative affect was shown
to partially influence the positive effects of vigorous exercise on
smoking. In contrast, Daniel et al. (2006) found that a reduction in
cigarette craving experienced by temporarily abstinent smokers
following 10 minutes of moderate intensity exercise was not due to
exercise effects on mood. They reached this conclusion as they found
no significant relationship between negative affect, positive affect,
and desire for a cigarette (Daniel, Cropley, & Fife-Schaw, 2006).
In addition to negative affect, Tart and colleagues (2010) also
investigated the role anxiety sensitivity might play in the exercisesmoking-negative affect relationship. Anxiety sensitivity (AS) refers to
the fear of experiencing sensations associated with anxiety (e.g., rapid
heart beat, sweating, nausea) (Tart et al., 2010). These researchers
found that people who were high in AS were more likely to smoke when
they experienced negative affect. It was also demonstrated that the
relationship between vigorous intensity physical activity, smoking, and
negative affect was stronger for individuals considered high in AS
compared to those who were low in AS. These results suggest that
smokers who are high in AS may derive greater benefit in vigorous
exercise as a way to alleviate the negative affect associated with
nicotine deprivation, which may in turn help them quit smoking.
In 2006 Everson et al. conducted a study to see if exercise could induce
a reduction in craving and withdrawal amongst a group of adolescents
(16-19 years old) who were temporarily abstaining from cigarettes.
Interestingly, they found that during ten minutes of cycling in a lab
setting the moderate intensity exercise group experienced a greater
degree of negative affect when compared to individuals in the
placebo control condition (Everson, Daley, & Ussher, 2006). The group
of adolescents chosen to take part in the study were all relatively
sedentary and the researchers postulate that this group may have
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found the moderate intensity exercise task demanding and distressing
(Everson et al., 2006).
In 2008 this same group of researchers conducted a study to determine
the differential effects of 10 minutes of vigorous versus moderate
intensity exercise on craving and withdrawal in a group of temporarily
abstinent young adults (18-25 years old). They found vigorous intensity
exercise to be associated with adverse mood outcomes during the
exercise bout. Despite this, when compared to the control group, both
the vigorous and moderate intensity exercise groups showed a
reduction in craving, both during the exercise bout and five minutes
following the exercise bout (Everson, Daley, & Ussher, 2008). These two
studies in concert bring to light a few considerations: (1) exercise
mechanisms may differ between adolescents and adult smokers trying
to quit; (2) for adolescents, if exercise helps them to quit long-term it
may not be because of acute post-exercise reduction in craving and
withdrawal symptoms; and (3) exercise might alter craving and
withdrawal through different mechanisms.
It is evident amongst non-smokers that exercise decreases physiological
and psychological responses to stress (Hughes, 1984; Sinyor, Schwartz,
Peronnet, Brisson, & Seraganian, 1983). Lack of an alternative method
for coping with stress is often cited by smokers as a reason for failed quit
attempts (Shiffman, Kassel, Gwaltney, & McChargue, 2005). For
temporarily abstinent smokers, self-paced walking has been shown to
reduce tension both during the walk and up to 20 minutes after (Taylor,
Katomeri, & Ussher, 2006). In this same study, exercise was shown to
reduce craving up to 20 minutes after the brisk walk and this effect was
found to be partially due to a reduction in tension (emotional stress)
(Taylor et al., 2006). Therefore, the authors suggested that exercise can
reduce the stress experienced during temporary abstinence which may
in turn reduce the urge to smoke (Taylor et al., 2006).
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1.7.4 Distraction
Tobacco treatment specialists often recommend that smokers trying to
quit use distraction as a technique to deal with the intense urge to
smoke a cigarette (TTS, 2010). The idea being that if the smoker
redirects their attention toward something else, then the urge will pass
without them breaking their resolve (TTS, 2010). Daniel et al. (2006)
conducted a study to determine if the influence of an acute bout of
exercise on craving and withdrawal symptoms was due to distraction.
Temporarily abstinent smokers were required to either: (1) cycle at a
moderate intensity for ten minutes (40-60% HRR); or (2) engage in a
cognitively distracting task for 10 minutes. The distraction task involved
sequentially adding numbers, at a rate of one per second as they
appeared upon a screen. The exercise group demonstrated a
significant reduction in withdrawal symptoms immediately during and
after exercise when compared to baseline. In contrast, when
compared to baseline, the cognitive distraction group did not
demonstrate any difference in withdrawal symptoms and desire to
smoke. Therefore, the authors concluded that cognitive distraction is
not one of the main mechanisms responsible for acute exercise effects
on craving and withdrawal. There is one important limitation of this
study that is worth noting. That is, the authors postulated that the
distraction task in this instance may have been too difficult for some
people, and as such, rather than simply being distracting it may have
been anxiety producing.
Taylor and Katomeri (2007) agreed with Daniel et al. (2006) in that
distraction is not the main mechanism by which exercise works. These
researchers found that following 15 minutes of light to moderate
intensity exercise, followed by two mentally demanding tasks (Stroop
colour word inference task and a speech task), temporarily abstinent
smokers did not demonstrate an increase in craving in the presence of
a lit cigarette. Additionally, an acute bout of exercise delayed the urge
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to smoke for 50 minutes post exercise. Therefore, these researchers
believe that the evidence does not support distraction as a
mechanism. Namely, because it is difficult to comprehend that the
distracting effects of 15 minutes worth of exercise could last as long as
50 minutes (Taylor & Katomeri, 2007).
In 2006 Ussher et al. compared five minutes of isometric exercise to five
minutes of body scanning (relaxation technique). Up to five minutes
post intervention both groups experienced a reduction in craving and
withdrawal. They suggested that the short lived craving and withdrawal
reduction demonstrated for both groups may implicate distraction as a
plausible mechanism in this instance (Ussher et al., 2006). Considering
these studies collectively, it is possible that distraction may play a small
role in the mechanistic effects of exercise early on in the exercise bout,
but it is unlikely to be the mechanism of action involved in any longer
lasting effects.
1.7.5 Expectancy
Patient expectancy has been shown to influence treatment outcomes
in populations such as those suffering from chronic lower back pain
and generalised anxiety disorder (Newman & Fisher, 2010; Smeets,
Beelen, Goossens, Schouten, Knottnerus, & Vlaeyen, 2008). In terms of
exercise specifically, it has been proposed that expectancy of the
benefits of exercise on mood may influence actual changes in mood
following exercise (Salmon, 2001). Daniel et al. (2007) conducted a
study to determine if smokers who enter an exercise programme may
gain some relief from nicotine craving and withdrawal symptoms simply
because they expect to (Daniel, Cropley, & Fife-Schaw, 2007). To
achieve this, these researchers manipulated how credible participants
believed exercise to be as a smoking cessation aid. Inactive smokers
who had undergone a night of abstinence were then randomised into
one of three groups: (1) positive – read a statement that exercise helps
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with withdrawal; (2) negative – read a statement that exercise has no
effect on withdrawal; and (3) ambiguous – read both a positive and a
negative statement. The physical activity that all participants engaged
in was 10 minutes on a stationary bicycle at a moderate intensity. These
researchers found that regardless of the expectations of the
participants, withdrawal symptoms were reduced both during and
after exercise. From this they concluded that the expectation of the
effects of exercise on withdrawal and craving does not influence
actual reductions in these variables (Daniel et al., 2007). However, there
were a number of limitations with this study that cast doubt as to
whether or not expectancy as a mechanisms can be completely ruled
out. These will be outlined and discussed in detail in study two (Chapter
three) of this dissertation.
In 2003, Ussher and colleagues conducted a large trial and randomised
smokers to either: NRT plus CBT plus brief exercise counselling or NRT plus
CBT plus brief health information counselling. They found no differences
between these two groups in terms of expectancy of intervention
efficacy, post intervention abstinence, or weight and fat gain. In this
instance, because the two groups were the same in terms of
expectancy and treatment outcomes it is not possible to rule out
expectancy as an influential factor in the effect of exercise on smoking
cessation.
1.7.6 Incompatible behaviours
In the exercise and smoking literature there is a significant crosssectional association between smoking cessation and exercise (King,
Marcus, Pinto, Emmons, & Abrams, 1996). Research suggests that
compared to sedentary individuals, people who engage in vigorous
intensity exercise are less likely to smoke (Tart et al., 2010). It was
demonstrated by Prochaska et al. (2008) that following a combined
CBT and exercise intervention, individuals who at six month follow-up
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were still exercising, were more likely to be smoke-free than their
counterparts who were no longer active. It is postulated that an
increase in confidence to quit smoking is associated with a concurrent
increase in confidence to take up exercise and vice versa (King et al.,
1996). Although a causal relationship cannot be inferred, it seems
possible that exercise may exert some influence over smoking
behaviour because the two behaviours are distinctly incompatible.
1.7.7 Neurobiological mechanisms
A number of neurobiological mechanisms are involved in the
maintenance of smoking behaviour. At this stage there are several
mechanisms postulated to be involved in the link between exercise
and the psychobiology of nicotine abstinence. Animal models have
shown that exercise stimulates the release of dopamine into the
striatum of the rat. This implies that exercise may be a mechanism for
reducing the drive for drug administration in general, or nicotine
specifically in the case of smoking (Wilson & Marsden, 1995). However,
such a change in regional brain activation following vigorous exercise
was not found in a group of regular exercisers (Wang, Volkow, Fowler,
Franceschi, Logan, Pappas, Wong, & Netusil, 2000). Vigorous exercise
has been shown to facilitate the release of endogenous opiods (e.g.,
Beta-endorphins), neurotransmitters that are also stimulated by smoking
and known to enhance mood (Angelopoulos, 2001). An inherent
difficulty with these neurotransmitter-exercise hypotheses is that both
endogenous opoids and dopamine, the neurotransmitter so integrally
linked to the addictive power of nicotine, are only triggered for release
in vigorous exercise (Everson et al., 2008). Therefore, these mechanisms
do not fit with the acute exercise finding that moderate intensity
exercise is sufficient to reduce craving and withdrawal (Taylor et al.,
2007).
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Smokers have higher cortisol levels than non-smokers (36% higher)
(Ussher, West, Evans, Steptoe, McEwan, & Clow, 2006). Between 12 and
24 hours after smokers quit, their cortisol levels will plummet (Steptoe &
Ussher, 2006). It is hypothesised that this reduction in cortisol, makes
quitting more difficult such that the greater the decline in cortisol the
worse the craving and withdrawal experience (Steptoe & Ussher, 2006).
Therefore, any method that could temporarily boost cortisol levels back
up during a quit attempt has intuitive appeal. Exercise and cortisol
have a unique relationship. Specifically, vigorous intensity exercise has
been shown to increase cortisol levels among non-smokers (Jacks,
Sowash, Anning, McGloughlin, & Andres, 2002). Scerbo and colleagues
(2010) investigated the effects of exercise on cortisol amongst
temporarily abstinent smokers in a cross-over design where participants
engaged over three consecutive days in 15 minutes of: passive sitting,
moderate intensity exercise (brisk walking), and vigorous intensity
exercise (running). These researchers found that the decline in cortisol
levels was attenuated in the vigorous intensity condition but not the
moderate intensity exercise condition. However, no difference in
cigarette craving was demonstrated between the two exercise
conditions and participants experienced a reduction in craving during
both exercise intensities (Scerbo, Faulkner, Taylor, & Thomas, 2010).
Therefore, it is unlikely that reductions in cortisol contribute to the effect
an acute bout of moderate intensity exercise has on craving and
withdrawal. However, it cannot be ruled out as a possible physiological
mechanism related to vigorous exercise effects on these variables.
1.8

The appeal of exercise as a smoking cessation strategy

The interest in multiple health behaviour change interventions is
increasing (Prochaska, Spring, & Nigg, 2008). As a multiple behaviour
change strategy, exercise and smoking cessation complement each
other well. Recent research indicates that when smoking cessation is
facilitated it may enhance an individual’s motivation to change other
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health behaviours (e.g., increase exercise). Considering that smoking
cessation may be a catalyst for change in other behaviours and that
exercise has been shown to acutely reduce the debilitating symptoms
of nicotine withdrawal, incorporating these two behaviours into one
intervention is appealing.
Due to the addictive nature of smoking cigarettes, those interested in
quitting do not always achieve abstinence. This is evident by the fact
that smoking rates amongst the general population in the developed
world have remained at approximately 20% since the 1990’s (TTS, 2010).
A proportion of the smoking population are hardened smokers who
may have unsuccessfully tried many times to quit. For these individuals
a harm reduction strategy might be appropriate. The primary objective
of a harm reduction strategy is to minimise the risk of harmful
consequences associated with tobacco use in smokers who find it
extremely difficult to quit and those who are unwilling to quit (deRuiter
& Faulkner, 2006). While becoming completely nicotine free offers the
best protection against morbidity and mortality; harm reduction is a
concept that, under the right circumstances, is gaining favour amongst
tobacco treatment specialists (TTS, 2010). For a smoking cessation aid
to be considered an effective harm reduction approach it must fulfil
certain criteria such as: (1) it should not increase or contribute to the
individuals’ level of nicotine dependence; and (2) the reduction
approach should not present any additional harm to the individual
(for the full list of harm reduction criteria see deRuiter and Faulkner
[2006]). Presently, the only smoking cessation aid that fulfils all the
criteria to be considered a harm reduction strategy is nicotine
replacement therapy. The evidence is certainly shaping up to align
physical activity as another harm reduction strategy (deRuiter &
Faulkner, 2006; Hatsukami et al., 2004).
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Smoking relapse rates are alarmingly high. Between 60% and 98% of
quit attempts will end in relapse within the first year; with the majority
(44%) occurring in the first two weeks (Garvey, Bliss, Hitchcock, Heinold,
& Rosner, 1992). There are a number of reasons why people relapse
that exercise may directly impact. For instance, post cessation weight
gain (10 lbs on average) is a leading cause of relapse (Bush, Levine,
Zbikowski, Deprey, Rabius, McAfee, & Wiatrek, 2009; Parsons, Shraim,
Inglis, Aveyard, & Hajek, 2009). Although the research on the potential
of exercise to ward off post cessation weight gain is equivocal, exercise
is nevertheless an essential component of any weight management
programme and should be encouraged (Fiore et al., 2008). Cigarette
cravings are one of the most often expressed difficulties related to
quitting. The intensity of craving experienced by an abstinent smoker
over the first few days of quitting often predicts their success (Ferguson,
Shiffman, & Gwaltney, 2006). The acute exercise and smoking literature
has demonstrated that an acute bout of moderate intensity exercise
has great potential to reduce cigarette cravings in temporarily
abstinent smokers (Taylor et al., 2007). Thus, exercise has potential as a
relapse prevention strategy.
In summary, a number of benefits specific to the promotion of physical
activity as a smoking cessation treatment cannot be overlooked: (1) it
is cost effective as part of a multiple behaviour change intervention; (2)
it is inexpensive for the smoker (as opposed to NRT); (3) it can safely be
indefinitely sustained; (4) it has minimal negative side effects; (5) it has
the opposite effect on morbidity and mortality amongst smokers and as
such provides great health benefits (deRuiter & Faulkner, 2006); and (6)
it is a quit smoking aid that spans the continuum of the quit process –
from quit attempt to relapse prevention. Given these potential benefits
continuing to pursue exercise as a quit smoking strategy is worthwhile
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1.9

Objectives and hypotheses of this dissertation

Much work has been done on the benefits of exercise as a smoking
cessation intervention. This thesis will concentrate on an area of the
research which has not been as well covered – mechanisms involved in
the utility of exercise and individual factors that may contribute to how
well exercise works as an adjunct smoking cessation aid. The objectives
and hypotheses of each study are outlined below.
1.9.1 Study one (Chapter two): Exercise provides further craving and
withdrawal relief for recently quit women who are using nicotine
replacement therapy (NRT)
Study one is an examination of exercise mechanisms of action that
might contribute to quit success in a combined NRT and exercise aided
smoking cessation programme. Smokers followed during a 14 week NRT
plus exercise aided smoking cessation programme which allowed for:
(1) the first examination of exercise as an adjunct to NRT to reduce
withdrawal symptoms and cigarette craving; (2) more accurate
estimates of the craving and withdrawal relief experienced following
exercise during a real quit attempt; and (3) exploration of exercise
mechanisms of action that might contribute to quit success in a
combined NRT and exercise aided smoking cessation programme
(e.g., magnitude of withdrawal and craving relief experienced
following a bout of exercise).
It was hypothesised that an acute bout of exercise would reduce
nicotine craving and withdrawal in a group of women attempting to
quit using NRT and exercise. It was believed that the greatest
withdrawal and craving relief would occur in the first week following
the quit date and at the NRT (NicoDerm® patch) nicotine drop-down
time points (i.e., 21mg to 14mg, 14mg to 7mg). It was further
hypothesised that women who experience a greater magnitude of
relief from craving and withdrawal following a 20-30 minute bout of

29
moderate intensity exercise would be more successful at abstaining
from cigarettes at the end of the 14-week NRT plus structured exercise
programme.
1.9.2 Study two (Chapter three): Exercise may help smokers quit
because they expect it will and because they believe it is a
credible quit smoking aid
Study two sought to examine whether treatment expectancy and
credibility were associated with outcome in terms of self-reported
craving and withdrawal in a group of women undergoing a real quit
attempt. The women involved were supplied with nicotine replacement
therapy patches (NRT) as well as an exercise regimen. This provided the
opportunity to compare expectancy and credibility beliefs regarding a
well established quit smoking aid such as NRT with a novel quit smoking
aid such as exercise. Furthermore, rather than only assess treatment
expectancy and credibility before the start of the treatment when
participants may have difficulty judging their actual beliefs regarding
treatment outcomes; it was possible to measure these two variables
immediately after quitting and at the end of the programme once they
had actually been through the process (Smeets et al., 2008).
It was hypothesised that exercise expectancy and credibility beliefs
would contribute to a reduction in craving and withdrawal symptoms
following an acute bout of exercise. It was also hypothesised that as
participants progressed through the NRT plus exercise quit smoking
programme their exercise expectancy and credibility beliefs would
increase.
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1.9.3 Study three (Chapter four): Exercise may be an effective
behavioural

support

strategy

for

coping

with

smoking

temptations during a quit attempt
The exercise and smoking literature supports the notion of exercise as a
meaningful coping resource during abstinence to prevent relapse
(Taylor et al., 2006). Exercise has been proposed as a strategy to
enhance coping ability and confidence to remain smoke free (Ussher
et al., 2008). However, it is not known if abstaining smokers would
confidently report replacing smoking with exercise when imagining a
relapse inducing situation. It is also unknown whether the quitter’s
confidence in exercise as a behavioural support strategy is situation
specific. With this in mind, the purpose of the present study was to
determine: (1) if women taking part in a combined NRT and exercise
aided smoking cessation programme report a temporal progression
from smoking to exercising in high risk situations; and (2) whether
confidence to use exercise as a coping strategy is situation dependent.
It was hypothesised that women engaging in an exercise aided quit
smoking programme would naturally substitute smoking for exercise as
a means of coping with situations that promote the resumption of
smoking. It was also hypothesised that of all high-risk relapse situations
those related to affect, particularly negative affect, would be the most
amenable to exercise as a coping strategy. Finally, it was hypothesised
that women who showed an increase in confidence to quit smoking
would demonstrate a reciprocal increase in exercise confidence.
1.10 Integrated article format
This dissertation is presented in an integrated article format. Therefore,
there is some overlap in material throughout, which is a product of this
dissertation style.
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2 CHAPTER TWO: EXERCISE PROVIDES FURTHER
CRAVING AND WITHDRAWAL RELIEF FOR RECENTLY
QUIT WOMEN WHO ARE USING NICOTINE
REPLACEMENT THERAPY

2.1

Introduction

Cigarettes kill millions of people worldwide every year (USDHHS, 2010).
For over 50 years health practitioners have been working to determine
how best to treat nicotine dependence (USDHHS, 2010). Current
guidelines recommend tobacco treatment specialists advocate a
combination

of

pharmacotherapy

tobacco
(Fiore,

dependence

Jaen,

&

Baker,

counselling,
2008).

First

and
line

pharmacotherapies such as the nicotine patch, bupropion, and
varenicline have been shown to double chances of quitting (TTS, 2010).
Unfortunately, this increased chance of becoming smoke-free only
equates to a 23% success rate at six months. Even comprehensive
programmes, that include both pharmacotherapy and behavioural
support, have limited success, with six month abstinence rates of 30%
(Fiore et al., 2008). Sobering statistics like these highlight the need for
identifying adjunct therapies that improve and sustain quit smoking
rates.
Cigarette cravings are one of the most often expressed difficulties
related to quitting. The intensity of craving experienced by an abstinent
smoker over the first few days of quitting often predicts their success
(Ferguson, Shiffman, & Gwaltney, 2006). When undergoing a period of
abstinence, smokers are likely to experience two forms of cigarette
cravings, background and episodic (Ferguson et al., 2006). Background
craving denotes a steady state of craving where the individual is
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plagued by a constant desire for a cigarette. Background craving may
be controlled by pharmacotherapy such as the nicotine patch,
bupropion and varenicline. Episodic cravings are surges in craving that
result in an intense desire to light up a cigarette. These are triggered by
exposure to stimuli associated with smoking (e.g., after a coffee or
when having a bad day at work) (Ferguson & Shiffman, 2009). The only
pharmacotherapy known to assist with episodic craving is oral nicotine
replacement therapy (NRT; e.g., gum and lozenge) (Ferguson &
Shiffman, 2009). A single session of exercise has been shown to have an
acute effect on cigarette cravings. In a recent review of the acute
exercise and smoking literature, Taylor and colleagues (2007) found
that nine out of ten studies showed exercise to reduce cigarette
cravings during temporary smoking abstinence (moderate to large
effect sizes [ES] between 0.50–4.6). Significant reductions in desire to
smoke have been observed for different intensities and types of
exercise. For example, isometric exercise at a very low intensity and of
a five minute duration has been shown to reduce the urge to smoke by
0.7 on a seven point scale (ES = 0.29)(Ussher, West, Doshi, & Sampuran,
2006) whereas 15-20 minutes of self-paced walking reduced the urge to
smoke by 4.6 on the same scale (ES = 3.7) (Taylor, Katomeri, & Ussher,
2005). In addition, longer periods of exercise (e.g., approximately 15
minutes of brisk walking) at a light-moderate intensity have been shown
to delay ad libitum smoking by up to 50 minutes, even when the
individual is presented with a challenging mental task or a lit cigarette
(Taylor & Katomeri, 2006; Taylor & Katomeri, 2007; Taylor et al., 2005).
The magnitude of the reduction in cravings is encouraging and
comparable with an acute response to oral NRT (Taylor, Ussher, &
Faulkner, 2007). Given the literature, it is plausible that the magnitude of
craving and withdrawal relief an abstinent smoker experiences through
a bout of exercise might influence their quit success.
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Although results from the acute exercise and smoking paradigm are
promising, this body of research has two inherent flaws. First, the
majority of studies include temporarily abstinent smokers rather than
quitters per se. Therefore, the severity of symptoms experienced may
not correspond entirely with those felt when an individual is fully
invested in their quit attempt. It also provides little insight into the utility
of exercise to help people quit more long-term and no insight into the
utility of exercise to help decrease withdrawal symptoms while on
pharmacotherapy (i.e., nicotine replacement therapy). Second, acute
studies take place within a laboratory setting. Such an artificial
environment bears little resemblance to an actual scenario a smoker
attempting to quit may experience. In short, these two flaws raise
questions about the ecological validity of these studies and their
findings.
Only one study appears to have combined an examination of the
acute and long-term effects of exercise on craving, withdrawal, and
smoking status amongst the same group of participants (Bock, Marcus,
King, Borrelli, & Roberts, 1999). Sixty two women (44 exercise, 18 contact
control) participated in 12 weeks of one hour weekly smoking cessation
cognitive behavioural therapy plus either: (1) three times per week, 3040 minutes of vigorous intensity exercise, or (2) three times per week 3040 minutes of wellness information. Cigarette craving and nicotine
withdrawal measures were administered immediately before and after
the last exercise session of each week of the programme. When
compared to the contact control, the exercise group reported
significantly less craving and withdrawal symptoms immediately
following exercise most weeks of the programme. These researchers
showed that exercise can be used throughout a quit attempt to
decrease feelings of nicotine withdrawal and cigarette cravings.
Additionally, exercise was found to be beneficial for weeks into a quit
attempt and reduced negative symptoms related to abstinence
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unrelated to the presence of a smoking trigger. The effects of an
exercise aided pharmacological based smoking cessation programme
(i.e., NRT) on nicotine withdrawal and cravings is unknown. There is
some evidence, however, that exercise combined with NRT facilitates
smoking cessation (Prapavessis, Cameron, Baldi, Robinson, Borrie,
Harper, & Grove, 2007). It should be noted that not all combined NRT
and exercise protocols yield promising results. Those that find no benefit
from exercise may be partially explained by poor adherence to the
exercise protocol (Kinnunen, Leeman, Korhonen, Quiles, Terwal,
Garvey, & Hartley, 2008; Ussher, Taylor, & Faulkner, 2008).
The present study followed smokers during a 14 week nicotine
replacement therapy patch plus exercise aided smoking cessation
programme which allowed for: (1) the first examination of exercise as
an adjunct to NRT to reduce withdrawal symptoms and cigarette
craving; (2) more accurate estimates of the craving and withdrawal
relief experienced following exercise during a real quit attempt; (3)
determination of how structured and progressive acute exercise relates
to quit success; and (4) exploration of exercise mechanisms of action
that might contribute to quit success in a combined NRT and exercise
aided smoking cessation programme (e.g., magnitude of withdrawal
and craving relief experienced following a bout of exercise).
It was hypothesised that an acute bout of exercise would reduce
nicotine craving and withdrawal in a group of women attempting to
quit and using NRT. It was believed that the greatest withdrawal and
craving relief would occur in the first week following the quit date and
at the NRT (NicoDerm® patch) nicotine drop-down time points (i.e.,
21mg to 14mg, 14mg to 7mg). It was further hypothesised that women
who experience a greater magnitude of relief from craving and
withdrawal following a 20 minute bout of moderate intensity exercise
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would be more successful at abstaining from cigarettes at the end of
the 14 week NRT plus structured exercise programme.
2.2 Method
2.2.1 Participants
Participants included 119 females undertaking the first and second
round of the Getting Physical on Cigarettes trial. Inclusion criteria
included: (1) aged between 18 and 70 years; (2) smoked in excess of
10 cigarettes per day for the past two years; and (3) wished to achieve
smoking abstinence. Exclusion criteria included: (1) contraindication to
regular exercise (e.g., disability, unstable angina); (2) contraindication
to using NRT; and (3) pregnancy. Participants provided written consent
and were also required to obtain written consent from a physician,
verifying that they were fit to exercise and use NRT before beginning
the programme.
It is important to emphasise that all participants taking part in the
research contained within this dissertation were female. A purely
female population was chosen because, in terms of quitting, women
are reported as being less successful than men (Jung, Fitzgeorge,
Prapavessis, Faulkner, & Maddison, 2010). In addition, women often
report post-cessation weight gain concern, which has been shown to
be associated with relapse (USDHHS, 2001). Given this, exercise may be
a particularly pertinent adjunct smoking aid for women (USDHHS, 2001).
Perhaps the most important reason of all is that some women,
especially those who prior to the trial were sedentary, would not have
taken part in this research if it involved exercising in front of men.
Therefore, to improve adherence to the programme it was determined
that an all female environment would be best. However, this means
that the findings contained within this body of work are not able to be
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generalised to men. In addition, determining gender differences is
beyond the scope of this dissertation
2.2.2 Ethical approval
The conduct of the trial followed the principles outlined in the
Declaration of Helsinki (World Medical Association, 2008) and the World
Health Organization, 2002 Good Clinical Research Practice. The
conduct and reporting of the trial followed CONSORT principles
(www.consort-statement.org). Ethical approval was obtained from the
University of Western Ontario Health Sciences Research Ethics Board
(#16306) and participation was entirely voluntary.
2.2.3 Design
2.2.3.1 Getting Physical on Cigarettes
The Getting Physical on Cigarettes (GPOC) trial was a Canadian
Cancer Society Research Institute funded trial (#019876) examining
smoking relapse prevention following a smoking cessation intervention.
The 14 weeks of the trial consisted of an exercise and NRT smoking
cessation intervention. On the fourth week participants quit smoking
and began the NicoDerm® 10 week transdermal patch programme.
Participants took part in three supervised exercise sessions per week
(between 20-30 minutes duration each session) for weeks one through
eight of the programme; followed by two supervised sessions per week
during weeks nine through 11, and one supervised session per week
during weeks 12, 13, and 14. For more information on the trial rationale
and method of Getting Physical on Cigarettes please see Jung,
Fitzgeorge, Prapavessis, Faulkner, and Maddision (2010). The Getting
Physical on Cigarettes trial registration can be found at clinicaltrials.gov
identifier NCT01305447. The women who took part in the GPOC trial
were the same as those who took part in the present study.
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2.2.3.2 The Exercise and Health Psychology Laboratory
The trial was delivered at the Exercise and Health Psychology
Laboratory (EHPL; www.ehpl.uwo.ca) at The University of Western
Ontario in London, Ontario.

The laboratory houses aerobic exercise

machines (treadmills, stair climbers, stationary bicycles, and rowing
machines) as well as a conference room for participants to complete
questionnaires pre- and/or post-exercise.
2.2.3.3 General procedure
The present study consisted of three acute exercise sessions, which
occurred on week five, week 11 and week 13. The first acute exercise
session (week five) occurred shortly after the participants quit smoking
and started NRT (week four). The second and third exercise bout
coincided with the period of time soon after participants reduced the
level of NRT patch strength from 21 mg to 14 mg (week 11) and 14 mg
to 7 mg (week 13). A flow-chart of the research design is displayed in
Figure 2.1 and a time line of the measurements and assessments in
Table 2.1.
Participants completed the Shiffman-Jarvik withdrawal scale (Shiffman
& Jarvik, 1976) immediately prior to and following the three acute
exercise sessions. Change in smoking withdrawal symptoms due to an
acute bout of exercise was determined by comparing Shiffman-Jarvik
subscale scores pre- to post-exercise. To be eligible for this analysis,
participants had to demonstrate that they were smoke-free (CO < six
ppm), adhered to their NRT programme, and followed their acute
exercise regime at the appropriate intensity (see Figure 2.1).
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Table 2.1. Schedule of Assessments

Baseline

4

Week
5
11

13

14

X

Quit smoking
Acute Exercise Session
Moderate/Vigorous Intensity

X

X

X

X

X

X

X

X

X

Exercise Intensity Verification
Peak VO2 Fitness Assessment
Heart-Rate Monitor

X

Smoking Abstinence Verification
Carbon Monoxide Assessment

X

X

Measures
Shiffman-Jarvik Withdrawal Scale (pre-exercise)
X
X
X
Shiffman-Jarvik Withdrawal Scale (post-exercise)
X
X
X
Fagerström Nicotine Dependence
X
Demographics Questionnaire
X
Actical Exercise Behaviour
X
X
Smoking Information
X
Note. Baseline refers to pre-trial and week 14 refers to post-trial. Week five acute
exercise session occurred just after the quit smoking date (week four); week 11 and
week 13 acute exercise sessions occurred just after a drop-down in nicotine patch
strength.
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Participants’ heart rate max was determined by the max heart rate
achieved during an aerobic fitness test completed at baseline.
Aerobic fitness was evaluated using a standardised, maximal,
incremental exercise protocol (Bruce Test) on a Woodway PPS
treadmill.
As a part of the GPOC trial participants were asked to adhere to an
individualised set exercise regimen for the 14 weeks of the trial. Exercise
sessions on week one through week three participants’ exercised at a
mild intensity, defined as 40-50% of their heart-rate reserve (HRR) (e.g.,
40% of HRR was defined as, heart-rate max [HRMax] – resting heart-rate
[RHR] x .4) + RHR) (CSEP). For exercise sessions from week four (quit
week) to week six participants were to exercise at a moderate intensity,
defined as 50-60% of their HRR (CSEP). For weeks seven to nine they
were required to exercise at between 60-70% of their HRR. From week
10 until the end of the programme participants were asked to engage
in vigorous intensity exercise, defined as 70%+ of their HRR (CSEP).
Inspection of the Polar heart-rate data revealed that all participants
met the week one – three exercise prescription. For the following weeks
(week four – 14) participants engaged in at least moderate intensity
exercise, or 50-60% of their HRR (CSEP). That is, not all participants
engaged in vigorous intensity exercise although it was asked of them.
2.2.4.1 Acute exercise session: week five protocol
The first acute exercise session, which occurred on week five, consisted
of 20 minutes of moderate intensity exercise. Moderate intensity
exercise was defined as the participant’s heart-rate being between
50% and 60% of heart-rate reserve (HRR). For example, 60% of the
participants’ HRR was defined as, (heart-rate max [HRMax] – resting
heart-rate [RHR] x .6) + RHR (CSEP).
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2.2.4.2 Acute exercise session: week 11 protocol
The second acute exercise session, which occurred on week 11,
consisted of 20 minutes of vigorous intensity exercise. Vigorous intensity
exercise was defined as the participant’s heart-rate being at least 70%
of her HRR ([HRMax – RHR x .75] + RHR) (CSEP).
2.2.4.3 Acute exercise session: week 13 protocol
The third acute exercise session, which occurred on week 13, consisted
of 20 minutes of vigorous intensity exercise (CSEP).
2.2.5 Nicotine replacement therapy regimen
All participants were provided with NRT in the form of NicoDerm®
transdermal patches. Participants were asked to wear the nicotine
patches for 24 hours a day, seven days a week, for 10 weeks as per the
manufacturer’s recommendations.
2.2.5.1 NicoDerm® three step programme
The NicoDerm® 10 week, three step programme, designed for smokers
who smoke 10 (or more) cigarettes per day, was followed. Accordingly,
a step one (21 mg) patch was to be applied daily for six weeks,
followed by a step two (14 mg) patch applied daily for two weeks, and
finally a step three (7 mg) patch applied daily for two weeks.
At the beginning of week four participants were given seven, step one
(21 mg) patches. Participants were to quit smoking and start the
patches within two to three days; hence, by week five participants had
been on NRT for three to five days. Patches containing 21 mg of
nicotine were distributed for six weeks. On week 10, participants were
given seven, step two (14 mg) patches; hence, by week 11 participants
had ‘stepped down’ to the lower dose of NRT. Patches containing 14
mg of nicotine were distributed for two weeks. Finally, on week 12,
participants were given seven, step 3 (7 mg) patches; hence, by the
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week 13 exercise session, participants had ‘stepped down’ again to a
lower dose of NRT. Patches containing the lowest dose of nicotine, 7
mg, were distributed for two weeks. Participants were not given
patches at the exercise session on week 14. Post-intervention, week 14,
assessments were scheduled at the end of the week to ensure
participants were no longer on NRT (absorbing nicotine).
2.2.5.2 NicoDerm® two step programme
Although all participants were smoking at least 10 cigarettes per day at
baseline, a few decreased their smoking prior to the week four quit
date. The participants who were smoking less than 10 cigarettes per
day at the week four quit date completed the NicoDerm® two step, 10
week, NRT patch programme (n = 14). The two step programme
consisted of step two (14 mg) and step three (7 mg) patches and is
designed specifically for smokers who smoke less than 10 cigarettes per
day. A step two (14 mg) patch was to be applied once daily for six
weeks, followed by a step three (7 mg) patch applied once daily for
four weeks.
Participants on the two patch 10 week protocol ‘stepped down’ from
14 mg NRT to 7 mg NRT on week 11. These participants, like the three
step programme participants, finished the 10 week system on week 14.
2.2.6 Demographic measures
Participant demographic information was gathered via self-report,
including age, employment, language spoken at home, number of
children and household income. These variables are described in Table
2.2. See Appendix 1 for a copy of this questionnaire.
2.2.6.1 Programme adherence
Programme adherence was determined by attendance to the exercise
sessions. One session had to be cancelled due to a national holiday.
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Participants’ attendance was compared to a total number of 32
exercise sessions ([eight weeks x three sessions] + [three weeks x two
sessions] + [three weeks x one session] – one session).
2.2.6.2 Nicotine dependence and other smoking characteristics
The Fagerström Test for Nicotine Dependence (FTND) (Heatherton,
Kozlowski, Frecker, & Fagerstrom, 1991) was administered at baseline
(Figure 2.1) to measure perceived cigarette dependence. The FTND is
scored out of 10 points (total) and is interpreted as follows: a score of
zero to two is indicative of very low addiction; a score of three to four,
low addiction; a score of five is related to medium addiction; a score of
six to seven, high addiction; and a score of eight to10 is related to very
high addiction. The FTND has shown high internal consistency and
adequate retest reliability (Pomerleau, Carton, Lutzke, & Flessland,
1994). This variable is described in Table 2.2. See Appendix 3 for a copy
of this questionnaire.
In addition to the FTND, participants were asked to indicate the number
of previous quit attempts they have undergone, length of the longest
quit attempt, the number of years they have smoked, the number of
cigarettes they smoked per day, and the percentage of family and
friends who smoke. These questions were asked of participants during
baseline assessments prior to the first exercise session. These variables
are described in Table 2.2. See Appendix 2 for a copy of this
questionnaire.
2.2.7 Physical activity behaviour
2.2.7.1 Actical® accelerometer
Moderate and vigorous (MV) intensity structured exercise minutes
(bouts of 10 minutes plus) were measured objectively pre- and postintervention using the Actical® Accelerometer (Minimitter, Oregon). The
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Actical® Accelerometer is sensitive to low frequency movements in the
range of 0.5-3.2 Hz, which is the common range for human movement
and has been shown to be a valid and reliable measure of physical
activity (Heil, 2006). Participants were instructed to wear the device on
the right hip for seven consecutive days during waking hours for the
week prior to the first exercise session (baseline). For complete data,
participants were required to provide a minimum of 10 hours per day
for at least five days (including one weekend day) (Trost, McIver, &
Pate, 2005). The raw data were analysed using custom software
KineSoft version 2.0.95 (KineSoft, New Brunswick, Canada). These
variables are described in Table 2.2.
2.2.7.2 Peak VO2 fitness assessment
Aerobic fitness was evaluated using a standardised, maximal,
incremental exercise protocol (Bruce Test) on a Woodway PPS
treadmill. A Cosmed Quark b2 indirect calorimetry metabolic system
(Cosmed S.r.I, Rome, Italy) was used to assess gas exchange variables.
Peak VO2 was expressed in (ml/kg/min) units. These data were used to
determine entry level fitness as well as fitness level changes from pre- to
post-intervention (Sjostrand, 1947). These variables are described in
Table 2.2.
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Table 2.2. Demographic characteristics, exercise and smoking behaviour.
Variable
Demographics:
Age
Language spoken at home (English)
Married
Yearly household income:
Below $50,000
Between $50,000 and $75,000
Above $75,000
Number of children
Occupation:
Employed
Student
Unemployed
Objective weekly physical activity (Actical):
Pre-intervention (exercise minutes at MV)
Post-intervention (exercise minutes at MV)
Peak VO2 (ml/kg/min)
Pre-intervention
Post-intervention
Carbon monoxide (CO) reading:
Pre-intervention
Post-intervention (14 weeks)
Smoking behaviour at baseline:
Cigarettes per day
Number of years smoking
Fagerström test of nicotine dependence
Percentage of family and friends that smoke:
Between 0 and 10%
Between 10 and 20%
Above 20%
Number of previous quit attempts

Mean (SD), %

40.64 (13.17)
95 %
25.9 %
71.7 %
12.3 %
16.0 %
1.22 (1.29)
71.1 %
9.6 %
19.3 %
20.89 (41.75)
30.21 (55.00)
28.56 (7.01)
30.42 (7.57)
17.33 (9.02)
6.48 (10.71)
16.76 (6.13)
22.06 (12.16)
5.65 (1.95)
72 %
12 %
16 %
3.91 (2.86)

2.2.8 Primary outcome measures
2.2.8.1 Smoking withdrawal
The Shiffman-Jarvik withdrawal scale is a 15 item questionnaire that
assesses withdrawal symptoms in abstaining smokers. The items were
presented as seven-point scales, where one indicates ‘definitely not’
and seven indicates ‘definitely’. The items were divided into five
subscales based on factor analysis: craving (five items), psychological
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symptoms (five items), physical symptoms (three items), sedation (one
item) and appetite (one item). Shiffman-Jarvik subscale scores do not
tend to drift over repeated assessments and use factor analysis to
group items according to their inter-correlations, which generally results
in reliable scales (Shiffman, West, & Gilbert, 2004). Reliability analyses
(Cronbach’s alpha scores) were computed at week five, week 11 and
week 13 for the constructs of craving, psychological symptoms and
physical symptoms. All alpha values reflected an acceptable level of
reliability and are presented in Appendix 16 (Kline, 1993).
The scale was administered immediately before and after the acute
exercise sessions during week five, week 11 and week 13. Only data
pertaining to those participants who reached the exercise intensity
goals, followed the NRT protocol and abstained from smoking prior to
the acute exercise sessions were included in the analyses. Data were
expressed as an average value for each subscale (out of seven) for
pre- and post-exercise as well as a percentage change (pre- to postexercise) reduction score.
2.2.1 Secondary outcome measure
2.2.1.1 Smoking abstinence
Smoking abstinence was verified post-intervention by self-report, and a
breath carbon monoxide (CO) reading of less than six parts per million
(ppm). Participants who failed to attend the post-intervention
assessment appointment, scored greater than six ppm breath carbon
monoxide, and/or reported smoking behaviour were considered a
smoker at week 14 (post-intervention).
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2.2.2 Adherence challenges and considerations
2.2.2.1 Smoking abstinence
Smoking abstinence was verified before the three acute exercise
sessions by self-report and a breath CO Smokerlyzer (the Micro
Smokerlyzer®; Bedfont Scientific) reading of less than six ppm
(Middleton & Morice, 2000). The measurement of breath CO level
provided an immediate, non-invasive, method of assessing smoking
status. Carbon monoxide monitors are sufficient to detect recent
smoking; CO has a half-life of about five to six hours (Middleton &
Morice, 2000). Withdrawal symptoms pre- and post-exercise from
participants who scored greater than six ppm breath carbon monoxide
and/or reported smoking within the last 10 hours were not included in
the analyses.
Although, CO measurement is acceptable it would have been prudent
to also report salivary cotinine levels. Cotinine is a bi-product of nicotine
and provides a more accurate representation of a smokers’ behaviour
than CO. All participants who took part in the research contained in
this dissertation provided salivary cotinine samples at baseline and
week 14. Unfortunately, within the research time frame cotinine
analyses were not received, and it is an acknowledged limitation of this
dissertation as a whole.
2.2.2.2 Acute exercise heart-rate prescription
Although participants were cautiously introduced to exercise, the
moderate and vigorous intensity did lead to discomfort for some of the
women. Some women were not fond of sweating, working hard, or
experiencing physical stiffness. To assist in alleviating stiffness and
physical discomfort, research staff taught participants to properly
warm-up prior to exercise, to cool down following an exercise session
and to stretch. In addition, to promote appropriate exercise intensity,
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research staff provided participants with a weekly exercise intensity
goal at the beginning of each exercise session and remained visible
throughout the exercise session.
As previously mentioned, exercise intensity was monitored and
recorded using polar heart-rate monitors. For the vigorous acute
exercise sessions, a few participants did not reach the exercise intensity
goal (week 11 - n = 8; week 13 - n = 4 ) but engaged in at least
moderate intensity exercise, or 50-60% of their HRR (CSEP). These data
were included in the analyses. Therefore, not all participants engaged
in vigorous intensity exercise although it was asked of them.
2.2.2.3 Nicotine replacement therapy
Prior to week four, participants were aware of the NicoDerm® 10 week
NRT protocol and which programme they were going to undertake
(two step programme or three step programme). Before starting the
patch, participants were told to read the booklet provided in the
NicoDerm® box and call the NicoDerm® 1-800 number with questions
and concerns.
To facilitate compliance with the NRT protocol, the appropriate
patches were distributed to each participant in weekly batches.
Compliance with the NicoDerm® protocol was monitored via the
completion of daily logs by participants. Recorded on the log was the
time of day a new patch was administered, when patches were
removed, any deviation from the 10 week NRT programme and any
problems or concerns. At the beginning of each week, log sheets from
the prior week were submitted to research staff and discussed with the
participant.
Failure to follow the NicoDerm® 10 week patch programme generally
stemmed from one of three themes: (1) the misconception that the
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patch eliminated all cigarette withdrawal symptoms or withdrawal
symptoms being misinterpreted as incorrect nicotine patch strength; (2)
the sense of eagerness to be finished using nicotine; or (3) sleep
disturbance or vivid dreams. Reluctance to follow protocol was
countered with the fact that smoking cessation is more likely when
pharmacotherapy is used as a part of the quit attempt (TTS, 2010) and
with the fact that smoking cessation using the NRT patch is highest
when proper NRT protocol is followed (TTS, 2010). Of the participants
who reported sleep disturbances, many persevered with 24 hour patch
use until the disturbances decreased or until the end of the 10 week
programme. However, 36 of the 119 participants opted to take the
patch off while sleeping. These participants were warned that nicotine
levels will be decreased in the morning and withdrawal symptoms and
cravings may be higher. Data from these individuals were included in
the analyses if the participants met the smoking abstinence and
exercise intensity requirements.
One participant (n = 1) a very heavy smoker, reported using selfpurchased patches in addition to the NRT provided by researchers. This
participant followed the NicoDerm® three step programme twice,
concurrently (i.e., two patches per day). Data from this individual were
included in the analyses if the participant met the appropriate smoking
abstinence and exercise intensity requirements.
One participant (n = 1) reported an ‘allergy’ to the NicoDerm® brand
NRT patches. To satisfy this individual, researchers provided her with the
Life® brand NRT patches (i.e., 21mg, 14mg and 7mg). This individual
followed the NicoDerm® protocol using Life® brand NRT patches. Data
from this individual were included in the analyses if the participant met
the

appropriate

requirements.

smoking

abstinence

and

exercise

intensity
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Participants who did not wear the patch daily and/or did not ‘step
down’ at the proper time (week 11, week 13) were removed from
subsequent analyses. Withdrawal and craving data for the participants
who completed the two step 10 week NRT programme were analysed
separately from the participants who completed the three step
protocol for week five (n = 14) and week 11 (n = 9). No differences were
revealed between the two protocols, hence the data were combined.
Participants who did the two step patch protocol did not provide week
13 withdrawal and craving data because they did not decrease patch
nicotine at that time.
2.2.2.4 Participant retention
Although no costs were incurred by the participants for the use of the
exercise equipment, NRT, or for campus parking, retention of
participants for 14 weeks was a challenge. Despite contacting
participants via telephone and email to keep them in the trial,
participant drop-out still occurred. See the flow chart for a schedule of
participant drop-out (Figure 2.1). Participants who dropped out prior to
week 14 assessments and/or did not attend week 14 assessments were
considered to be smoking post-intervention.
Due to attrition, absenteeism and/or smoking lapses from week to
week, the number of participants fluctuated over the three acute
exercise sessions (week five, n = 69; week 11, n = 37; week 13, n = 26)
(Figure 2.1). A total of 20 participants engaged in all three acute
exercise sessions.
2.2.3 Power calculation
25 participants are required at week five, week 11, and week 13
exercise sessions to provide power of 80% (p < 0.05) to detect a 0.8 (SD
– 1.2) difference between pre- and post-exercise cigarette craving
(SamplePower 3-IBM SPSS). No power calculation was computed for
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the exploratory research question – is there a difference between week
14 non-smokers and week 14 smokers on the magnitude of change of
withdrawal symptoms pre- to post-exercise.
2.2.4 Statistical Analyses
Separate repeated ANOVAs were used to analyse differences in the
withdrawal scales of the Shiffman-Jarvik questionnaire pre- to postexercise for each acute exercise session (week five, week 11, week 13).
Bonferroni correction set the alpha at .003. Planned comparison t-tests
at week five were used to compare the magnitude of relief found on
the scales of the Shiffman-Jarvik questionnaire between week 14
smokers and non-smokers.

In addition, t-tests were used to analyse

differences in pre-exercise withdrawal symptoms for week 14 smokers
and non-smokers. Because pre-exercise craving scores differed for
week 14 smokers and non-smokers, an ANCOVA was used to compare
the craving magnitude between the two groups (non-smokers vs.
smokers at week 14). Assumptions for ANCOVA (i.e., homogeneity of
regression) were met. A chi-square was used to determine the
relationship between week 14 smoking abstinence and exercise
programme adherence.
2.3 Results
2.3.1 Did exercise reduce withdrawal?
Significant reductions in cigarette craving were demonstrated following
exercise at all three time points (week five: F[1,68] = 28.281, p < .001, η2
= .294; week 11: F[1,36] = 12.245, p < .001, η2 = .252; week 13: F[1,25] =
4.522, p < .05, η2 = .153) 1 (Figure 2.2).

1. No difference was found between withdrawal results at any of the time points dependent
on mg dose of NRT. Therefore, all individuals wearing a patch and meeting inclusion criteria
were included in each craving and withdrawal analysed time point.
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Figure 2.2. Cigarette craving before and after an acute bout of exercise for women
that met inclusion criteria at each time point (week five n = 69, heart-rate [HR] ≥ 50%
of heart-rate reserve [HRR]; week 11 n = 37, HR ≥ 70% of HRR; week 13 n = 26, HR ≥ 70%
of HRR).
* p < 0.05 difference in cigarette craving before and after exercise.
** p < 0.001 difference in cigarette craving before and after exercise.

Significant increases in the physical symptoms related to nicotine
withdrawal were demonstrated following exercise at all three time
points (week 5: F[1,68] = 21.698, p < .001, η2 = .242; week 11: F[1,36] =
21.719, p < .001, η2 = .376; week 13: F[1,25] = 5.849, p < .05, η2 = .190)
(Figure 2.3)
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Figure 2.3. Physical withdrawal symptoms before and after an acute bout of exercise
for women that met inclusion criteria at each time point (week five n = 69, heart-rate
[HR] ≥ 50% of heart-rate reserve [HRR]; week 11 n = 37, HR ≥ 70% of HRR; week 13 n =
26, HR ≥ 70% of HRR).
* p < 0.05 difference in nicotine withdrawal symptoms before and after exercise.
** p < 0.001 difference in cigarette craving before and after exercise.

A significant reduction in the nicotine withdrawal symptom of sedation
was shown following exercise at week five (F[1,68] = 20.464, p < .001, η2
= .231) and 11 (F[1,36] = 8.945, p < .001, η2 = .199) (4). No significant
acute change in sedation was observed at week 13. It is however
worth noting that week 13 acute reductions in sedation approached
significance (F[1, 25] = 3.585, p = .070 , η2 = .125) (Figure 2.4).
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Figure 2.4. Sedation withdrawal symptoms before and after an acute bout of exercise
for women that met inclusion criteria at each time point (week five n = 69, heart-rate
[HR] ≥ 50% of heart-rate reserve [HRR]; week 11 n = 37, HR ≥ 70% of HRR; week 13 n =
26, HR ≥ 70% of HRR).
* p < 0.001 difference in nicotine withdrawal symptoms before and after exercise.

Significant reductions in psychological withdrawal symptoms were
demonstrated following exercise at week five (F[1,68] = 28.354, p < .001,
η2 = .294) and 11 (F[1,36] = 16.885, p < .001, η2 = .319) (Figure 2.5). No
significant acute change in psychological withdrawal was observed at
week 13. However, it should be noted that week 13 acute reductions in
this withdrawal symptom approached significance (F[1, 25] = 3.252, p =
.083 , η2 = .115) (Figure 2.5).
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Figure 2.5. Psychological withdrawal symptoms before and after an acute bout of
exercise for women that met inclusion criteria at each time point (week five n = 69,
heart-rate [HR] ≥ 50% of heart-rate reserve [HRR]; week 11 n = 37, HR ≥ 70% of HRR;
week 13 n = 26, HR ≥ 70% of HRR).
* p < 0.001 difference in nicotine withdrawal symptoms before and after exercise.

No significant reduction in appetite was shown following exercise at
week five (F[1,68] = .169, p < .682, η2 = .002), week 11 (F[1,36] = .030, p <
.865, η2 = 0.865) or week 13 (F[1,25] = .658, p < .425, η2 = .026) (Figure
2.6).
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Figure 2.6. Appetite withdrawal symptoms before and after an acute bout of exercise
for women that met inclusion criteria at each time point (week five n = 69, heart-rate
[HR] ≥ 50% of heart-rate reserve [HRR]; week 11 n = 37, HR ≥ 70% of HRR; week 13 n =
26, HR ≥ 70% of HRR).

2.3.2 Did the magnitude of withdrawal relief experienced following
exercise relate to end of programme abstinence?
There was no difference in the magnitude of change in the withdrawal
subscales experienced following an acute bout of exercise at week
five between women classified as non-smokers at week 14 and smokers
at week 14 (Figure 2.7).
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Figure 2.7. The magnitude of change in withdrawal symptoms following an acute
bout of exercise for women who that met inclusion criteria at week five. Smoking (n =
22) vs. non-smoking (n = 47) status is as at week 14. A negative score denotes a
reduction in symptoms; a positive score denotes an increase in symptoms.

2.3.3 Smoking cessation outcomes
Fifty eight percent (n = 69) of participants were able to quit smoking on
the week four quit date (CO < six ppm). At the end of the programme
(week 14) 51.3% of participants were considered smoke free (CO < six
ppm). Smoking abstinence was related to attendance to the exercise
programme (x2[2, n=119] = 52.27, p < .001) (Table 2.3).
Participants smoking at week 14 (M=4.19, SD=1.45) experienced greater
craving prior to exercise than those considered smoke-free at week 14
(M=3.43, SD=1.48) (t = -2.007, p < .05).
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Table 2.3. Breakdown of participants smoking status at week 14 in relation to
attendance to the exercise portion of the programme (n = 119)
Exercise Programme Attendance
80-100%
60-80%
<60%
Non-smoking at week 14
Number of participants
Percent of total
Smoking at week 14
Number of participants
Percent of total

Total

45
37.8%

12
10.1%

4
3.4%

61
51.3%

7
5.9%

17
14.3%

34
28.6%

58
48.7%

2.4

Discussion

2.4.1 Craving and withdrawal
The present study examined the potential of exercise to reduce
withdrawal symptoms and cigarette cravings related to smoking
abstinence. The results were obtained in a design that overcame
numerous limitations of previous acute exercise and smoking cessation
research (e.g., a more ecologically valid setting, used NRT, true quit
attempt) and made several novel contributions to the literature.
Results of the present study indicate that an acute bout of moderate to
vigorous intensity aerobic exercise can reduce symptoms of nicotine
withdrawal and cigarette craving early in the quit attempt of women
trying to give up cigarettes. Three to five days into the quit attempt,
exercise reduced craving and withdrawal for individuals on NRT. These
first few days and weeks of the quit attempt often determine success or
failure (Shiffman, Paty, Gnys, Kassel, & Hickcox, 1996). These findings
demonstrate that early in a quit attempt, exercise is a useful tool for the
kit of a smoker attempting to quit; a tool that does not become
redundant in the presence of NRT. In exercise, tobacco treatment
specialists have an evidence based adjunct therapy to recommend for
reducing craving and withdrawal symptoms during this critical time in
their quit attempt.

66
The results suggest that there may be a timing effect for exercise. That
is, it may have the greatest effect during the early stages of a quit
attempt. However, seven and nine weeks into the quit attempt (week
11 and 13 of the programme) the beneficial effects of exercise were still
visible, although they were not always significant. These results
correspond with those demonstrated by Bock et al. (1999). These
researchers also found a reduction in craving and withdrawal following
exercise for the majority of the weeks they measured it. The important
distinction between their work and the present study is the absence of
NRT. No doubt when used appropriately, over time NRT improves
abstinent rates. Perhaps, NRT so effectively controlled withdrawal
symptoms later in the quit attempt that exercise no longer made a
significant contribution. Nevertheless, the effect size for overall
withdrawal at week 13 (.128) was large

enough

to warrant

recommending exercise at any point in the quit attempt. In addition,
the decrease in craving demonstrated at all time points justifies
promoting exercise as a strategy for dealing with cue-elicited cigarette
cravings.
Craving can be conceptually compartmentalised into two categories cue-induced craving and background craving. Clinically, craving is
one of the most common symptoms that smokers are concerned
about and the average intensity level of craving an abstinent smoker
experiences in the first few days or weeks of the quit attempt often
predicts quit success (Shiffman et al., 1996). The identification of
adjunct quit smoking therapies to address both types of craving is of
clinical importance.
Exercise has been shown to ameliorate cue-induced craving in
temporarily abstinent smokers (Janse Van Rensburg, Taylor, Hodgson, &
Benattayallah, 2009; Taylor & Katomeri, 2007). In a laboratory setting,
exercise has the potential to reduce an individual’s cigarette craving
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reactions to a smoking related cue and delay ad libitum smoking. Cueinduced, or episodic cravings, are generally conceptualised as bouts
of intense craving characterised by a surge in craving usually triggered
by exposure to stimuli associated with smoking (Ferguson & Shiffman,
2009). In this case, no such stimuli was presented and, when
participants entered the facility, the craving they were experiencing
was not greatly spiked, as evident by the before exercise craving
scores at all time points. Therefore, it seems reasonable to suggest that
background craving was being assessed and that early on in a quit
attempt exercise has the ability to at least temporarily reduce
background craving. This finding is novel for two reasons. First, up until
now, research evidence suggested that exercise was useful for
reducing episodic craving but provided limited protection against
background craving. Second, it highlights the potential of exercise as a
harm reduction strategy – extending the period of time between
cigarettes and effectively reducing the number of cigarettes smoked in
a day (deRuiter & Faulkner, 2006).
A review of the acute exercise and smoking literature suggests that a
single session of exercise has the ability to reduce craving, withdrawal
and negative affect (Taylor et al., 2007). The DSM-IV lists eight
symptoms related to nicotine withdrawal (depressed mood, insomnia,
irritability, anxiety, difficulty concentrating, restlessness, decreased heart
rate, increased appetite or weight gain) (American Psychiatric
Association, 1994) and exercise has been shown to acutely reduce
many of these (Taylor & Katomeri, 2007). However, it is important to
note that exercise does not consistently alleviate these symptoms. For
example, Ussher and colleagues (2001) found that 10 minutes of
moderate

intensity

exercise

reduced

the

symptom

of

poor

concentration, whereas Janse Van Rensburg et al. (2008), using the
same duration and intensity, did not (Janse Van Rensburg & Taylor,
2008; Ussher, Nunziata, Cropley, & West, 2001). The results of the present

68
study also suggest that an acute bout of exercise may reduce some
nicotine withdrawal symptoms to a greater extent than others.
Within the present study the withdrawal symptoms were broken down
into four categories: psychological symptoms, physical symptoms,
appetite, and sedation. This made it possible to specify which
withdrawal constructs exercise was able to ameliorate and at what
stage in the quit attempt.
Research supports the psychological mood enhancing benefits of
acute exercise within the general adult population (Biddle, 2000). The
same also seems to be true for female smokers undergoing a quit
attempt (Bock et al., 1999). The present study demonstrated that an
acute bout of both moderate and vigorous exercise is an effective way
to reduce psychological withdrawal symptoms at the beginning and
throughout a quit attempt. At week 13 of the programme the results
were non-significant. This may be a result of the combination of
variables that made up psychological withdrawal on the ShiffmanJarvik scale. For instance, the withdrawal symptoms of irritability and
concentration

both

contributed

to

this

variable.

As

previously

mentioned exercise does not consistently reduce concentration
difficulties associated with quitting; a lack of effect in this instance
would have diminished any significant psychological withdrawal effect.
An alternative explanation is that the sample size at week 13 was too
small for a significant difference to be detected, considering the size of
the effect (.115) this is definitely possible.
Amongst the general population vigorous intensity exercise has been
shown to suppress appetite (Blundell & King, 2000). It is very common for
women to gain weight when they quit smoking (average five
kilograms) (Parsons, Shraim, Inglis, Aveyard, & Hajek, 2009). For many
women this weight gain is unacceptable and drives them back to
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smoking (Schneider & Waters, 2007). Identifying adjunct therapies that
can assist quitters trying to avoid weight gain is essential. To our
knowledge only one other study has assessed the effect of exercise on
the self-reported withdrawal symptom of appetite (Ussher et al., 2001).
These researchers found exercise had no effect on appetite, perhaps
because they used a less than vigorous intensity exercise protocol.
However, the present study found similar results to that of Ussher et al.
(2001) when quitters were exercising at both moderate and vigorous
intensities. Exercise interventions for smoking cessation do not always
report a reduction in post cessation weight gain at the end of the
programme (Ussher et al., 2008). If exercise does not effectively reduce
the increase in appetite experienced during quitting then potential
weight reduction benefits may be thwarted by powerful food cravings.
Further research is needed to determine whether exercise leads to a
delay in snack foods high in fat and sugar content (Thayer, Peters III,
Takahashi, & Birkhead-Flight, 1993).
Following an acute bout of both moderate and vigorous intensity
exercise

participants

experienced

an

increase

in

the

physical

symptoms associated with withdrawal. This finding is most likely a result
of the question ‘is your heart beating faster than usual’. As you would
expect following a bout of moderate to vigorous intensity exercise
participants answered yes to this question. Perhaps of clinical
importance is determining individual differences, which may influence
recommending

exercise

as

an

adjunct

therapy.

For

instance,

individuals who suffer from anxiety or panic disorders, of which a rapid
heartbeat is a distressing symptom, may benefit from reassurance that
an increased heartbeat is a normal consequence of exercise
(American Psychiatric Association, 1994). Furthermore, it has been
suggested that because the decrease in heart-rate is most likely an
offset effect (due to less nicotine in the body), there is no relevance for
using heart-rate decrease to assess withdrawal (Shiffman et al., 2004).

70
Hence, the inclusion of heart-rate questioning in the Shiffman-Jarvik
scale may be perceived as a limitation of this assessment.
Within the smoking and exercise literature, Taylor and colleagues (2006)
reported increases in energy following a one mile brisk walk amongst
temporarily abstinent smokers; and Thayer et al. (1993) demonstrated
that immediately following five minutes of brisk walking, smokers’
energy levels were increased (Taylor, Katomeri, & Ussher, 2006; Thayer
et al., 1993). The present study demonstrated that following an acute
bout of moderate or vigorous intensity exercise the physical withdrawal
symptom of sedation was significantly reduced. Smokers who quit are
often plagued by extreme fatigue (TTS, 2010). Present study findings
combined with previous research indicate that exercise has great
potential to alleviate this debilitating withdrawal symptom.
The current study involved abstinent smokers engaging in both
moderate and vigorous intensity exercise. Bock and colleagues (1999)
demonstrated that vigorous exercise has the ability to produce acute
improvements

in

withdrawal

symptoms,

cigarette

craving,

and

negative affect among sedentary women attempting to quit smoking.
In comparison, other studies have found vigorous intensity exercise
increased withdrawal symptoms in young, adult, sedentary smokers
whereas moderate intensity did not (Everson, Daley, & Ussher, 2008).
It was demonstrated that early in a quit attempt involving NRT a bout of
moderate intensity exercise was enough to reduce craving and
withdrawal symptoms. Later on in the quit process, once smokers
garnered some exercise experience, vigorous intensity exercise
continued to reduce craving and some withdrawal symptoms.
Unfortunately, as the two intensities of exercise occurred at such
different times in the quit attempt it was not possible to directly
compare intensity effects. It is however possible to infer that an exercise
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programme that moves individuals from moderate through to vigorous
intensity exercise is feasible. If recently quit smokers can leave a
structured exercise programme working out at a vigorous intensity then
they have a health advantage over those who leave at a moderate
intensity (CSEP). Future research should compare the effects of
moderate versus vigorous intensity exercise at different points during
the quit attempt.
2.4.2 Magnitude of acute exercise relief as a factor of quit success
The acute exercise paradigm more often than not involves a smoker
undergoing a period of temporary abstinence before engaging in
exercise. It is assumed from these experimental studies that measures of
cigarette craving and nicotine withdrawal symptoms provide a
prediction of how well exercise works to keep people off cigarettes
(Taylor & Katomeri, 2007). However, a disconnect exists within the
literature; whereas temporarily abstinent smokers in an acute setting
show a reduction in craving and withdrawal symptoms long-term
exercise interventions do not reliably boost smoking abstinence rates
(Fiore et al., 2008; Taylor et al., 2007; Ussher et al., 2008).
This study attempted to bridge the gap between these two bodies of
research and investigate a possible mechanism responsible for the
beneficial effects of exercise. The magnitude of craving and
withdrawal relief experienced did not differ between successful and
unsuccessful quitters (in an NRT and exercise programme). This finding
highlights the complexity of quit success and suggests that numerous
factors are involved in determining an individual’s quit status.
Craving ratings are a reliable indicator of relapse (Shiffman et al., 1996).
Indeed, the present study showed that those who would eventually
relapse by the end of the programme started out with higher cigarette
cravings following initial smoking abstinence. The findings suggest that
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the benefits of exercise are not discriminatory. If the effort is made to
exercise during abstinence, regardless of background craving levels,
most individuals will experience some acute craving relief. This implies
that health practitioners can confidently recommend exercise as a
cessation aid to any woman attempting to quit and know that in all
likelihood she will experience some acute craving relief. In addition,
irrespective of smoking outcome, increases in physical activity should
be seen as an important outcome in its own right (deRuiter & Faulkner,
2006).
2.4.3 Limitations
As with any research, there are limitations to this study that are worth
noting. The fact that the present study did not include an equal
contact control group is a limitation. As such, it cannot be said for
certain that any reduction in craving and withdrawal following exercise
was specifically related to exercise and not to other environmental
factors such as group interaction. However, the main aim was not to
determine how well an acute bout of moderate-vigorous intensity
exercise reduces craving and withdrawal, as this is reasonably well
established, but to determine what factors might be related to exercise
effectiveness; and whether exercise reduces craving and withdrawal
when on NRT. Regardless, in the future it may be advantageous to
have a standard treatment control condition (e.g., NRT plus cognitive
behavioural therapy) (Bock et al., 1999).
The findings from the present study are only generalisable to female
smokers who managed to use NRT. A large number of individuals were
excluded from the analyses because they were not considered smoke
free at the time of the intervention. The women included in the week
five analyses had a mean Fagerström nicotine dependence score of
5.65, which is considered a medium level of dependence. It may be
that this type of intervention in general is more suited to individuals who
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are only moderately dependent on nicotine and who can tolerate
both regular exercise and NRT use.
Finally, there were many criteria that had to be met (e.g., CO < six
ppm, on NRT, came for exercise) before an individual was included in
the dataset. The strict inclusion criteria invariably led to a small sample
size by week 13, which resulted in the analyses being underpowered.
2.4.4 Future direction
A number of important research questions remain unanswered. For
example, the duration of craving and withdrawal relief experienced
following the exercise bout was not assessed. Therefore, it remains
unclear as to how long post exercise relief persists. Determining the
duration of relief exercise provides would help provide insight into the
clinical relevance of this type of adjunct as a harm reduction
technique.
The present study determined that it is not just the craving and
withdrawal relief experienced from a bout of exercise per se that
makes exercise a useful tool for quitters. Future research should
continue to explore the mechanisms underpinning the beneficial
effects of exercise. Determining how exercise works and for whom
would allow clinicians to prescribe this cessation aid more effectively.
2.4.5 Conclusions
Promoting exercise among individuals using NRT is appropriate; and
can reduce withdrawal and craving symptoms associated with
smoking abstinence. The findings demonstrate that exercise can
alleviate negative withdrawal symptoms and cigarette cravings at any
point during the quit attempt but is of upmost importance early on in
the quit. It is important for clinicians recommending exercise to consider
the potential benefits (e.g., will help with craving) and limitations (e.g.,
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may not help with all psychological withdrawal symptoms) of exercise
as a quit smoking aid. The magnitude of the relief felt does not translate
to nicotine abstinence success in a 14 week exercise and NRT aided
smoking cessation programme. Knowledge of these mechanisms is vital
as it offers precise guidance and understanding for both the health
professional and quitter. No matter what the mechanism, the
immediate relief that female quitters experience following exercise are
concrete and universal.
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3 CHAPTER THREE: EXERCISE MAY HELP SMOKERS QUIT
BECAUSE THEY EXPECT IT WILL AND BECAUSE THEY
BELIEVE IT IS A CREDIBLE QUIT SMOKING AID

3.1

Introduction

There is much research to suggest that moderate intensity exercise has
a positive acute effect on cigarette craving and withdrawal symptoms
in temporarily abstinent smokers (Taylor, Ussher, & Faulkner, 2007). The
magnitude of reduction in craving and withdrawal reported in these
experimental studies shows an acute bout of exercise to be at least as
effective as oral nicotine replacement therapy (NRT) (Taylor et al., 2007;
West & Shiffman, 2001). However, while there is enough evidence to
support clinicians recommending exercise as an adjunct therapy to
reduce nicotine craving and withdrawal, there remains scope for
improving its effectiveness.
One way to improve the effectiveness of exercise interventions is to
identify modifiable factors accountable for the influence of exercise on
craving and withdrawal. Beliefs related to treatment credibility and
expectancy have been proposed as two such factors in other
treatable conditions, such as chronic lower back pain and generalised
anxiety disorder (Newman & Fisher, 2010; Smeets, Beelen, Goossens,
Schouten, Knottnerus, & Vlaeyen, 2008). These two variables have been
shown to be distinct from one another. Credibility refers to how
believable, convincing, and logical the treatment seems whereas
expectancy refers to treatment outcomes the individual believes or
hopes will take place (Kazdin, 1979). Both definitions involve beliefs,
which are thought to consist of cognitive and affective components
(Devilly & Borkovec, 2000). It is proposed that credibility beliefs are
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cognitive in nature whereas expectancy beliefs are affective, similar to
those involved in hope (Devilly & Borkovec, 2000).
Patient expectancy and credibility has been shown to influence
treatment outcomes in a number of populations. For example, Smeet
and

colleagues

(2008)

showed

that

treatment

credibility

and

expectancy had modest predictive power when it came to treatment
outcomes for sufferers of chronic lower back pain (Smeets et al., 2008).
Newman and Fisher (2010) found evidence for their hypothesis that
positive changes in expectancy and credibility with regards to
cognitive behavioural therapy led to positive symptom changes in
those suffering from generalised anxiety disorder (Newman & Fisher,
2010). In terms of exercise specifically, it has been proposed that
expectancy of the benefits of exercise on mood may influence actual
changes in mood following exercise (Salmon, 2001). As an example,
Desharnais et al. (1993) conducted an experiment to determine if the
exercise-psychological enhancement connection was based on
expectancy. They found that following 10 weeks of supervised exercise
the control group and experimental group (received information that
exercise enhances psychological well-being) had the same fitness
improvements. However, the experimental group showed a significant
increase in self-esteem over time whereas the control group did not
(Desharnais, Jobin, Cote, Levesque, & Godin, 1993). Research on
whether credibility beliefs are involved in the actual mood enhancing
benefits of exercise does not seem to have been conducted.
Given the research on the psychological constructs of expectancy and
credibility it seems reasonable that these beliefs may be associated
with the effects of exercise on craving and withdrawal outcomes in an
exercise aided quit smoking programme. Daniel and colleagues (2007)
have published the only known study to investigate exercise
expectations and specific craving and withdrawal outcomes. These
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researchers examined whether expectations of the effects of exercise
would relate to reductions in cigarette craving and withdrawal in
temporarily abstinent smokers following a 10 minute bout of moderate
intensity exercise (Daniel, Cropley, & Fife-Schaw, 2007). Forty five
sedentary smokers were randomised into one of three groups where
they read either a positive, negative or neutral statement concerning
the effects of exercise on the withdrawal symptoms associated with
smoking abstinence; the

manipulation of participants’ exercise

expectations was deemed successful. Immediately prior to reading the
expectancy

text

and

completing

a

credibility

questionnaire,

temporarily abstinent smokers engaged in 10 minutes of moderate
intensity exercise. Regardless of group, all participants showed a
significant reduction in cigarette craving and withdrawal symptoms
(e.g.,

irritability,

depression,

tension,

restlessness,

stress,

difficulty

concentrating) following the bout of exercise. This led these researchers
to conclude that “expectations of the effects of exercise on withdrawal
and desire to smoke does not influence actual reductions in withdrawal
symptoms and desire to smoke” (p. 129). However, the conclusion
reached by Daniel et al. (2007) requires further investigation before it
can be accepted confidently.
The results of Daniel et al. (2007) were based on the manipulation of
expectancy but measured on a credibility scale. Though the terms
expectancy and credibility are sometimes used interchangeably there
is evidence to suggest that these two constructs are distinct (Devilly &
Borkovec, 2000). As such, distinguishing between these two constructs is
important (Devilly & Borkovec, 2000). In addition, the results were
garnered from a group of temporarily abstinent smokers rather than a
group of quitters. Therefore, the severity of symptoms experienced may
not correspond entirely with those felt when an individual is fully
invested in their quit attempt. As such, it is not possible to generalise
these findings to smokers undergoing a real quit attempt. Finally, Daniel
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et al. (2007) manipulated exercise expectancy beliefs through text and
categorised smokers as either: high, ambiguous or low in expectancy.
External validity might be improved by measuring actual exercise
expectancy of smokers and categorising them accordingly (Newman
& Fisher, 2010). All things considered, the results obtained by Daniel et
al. (2007) do not definitively rule out expectancy effects as a possible
mechanism for the reductions in craving and withdrawal demonstrated
following an acute bout of exercise.
The primary objective of the present study was to examine whether
treatment expectancy and credibility were associated with outcome in
terms of self-reported craving and withdrawal in a group of women
undergoing a real quit attempt. The women involved were supplied
with NRT patches as well as an exercise regimen. Thus providing the
opportunity for the secondary objective, to compare expectancy and
credibility beliefs regarding a well established quit smoking aid such as
NRT with a novel quit smoking aid such as exercise. Furthermore, rather
than only assess treatment expectancy and credibility before the start
of the treatment, when participants may have difficulty judging their
actual beliefs regarding treatment outcomes; the present study
allowed

for

the

measurement

of

participants’

credibility

and

expectancy beliefs of two treatments (exercise and NRT) immediately
after quitting and at the end of the 14 week programme (Smeets et al.,
2008).
It was hypothesised that exercise expectancy and credibility beliefs
would contribute to a reduction in craving and withdrawal symptoms
following an acute bout of exercise. It was also hypothesised that as
participants progressed through the NRT plus exercise aided quit
smoking programme their exercise expectancy and credibility beliefs
would increase.
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3.2

Methods

3.2.1 Participants
Participants included 58 females undertaking the third round of the
Getting Physical on Cigarettes (GPOC) trial (Jung, Fitzgeorge,
Prapavessis, Faulkner, & Maddison, 2010). The inclusion and exclusion
criteria were the same as that outlined in section 2.2.1.
3.2.2 Ethical approval
See section 2.2.2 for details.
3.2.3 Design
3.2.3.1 Getting Physical on Cigarettes
See section 2.2.3.1 for details. The 58 women who took part in the
present study all took part in the GPOC trial.
3.2.3.2 The Exercise and Health Psychology Laboratory
See section 2.2.3.2 for details.
3.2.3.3 General procedure
The present study examined whether participants’ expectancy and
credibility beliefs regarding exercise as a smoking cessation treatment
were associated with change, from pre- to post-exercise, in selfreported cigarette craving and withdrawal symptoms (psychological
and sedation) at week five. This study also compared participants’
expectancy and credibility beliefs regarding NRT and exercise over a
14 week exercise aided smoking cessation programme.
Participants engaged in a 14 week exercise programme, GPOC (Jung
et al., 2010), at the Exercise and Health Psychology Laboratory at the
University of Western Ontario. On the fourth week of the exercise
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programme participants began a smoking cessation attempt, and a 10
week NicoDerm® NRT transdermal patch programme. Pre-intervention
assessments were completed before week one, at baseline; postintervention assessments were completed on a date after the
participants’ last exercise session, when they had finished the NRT
programme, on week 14. A flow-chart of the research design is
displayed in Figure 3.1 and a timeline of the measurements and
assessments in Table 3.1.
The acute bout of exercise under investigation occurred on the first
exercise session on week five, shortly after the participants quit smoking
and started NRT (week four). Participants completed the ShiffmanJarvik Withdrawal Scale (Shiffman & Jarvik, 1976) immediately prior to
and following the 20 minute moderate intensity exercise session.
Change in nicotine craving and withdrawal symptoms due to an acute
bout of exercise was determined by comparing Shiffman-Jarvik
subscale scores pre- to post-exercise. To be eligible for this analysis,
participants had to demonstrate a carbon monoxide score of < six
ppm, adhere to their NRT programme, and follow their acute exercise
regime at the appropriate intensity.
Questionnaires pertaining to participants’ perceived expectancy and
credibility of the two smoking cessation aids (exercise and NRT) were
completed immediately before the first exercise session on the
appropriate week (Table 3.1). To be eligible for analyses, the
participants had to adhere to the NRT programme, and follow the
exercise regime.
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Table 3.1. Schedule of Assessments

Quit Smoking

Week
Base4 5
line
X

Demographics Questionnaire
Smoking Ladder
Exercise Readiness

X
X
X

Treatment Expectancy and Credibility Scale

X

X

Acute Exercise Regimen
Shiffman-Jarvik Withdrawal Scale (pre-exercise)
Shiffman-Jarvik Withdrawal Scale (post-exercise)
Smoking Variables
Carbon Monoxide Assessment
Fagerström Nicotine Dependence
Smoking Information
Previous Patch Use

14

X

X
X
X

X
X
X
X

X

X

X

Exercise Variables
Actical Exercise Behaviour
X
Godin Lesiure Time Questionnaire
X
X
X
X
Peak VO2 Fitness Assessment
Note. Baseline refers to pre-trial and week 14 refers to post-trial. Participants began
their smoking cessation attempt and nicotine replacement therapy (NRT) on week
four (quit week).
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Figure 3.1. Research
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commend
dations.
3.2.5.1 NiicoDerm® three step
p program
mme
See sectio
on 2.2.5.1 for details.
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3.2.5.2 NicoDerm® two step programme
See section 2.2.5.2 for details. Seven of the 58 participants were on the
two step programme.
3.2.6 Demographic measures
See section 2.2.6 for details. These variables are described in Table 3.2.
3.2.6.1 Nicotine dependence and other smoking characteristics
See section 2.2.6.2 for details. These variables are described in Table
3.2.
3.2.6.2 Previous patch use
Participants were asked whether they had used the nicotine
replacement therapy patch in the past, the number of quit attempts it
was used with and whether they found it enhanced their previous quit
attempt. These variables are described in Table 3.2.
3.2.6.3 Programme adherence
See section 2.2.6.1 for details.
3.2.6.4 Smoking ladder scale
The smoking ladder scale was administered at baseline and used to
determine whether or not a participant was ready to quit smoking
(Biener & Abrams, 1991; Prochaska & DiClemente, 1983). This scale
separated smokers into one of five categories of varying degrees of
readiness to quit, and is based on the stages of change: precontemplation (one and two on the ladder); contemplation (three and
four on the ladder); preparation (five and six on the ladder);
maintenance (seven and eight on the ladder); and action (nine and 10
on the ladder). Ten statements were presented (two based on each
stage) and participants were asked to tick only one statement – the
statement that best described their current thoughts about quitting
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smoking. These variables are described in Table 3.2. See Appendix 5 for
a copy of this questionnaire.
3.2.7 Physical activity behaviour
3.2.7.1 Godin leisure time exercise questionnaire (LTEQ)
Subjective accounts of exercise behaviour were obtained via the
Godin LTEQ at baseline and week 14 assessments. The Godin LTEQ
measured exercise specifically, covering the frequency of mild,
moderate and strenuous exercise performed during free time for at
least 15 minutes during the past seven days. A total score was derived
by summing the reported weekly frequency (f) of participation at each
of the three intensity levels multiplied by the corresponding estimated
metabolic equivalents (METs) value (e.g., [f]3 [mild] + [f]5 [moderate] +
[f]9 [strenuous]). A MET is a unit that represents the metabolic
equivalent of an activity expressed in multiples of resting rate of oxygen
consumption (CSEP). These variables are described in Table 3.2. See
Appendix 6 for a copy of this questionnaire.
3.2.7.2 Actical® accelerometer
See section 2.2.7.1 for details. Only the pre-intervention results for this
objective measure of exercise behaviour were collected and
presented. This variable is described in Table 3.2.
3.2.7.3 Peak VO2 fitness assessment
See section 2.2.7.2 for details. These variables are described in Table
3.2.
3.2.7.4 Stage of exercise readiness questionnaire
The stage of exercise readiness questionnaire was administered at
baseline and used to determine whether or not a participant was
physically active on a regular basis (Prochaska & DiClemente, 1983).
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This questionnaire separated people into one of five categories of
varying degrees of exercise behaviour: pre-contemplation – do not
exercise on a regular basis and are not thinking about changing in the
next six months, contemplation – do not currently exercise on a regular
basis but are thinking about changing in the next six months,
preparation – exercise sometimes but not on a regular basis,
maintenance – exercise regularly and have been doing so for the last
six months, or action – exercise regularly and have done so for longer
than six months. Five statements were presented (one based on each
stage) and participants were asked to tick only one statement – the
statement that best describes their current physical activity behaviour.
The SERQ has a demonstrated reliability of 0.78 when taken over a two
week period (Marcus, Rakowski, & Rossi, 1992). This variable is described
in Table 3.2. See Appendix 7 for a copy of this questionnaire.
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Table 3.2. Demographic characteristics, exercise and smoking behaviour.
Variable
Demographics:
Age
Language spoken at home (% English)
Married
Yearly household income:
Below $50,000
Between $50,000 and $75,000
Above $75,000
Number of children
Occupation:
Employed
Student
Unemployed
Value quitting smoking at baseline (one - nine)
Four – six = somewhat
Seven – nine = extremely
Readiness for Change:
Cessation Readiness:
Pre-contemplation
Contemplation
Preparation
Action
Maintenance
Exercise Readiness:
Pre-contemplation
Contemplation
Preparation
Action
Maintenance
Exercise behaviour:
Objective physical activity (Actical)
Pre-intervention (minutes per week MPVA)
Pre-intervention (number of bouts > 10 minutes)
Self-report physical activity (Godin)
Pre-intervention (metabolic equivalent)
Post-intervention (metabolic equivalent)
Peak VO2 (ml/kg/min):
Pre-intervention
Post-intervention
Carbon monoxide (CO) reading:
Pre intervention (baseline)
Post intervention (14 weeks)
Smoking behaviour:
Cigarettes per day
Number of years smoking

Mean (SD), %

42.72 (13.43)
96 %
32 %
56 %
11 %
33 %
1.89 (2.35)
73 %
13 %
14 %
2%
98%

0%
0%
53 %
40 %
7%
0%
51 %
35 %
7%
7%

99.50 (73.31)
0.80 (1.54)
18.22 (17.13)
39.69 (21.86)
23.23 (6.32)
31.16 (6.82)
11.96 (9.25)
6.83 (11.07)
17.80 (8.24)
22.54 (12.93)
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Fagerström test of nicotine dependence
Percentage of family and friends that smoke:
Between 0 and 10%
Between 10 and 20%
Above 20%
Number of previous quit attempts
Previously tried to quit smoking with nicotine patch
Previous quit attempts with nicotine patch:
One
Two
Three
Four

5.02 (2.16)
32 %
14 %
54 %
6.49 (14.54)
51%
56%
26%
9%
9%

3.2.8 Outcome Measures
3.2.8.1 Treatment expectancy and credibility questionnaire
The treatment expectancy and credibility questionnaire (ECQ) was
developed by Devilly and Borkovec (2000) and adapted for use in the
current study. The original showed good internal consistency and good
test-retest reliability (Devilly & Borkovec, 2000).

The participant was

asked to judge whether she thought or felt that the treatment would
help her to quit smoking. The ECQ consisted of seven items. Items one,
two, and three in set I, relate to the construct of credibility and are
considered ‘think’ items. Item four from set I, and items one and two
from set II, relate to the construct of expectancy. Expectancy item four
was a ‘think’ item and items one and two were ‘feel’ questions. In
addition, item five was a measure of how valued the outcome of
quitting smoking was to the individual. The ECQ used a nine point scale,
and responses to questions were either one (not at all) to nine
(extremely), or one (none) to nine (all). For each question (except
question five) participants had to provide a response for both exercise
and NRT. To examine change over time, the CEQ was administered at
baseline, week five, and week 14. Reliability analyses (Cronbach’s
alpha scores) were computed for EX-EXP, EX-CRED, NRT-EXP, and NRTCRED at these time points. All alpha values reflected an acceptable
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level of reliability and are presented in Appendix 16 (Kline, 1993). See
Appendix 9 for a copy of this questionnaire.
3.2.8.2 Smoking withdrawal
See section 2.2.8.1 for details of the Shiffman-Jarvik withdrawal scale.
Only the craving, sedation, and psychological symptoms subscales
were analysed. The rationale was that only these variables exhibited
pre- to post-exercise change in study one (chapter two). Reliability
analyses (Cronbach’s alpha scores) were computed at week five,
using the before acute exercise session raw data for the constructs of
craving and psychological symptoms. All alpha values reflected an
acceptable level of reliability and are presented in Appendix 16 (Kline,
1993).
The scale was administered immediately before and after the acute
exercise session on week five; only data pertaining to those participants
who reached the exercise intensity goal, followed the NRT protocol,
and abstained from smoking were included in the analyses. Data were
expressed as a magnitude of change (pre- to post-exercise) reduction
score.
3.2.8.3 Smoking abstinence
See section 2.2.1.1 for details.
3.2.9 Challenges and considerations
3.2.9.1 High versus low exercise expectancy and credibility
Participants were categorised as either ‘high’ or ‘low’ in terms of their
perceptions of exercise credibility and expectancy as a smoking
cessation treatment. The categories were developed using the cut
point function in the IBM SPSS Statistics 19 software. The number of cut
points chosen was one. The low group (credibility and expectancy)
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was only low relative to the high group (M [low group] = 6.93 vs. M [high
group] = 8.71, credibility; M [low group] = 7.01 vs. M [high group] = 8.80,
expectancy). Descriptive statistics for the high and low exercise
credibility and expectancy groups can be found on Table 3.3.
3.2.9.2 Physical activity measurement
Due to the time frame of the research it was not possible to obtain an
objective measurement of post-intervention physical activity behaviour
for this group of participants. Therefore, in terms of post-intervention
physical activity behaviour only self-report data was available and
reported in this study. It has been demonstrated that people tend to
over report their physical activity data when they self-report, making it
a less accurate measurement of physical activity than when
objectively measured (Taber, Stevens, Murray, Elder, Webber, Jobe, &
Lytle, 2009).
3.2.9.3 Smoking abstinence
See section 2.2.2.1 for details.
3.2.9.4 Nicotine replacement therapy
See section 2.2.2.3 for details. Specific to this group of women, four
participants opted to take the patch off while sleeping. These
participants were warned that their nicotine levels would be decreased
in the morning and withdrawal symptoms and cravings may be higher.
Data from these individuals were included in the analyses if the
participants met the smoking abstinence and exercise intensity
requirements.
3.2.9.5 Participant retention
Although no costs were incurred to the participants for the use of the
exercise equipment, NRT, or for campus parking, retention of
participants for 14-weeks was a challenge. Despite contact via
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telephone and email to keep participants in the trial, participant dropout occurred. Participants who dropped out prior to week 14
assessments and/or did not attend week 14 assessments were
considered to be smoking post-intervention.
The number of participants differed from week to week due to attrition
and absenteeism. A total of 28 participants provided continuous
(baseline, week five, week 14) abstinent smoker questionnaire data;
nine participants provided continuous (baseline, week five, week 14)
non-abstinent smoker questionnaire data.
3.2.10 Power calculation
20 participants would be required in both the high and low expectancy
groups to provide power of 80% (p < 0.05) to detect a 1.1 mean
difference (SD – 1.2) between groups (pre- to post-exercise) for
cigarette cravings.

Hence, if the low expectancy group has a 0.7

magnitude of change pre- to post-exercise, the high expectancy
group must have a 1.8 magnitude of change to detect a significant
difference. No power calculation was computed for the exploratory
question

–

comparing

between

participants’

expectancy

and

credibility beliefs regarding NRT and exercise over a 14-week NRT plus
exercise aided smoking cessation programme.
3.2.11 Statistical analyses
Separate repeated ANOVAs were used to analyse differences
between the high and low expectancy groups in cigarette craving and
psychological withdrawal pre- to post-exercise for the acute exercise
session at week five. Separate repeated ANOVAs were also used to
analyse differences in the expectancy and credibility constructs of
exercise and NRT at different time points (baseline, week five, week 14),
and to determine change over time. Univariate ANOVAs were
conducted to compare week 14 EX-EXP between smokers and non-
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smokers, and differences between week 14 EX-CRED with NRT-CRED for
non-smokers. Pearson product moment correlations were used to
examine relationships between EX-EXP, EX-CRED, NRT-EXP, NRT-CRED,
NRT patch experience, and exercise programme attendance. Planned
comparison t-tests were used to compare baseline exercise variables to
week 14 exercise variables. A chi-square was used to determine the
relationship between week 14 smoking abstinence and exercise
programme adherence.
3.3 Results
3.3.1 Does the magnitude of withdrawal relief relate to exercise
expectancy and exercise credibility beliefs?
Exercise expectancy and exercise credibility scores at week five were
highly correlated (n = 47, r = .847, p < .001 [2-tailed]). Descriptive
statistics for the high and low2 EX-EXP and EX-CRED groups are
presented in Table 3.3.
Table 3.3. Descriptive statistics for the classifications of high and low exercise
expectancy and credibility at week five.

LOW
HIGH

N
30
17

Exercise Expectancy
Min
Max
Mean
3.00
8.00
7.01
8.33
9.00
8.80

SD
1.14
.26

N
21
26

Exercise Credibility
Min
Max
Mean
3.67
8.00
6.93
8.33
9.00
8.71

SD
1.25
.29

Those considered high in EX-EXP at week five had a significantly greater
reduction in cigarette craving following an acute bout of exercise
when compared to those lower in EX-EXP (F[1,39] = 5.591, p < .05, η2 =
.113) (Figure 3.2). Similar results were demonstrated for EX-CRED at
week five, with those in the high EX-CRED group experiencing a greater

For ease of expression the two expectancy and credibility groups will be called high
and low. However, in this instance the low group is only low relative to the high group.
See Table 3.3 for a breakdown of the group actual frequencies.

2
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reduction in craving compared to their counterparts who were lower in
EX-CRED (F[1,44] = 6.511, p < .05, η2 = .129) (Figure 3.3).
Following an acute bout of exercise at week five, there was no
significant difference in the magnitude of reduction for psychological
or sedation withdrawal symptoms between women high in EX-EXP and
those who were low in EX-EXP (psychological: F[1,39] = 2.556, p = .117,
η2 = .055; sedation: F[1,39] = .257, p = .615, η2 = .006) (Figure 3.2). Similar
results were demonstrated for EX-CRED at week five, (psychological:
F[1,39] = 2.413, p = .127, η2 = .052; sedation: F[1,39] = 1.425, p = .239, η2 =
.031) (Figure 3.3). It is however worth mentioning that for both EX-CRED
and EX-EXP those in the high group experienced a greater reduction in
psychological and sedation withdrawal symptoms following an acute
bout of exercise.
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Figure 3.2. Change in withdrawal symptoms before and after an acute bout of
exercise at week five between recently quit smokers classified as high (n = 14) or low
(n = 27) in exercise expectancy (EX-EXP) (* p < 0.05).
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Figure 3.3. Change in withdrawal symptoms before and after an acute bout of
exercise at week five between recently quit smokers classified as high or low in
exercise credibility (EX-CRED). Craving: high (n = 25) low (n = 21); psychological and
sedation: high (n = 22) low (n = 19) (* p < 0.05).

Irrespective of EX-EXP and EX-CRED beliefs significant reductions in
cigarette craving at week five were demonstrated following exercise
for all participants regardless of week five exercise EX-EXP (n = 41) or EXCRED (n = 46) score (EX-EXP: F[1,39] = 45.952, p < .001, η2 = .541; EXCRED: F[1,44] = 50.453, p < .001, η2 = .534). Significant reductions in
psychological symptoms related to nicotine abstinence were also
demonstrated at week five following exercise regardless of EX-EXP or
EX-CRED beliefs at week five (n=41) (EX-EXP: F[1,39] = 19.941, p < .001,
η2 = .338; EX-CRED: F[1,39] = 15.181, p < .001, η2 = .280). Similarly, a
significant reduction in the nicotine withdrawal symptom of sedation
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was demonstrated at week five for all participants regardless of EX-EXP
or EX-CRED beliefs reported at week five (n=41) (EX-EXP: F[1,39] =
12.504, p < .001, η2 = .243; EX-CRED: F[1,39] = 10.153, p < .003, η2 = .207).
3.3.2 Expectancy and credibility change throughout the programme
A significant increase over time for ratings of NRT expectancy (NRT-EXP)
and exercise expectancy (EX-EXP) was demonstrated for women who
were smoke free at week 14 (CO<6ppm) (F[2,108] = 3.720, p < .05, η2 =
.064) (Figure 3.4). There was no significant group (NRT, exercise) by time
interaction (F[2,108) = .021, p = .980, η2 = .000) (Figure 3.4).

Non-Smokers Expectancy Score (1-9)

9

Exercise
NRT

8

7

6

5
Baseline

5

14

Week of Intervention
Figure 3.4. Exercise and NRT expectancy scores for women considered non-smokers at
the end of the programme (n = 28; CO < six ppm). Significant change over time for
both exercise and NRT expectancy (p < 0.05).
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A significant increase over time for ratings of NRT credibility (NRT-CRED)
and exercise credibility (EX-CRED) was demonstrated for women who
were smoke free at week 14 (CO < six ppm) (F[2,108] = 8.920, p < .001,
η2 = .252) (Figure 3.5). Overall there was no significant time by group
interaction (F[2,108] = 1.990, p = .147, η2 = .070) (Figure 3.5). Between
baseline and week 14 both EX-CRED and NRT-CRED increased; from
week five to week 14 EX-CRED reduced slightly whereas NRT-CRED
increased slightly. However, due to the exploratory nature of the
research a univariate ANOVA was conducted to determine if there was
a significant difference between week 14 EX-CRED (M – 7.399, SD –
1.659) and NRT-CRED (M – 8.016, SD – 1.125) for these non-smokers. No
significant difference was demonstrated (F[1,58] = 2.837, p = .097, η2 =
.047) (Figure 3.5).
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Figure 3.5. Exercise and NRT credibility scores for women considered non-smokers at
the end of the programme (n = 28, CO < six ppm). Significant change over time for
both exercise and NRT credibility (p < 0.05).

No significant change over time for ratings of EX-EXP were observed for
women considered smokers at week 14 (CO > six ppm) and women
considered non-smokers at week 14 (CO < six ppm) (F[2,70] = 1.068, p =
.355, η2 = .059) (Figure 3.6). Both groups of women (week 14 smokers,
non-smokers) showed a slight increase from baseline to week five for
EX-EXP and then diverged, with non-smokers demonstrating a slight
increase from week five to week 14 and smokers showing a slight
decrease from week five to week 14. However, there was no significant
difference over time between these two groups on EX-EXP (F[2,70] =
1.180, p = .319, η2 = .065) (Figure 3.6). Again, due to the exploratory
nature of the research a univariate ANOVA was conducted to
determine if there was a significant difference between week 14 EX-EXP
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for smokers (M – 7.233, SD – 1.165) and non-smokers (M – 7.799, SD –
1.176). No significant difference was demonstrated (F[1,58] = 1.748, p =
.194, η2 = .044) (Figure 3.6).

Exercise Expectancy Score (1-9)

9

Wk 14 non-smokers
Wk 14 smokers

8

7

6

5
Baseline

5

14

Week of Intervention
Figure 3.6. Exercise expectancy scores for women considered smokers (n = 9, CO > six
ppm) and non-smokers (n = 28, CO < six ppm) at the end of the programme.

A significant change over time for ratings of EX-CRED was observed for
women considered smokers at week 14 (CO > six ppm) and women
considered non-smokers at week 14 (CO < six ppm) (F[2,70] = 4.968, p <
.01, η2 = .124) (Figure 3.7). Both groups of women showed an increase
from baseline to week five for EX-CRED and a slight decrease from
week five to week 14. However, EX-CRED at week 14 for both groups
was higher than at baseline (Figure 3.7). There was no significant
difference between over time these two groups on EX-CRED (F[2,70] =
.036, p = .965, η2 = .001) (Figure 3.7).
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Figure 3.7. Exercise credibility scores for women considered smokers (n = 9, CO > six
ppm) and non-smokers (n = 28, CO < six ppm) at the end of the programme.
Significant change over time for exercise credibility (p < 0.05).

No significant change over time was demonstrated for ratings of NRTEXP for women who were smoking at week 14 and those who were not
smoking at week 14 (F[2,70] = 1.751, p = .181, η2 = .048) (Figure 3.8).
There was no significant interaction effect between smokers and nonsmokers in NRT-EXP (F[2,70] = .322, p = .726, η2 = .009) (Figure 3.8).
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Figure 3.8. NRT expectancy scores for women considered smokers (n = 9, CO > six
ppm) and non-smokers (n = 28, CO < six ppm) at the end of the programme.

A significant increase over time for ratings of NRT-CRED was observed
for smokers and non-smokers (F[2,70] = 7.355, p < .001, η2 = .174) (Figure
3.9). There was no significant interaction effect between smokers and
non-smokers in NRT-CRED (F[2,70] = .175, p = .840, η2 = .005) (Figure 3.9).
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Figure 3.9. NRT credibility scores for women considered smokers (n=9, CO>6ppm) and
non-smokers (n=28, CO<6ppm) at the end of the programme. Significant change
over time for NRT credibility (p < 0.05).

3.3.3 Were EX-EXP and EX-CRED changes over time different between
those who were high vs. low in these variables?
No significant difference in change in EX-EXP over time (baseline to
week five) was demonstrated between the low and high EX-EXP groups
(F[1,40] = 3.390, p = .073, η2 = .078). Similarly, no significant difference in
EX-CRED over time (baseline to week five) was demonstrated between
the low and high EX-CRED groups (F[1,40] = 3.320, p = .076, η2 = .077)
However, a trend effect was observed for both EX-EXP and EX-CRED,
with the high expectancy and credibility groups exhibiting a greater
increase in EX-EXP and EX-CRED than the low expectancy and
credibility groups (Table 3.4).
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Table 3.4. Baseline and week five exercise expectancy and credibility scores for high
and low exercise expectancy and credibility groups.

Baseline
Week five

Exercise Expectancy
LOW (n = 28)
HIGH (n = 14)
Mean
SD
Mean
SD
7.00
1.14
7.97
0.93
7.05
1.16
8.78
0.28

Exercise Credibility
LOW (n = 19)
HIGH (n = 23)
Mean
SD
Mean
SD
6.49
1.41
7.46
1.25
6.89
1.30
8.71
0.29

3.3.4 Correlations
No significant correlations (p > .05) were found between previous
patch use experience and NRT-EXP (baseline [r = .198]; week five [r =
.030]; week 14 [r = -.036]) or NRT-CRED (baseline [r = .150]; week five [r =
-.098]; week 14 [r = -.134]). Similarly, no significant correlations were
demonstrated between the percent of previous quit success attributed
to the patch and NRT-EXP (baseline [r = .382]; week five [r = .027]; week
14 [r = .047]) or NRT-CRED (baseline [r = .100]; week five [r = .006]; week
14 [r = .013]).
No significant correlations (p > .05) were found between exercise
programme attendance and EX-EXP (baseline [r = -.044]; week five [r =
.144]; week 14 [r = .257]) or EX-CRED (baseline [r = -.162]; week five [r =
.241]; week 14 [r = .192]).
A significant correlation (p < .05) was found between EX-CRED and
NRT-CRED (r = .447, p < .01). However, no significant correlation (p > .05)
was found between EX-EXP and NRT-EXP (r = .227).
3.3.5 Smoking cessation outcomes
48.1% (n = 38) of participants were able to quit smoking on the week
four quit date (CO < six ppm). At the end of the programme (week 14)
60.3% of participants were considered smoke free (CO < six ppm).
Smoking abstinence was related to attendance to the exercise
programme (x2[2, n = 58] = 14.758, p = .001) (Table 3.5).
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Table 3.5. Breakdown of participants smoking status at week 14 in relation to
attendance to the exercise portion of the programme (n = 58)
Exercise Programme Attendance
80-100%
60-80%
<60%
Non-smoking at week 14
Number of participants
Percent of total
Smoking at week 14
Number of participants
Percent of total

Total

27
46.6%

2
3.4%

6
10.3%

35
60.3%

6
10.3%

4
6.9%

13
22.4%

23
39.7%

3.4

Discussion

3.4.1 Exercise expectancy and credibility scores as a factor of craving
and withdrawal relief
Similar to the work of Daniel et al. (2007), participants were categorised
as either high or low in EX-EXP and EX-CRED at week five. Interestingly, it
was demonstrated that individuals who were categorised as high in EXEXP and EX-CRED had a significantly greater reduction in craving
following an acute 20 minute bout of moderate intensity exercise,
compared to those who were categorised as low in these two
variables. This finding contradicts the findings of Daniel et al. (2007), but
is in accordance with the psychotherapy outcome research that
underscores the influence of these two variables (Newman & Fisher,
2010; Smeets et al., 2008). However, no significant differences between
high and low groups were found for either psychological withdrawal, or
the withdrawal symptom of sedation, findings that concur with those
reported by Daniel et al. (2007). In addition, in accordance with Daniel
and colleagues (2007), regardless of EX-EXP and EX-CRED beliefs all
participants experienced a reduction in craving and withdrawal
following an acute bout of moderate intensity exercise. Taken together,
these findings suggest that expectancy and credibility beliefs are not a
major mechanism by which exercise reduces the debilitating effects of
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nicotine abstinence amongst both temporarily and recently quit
smokers, but they may play some role.
Overall, the findings relating to the magnitude of craving and
withdrawal relief experienced following exercise, both contradict and
corroborate those of Daniel et al. (2007). This disparity may best be
explained by examining the differences between these two studies. In
the first instance, the participants that took part in the Daniel et al.
(2007) study were required only to engage in temporary abstinence
(12-15 hours) whereas the women who took part in the present study
signed up for a 14 week exercise aided quit smoking programme.
Therefore, the women in this study were fully invested in a quit attempt
at week five of the programme, when the difference in craving
between groups was observed. In the psychotherapy literature, there is
evidence to suggest that the more invested in treatment outcomes an
individual is, the greater the influence of expectancy and credibility
beliefs on therapeutic effects (Greenberg, Constantino, & Bruce, 2006).
Recently, change in expectancy has been suggested as a mechanism
by which cognitive behavioural therapy leads to symptom change in
generalised anxiety disorder (Newman & Fisher, 2010). Within the
present paradigm, women in the high EX-EXP and EX-CRED group
demonstrated an increase in these variables from baseline to week five
whereas those in the low EX-EXP and EX-CRED groups did not. Although
this difference was not significant, it provides support for the notion that
positive changes in expectancy and credibility beliefs, in relation to
treatment, support improvement in symptoms.
The results of Daniel and colleagues (2007) were based on a
manipulated EX-EXP. In contrast, participants EX-EXP in the present
study developed throughout the five weeks they were taking part in
the intervention. As such, naturally occurring exercise expectancy
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scores in the high EX-EXP group (mean 8.8/9) were greater than those in
the Daniel et al. (2007) manipulated high EX-EXP group (mean 7.5/10).
Perhaps, to experience an added reduction in craving recently quit
smokers had to believe, almost without a doubt, that exercise would
reduce the cigarette cravings associated with nicotine abstinence.
Daniel and colleagues (2007) based their findings on the manipulation
of expectancy measured on a credibility scale. Although expectancy
and credibility beliefs may share commonalities they are essentially
different (Devilly & Borkovec, 2000). Smokers may think that a new
treatment such as exercise is credible, but this may differ from what
they really feel or expect will be the outcome of treatment. As such,
the findings of Daniel et al. (2007) may not actually be based on
participants’ expectancies and should be interpreted with caution.
In the present study participants engaged in 20 minutes of moderate
intensity exercise as opposed to 10 minutes. In the acute exercise and
smoking literature 20 minutes of moderate intensity exercise has been
shown to have a greater impact on craving and withdrawal symptoms
in temporarily abstinent smokers compared to 10 minutes of the same
intensity exercise (Taylor et al., 2007). Perhaps, duration of exercise and
EX-EXP interact in a way that impacts the influence of this variable on
craving outcomes following an acute bout of exercise.
All women in the present study were using NRT in conjunction with
exercise to help them quit smoking. Smokers in the Daniel et al. (2007)
study were only temporarily abstinent and as such were not on NRT. In
this instance, it is difficult to explain how NRT use might have influenced
the results. Previous NRT and expectancy research has demonstrated
that smokers strongly believe NRT will effectively reduce cigarette
cravings

(Juliano

&

Brandon, 2004).

Possibly, the

simultaneous

administration of exercise with NRT, a well established credible quit
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smoking aid, guided participants to believe exercise to be a relevant
and logical quit smoking aid also. That is, participants’ predictions
regarding the beneficial effects of exercise were bolstered because
they believed they could fall back on NRT. It was demonstrated that
week five EX-CRED and NRT-CRED were highly related, which supports
this notion, but it is refuted by the lack of correlation between EX-EXP
and NRT-EXP at week five. This finding also underscores the difference
between expectancy and credibility as constructs.
A number of demographic variables were different between the two
studies. For instance, women in the present study were more likely to
be: older, employed, smoking for longer, smoked more per day, and
were more heavily addicted. There were also gender differences.
Namely, the present study was a cohort of women only whereas Daniel
et al. (2007) included both men and women. It is perhaps unlikely that
any of these variables made any real contribution to the resultant
differences however it is worth acknowledging them.
EX-EXP and EX-CRED do not invariably carry the burden of craving and
withdrawal outcome following an acute bout of exercise. However,
individuals who held strong EX-EXP and EX-CRED beliefs did experience
an added reduction in cigarette craving following an acute bout of
moderate intensity exercise. The question is whether or not this added
reduction in craving is clinically relevant (Smeets et al., 2008). Cigarette
cravings are one of the most often expressed difficulties related to
quitting. The intensity of craving experienced by an abstinent smoker
over the first few days of quitting is often predictive of their success
(Ferguson, Shiffman, & Gwaltney, 2006). That being the case, every
further reduction, no matter how small, may be of clinical relevance.
Each year at least 70 percent of smokers see a physician (Fiore, Jaen, &
Baker,

2008).

Others

come

into

contact

with

dentists,

nurse

practitioners, nurses, physical therapists, occupational therapists,
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pharmacists, and counsellors (Fiore et al., 2008). Therefore, almost all
clinicians are in a position to intervene with smokers and offer them
tobacco treatment (Fiore et al., 2008). If clinicians were to advocate
exercise as an adjunct cessation aid it may serve to bolster smokers EXEXP and EX-CRED beliefs. The challenge with this rests not so much on
the smoker as it does on the clinician.
3.4.2 Comparison of exercise and NRT expectancy and credibility
beliefs
Expectancy and credibility are intervention components common to all
treatment modalities (Newman & Fisher, 2010). One aim of the present
study was to compare smokers’ expectancy and credibility beliefs
concerning exercise as a quit smoking aid with their beliefs pertaining
to NRT as a quit smoking aid. The framework of the present study
provided the opportunity to investigate initial expectancy and
credibility beliefs, as well as an examination of change in these
variables over time. Although expectancy and credibility scores at
week five were found to be highly correlated, previous research
provides evidence that these two variables are related yet separate
(Devilly & Borkovec, 2000). As such, separate analyses of these
variables were conducted and commentary on each is provided.
Amongst women who were successfully quit at week 14 of the NRT plus
exercise aided cessation programme both NRT-EXP and EX-EXP showed
a significant increase over time. To appreciate the importance of this
finding a major perceptual difference between these two cessation
aids needs to be highlighted. The nicotine patch has been sold over
the counter since 1996 and is a well established smoking cessation
treatment, recognised and used by many smokers (TTS, 2010). In
contrast, exercise is a comparatively unknown and novel adjunct quit
smoking therapy (Ussher, Taylor, & Faulkner, 2008). Despite this, this
group of women believed they would derive benefit from both
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treatments offered. By no means does this result imply that NRT and
exercise are equally effective quit smoking treatments. It does however
infer that quitters likely attribute some of their success to the exercise
portion of the programme (Kazdin, 1979). Two possible consequences
of this result are worth noting. First, if these women believe exercise to
be a useful quit smoking aid, then they may be more likely to
recommend it to others trying to quit. Second, continued exercise
adherence post intervention is a common problem with intensive
supervised exercise and smoking cessation programmes (Ussher et al.,
2008). Believing exercise contributes to abstinence may make these
women

more

likely

to

continue

exercising

upon

programme

termination.
Among those non-smoking at week 14 EX-CRED and NRT-CRED scores
significantly increased over time. Interestingly, although not statistically
significant, as these women were about to leave the programme
(week 14) their EX-CRED beliefs reduced slightly (remaining above
baseline) whereas their NRT-CRED beliefs increased slightly. These
women successfully quit using NRT, leaving little doubt in their mind that
NRT is a credible quit smoking aid. In addition, at the time of
questionnaire completion they had been without the patch for at least
one week and were possibly experiencing renewed craving and
withdrawal symptoms, albeit psychological in nature (TTS, 2010). It is
speculated that these factors may have influenced their NRT-CRED
scores. In contrast, EX-CRED may have been eroded at programme
termination, due to a lack of confidence in exercise without concurrent
NRT administration and the Getting Physical on Cigarettes programme.
Perhaps, it may have been possible to bolster EX-CRED for these
women with an end of programme debrief and counselling session
(Greenberg et al., 2006).
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The results indicate that EX-EXP for both smokers and non-smokers (at
week 14) was comparable. However, it is worth noting that EX-EXP
increased from week six to week 14 for women who were successful in
the programme, and decreased during the same period for women
who were not. Perhaps, if the smoking group had comparable numbers
to the non-smoking group a significant difference at week 14 may have
been demonstrated. It is logical that at the end of an exercise aided
quit smoking programme, women who had not succeeded would lose
hope in exercise as a cessation strategy. Perhaps, these smokers
engaged in a form of self-serving bias, whereby they began to doubt
the value of exercise as a quit smoking strategy in order to attribute
their cessation failure to an external factor (the exercise programme)
(Greenberg, Pyszczynski, & Solomon, 1982). Interestingly, no discernable
pattern for NRT-EXP was demonstrated between smokers and nonsmokers.
Regardless of quit success, during the intervention all women believed
exercise to be a highly credible quit smoking aid. For the majority of
smokers quitting is not a one-time event. Seventy six percent of people
who have quit smoking made at least one attempt before they were
successful, and approximately 80% of current smokers have attempted
to quit at least once (TTS, 2010). In addition, six months post intervention,
relapse is an unfortunate possibility for those who initially achieve
abstinence (Fiore et al., 2008). In all eventuality, a significant proportion
of these women will attempt to quit smoking again in the 12 months
following programme termination (TTS, 2010). Strong positive credibility
beliefs make it more likely that they will try to quit smoking using
exercise in the future (Juliano & Brandon, 2004).
Expectancy and credibility are variables common to all smoking
cessation treatment strategies. Research in the field of clinical
psychology substantiates that these variables exert some influence
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over behavioural outcomes, and that this influence should be utilised
(Kirsch & Lynn, 1999). In the present study, EX-EXP and EX-CRED
remained high throughout the course of the programme, without any
explicit intervention or manipulation. It would seem that taking part in
the programme was sufficient enough to keep EX-EXP and EX-CRED
ratings high. Researchers in the expectancy and credibility area have
demonstrated that actual experience with therapeutic treatment
exerts a powerful influence over these two variables (Kazdin, 1979). Any
quit smoking treatment that smokers can believe in from pre- to postquit and beyond has merit. That is, exercise may be a cost effective
quit smoking aid because it spans the gamut, from an initial quit
smoking treatment to relapse prevention strategy.
It was demonstrated that EX-EXP and EX-CRED were not related to
adherence. Previous research with clinically depressed individuals has
shown that those who believed in the effectiveness of their therapy
were less likely to drop out, and more likely to adhere to the treatment
offered (Elkin, Yamaguchi, Arnkoff, Glass, Sotsky, & Krupnick, 1999).
Finding EX-EXP and EX-CRED to be unrelated to adherence in an
exercise aided quit smoking programme seems counterintuitive.
However, the clinical implications are great. Specifically, it provides
some indication that smokers’ who do not have complete faith in
exercise as a quit smoking strategy, may still be willing to adhere to a
programme such as this. As previously mentioned, adherence is one of
the biggest hurdles with exercise aided smoking cessation programmes.
This finding implies that factors other than these variables are
implicated in adherence difficulties related to an exercise aided quit
smoking programme.
3.4.3 Limitations
A potential bias regarding EX-EXP and EX-CRED beliefs can be
identified. Expectancy and credibility scores for this group of women
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were high upon entry into the programme (EX-EXP and EX-CRED mean
of 7/9). The results were obtained from a group of female smokers who
agreed to participate in a research programme involving exercise. It is
possible that offering exercise to these women as a quit smoking aid
may have had some bearing on their expectancy and credibility
beliefs. For example, it is likely that they believed exercise to be a
credible quit smoking aid and hoped that it would help them to quit
smoking, because it was being offered through a reputable institution.
Similarly, the manipulated scores reported by Daniel et al. (2007) were
relatively high even in the low condition (five and a half out of 10 on
the credibility scale). In addition, when compared to a control group,
Ussher et al. (2009) found that temporarily abstinent smokers who
engaged in 10 minutes of isometric exercise believed it to be a credible
quit smoking strategy, and reported that they would recommend it to
other smokers trying to quit (Ussher, Cropley, Playle, Mohidin, & West,
2009). Therefore, generalising results obtained to smokers who do not
take part in research studies such as this may not be possible. Perhaps,
the only way to truly minimise this expectancy effect would be to enrol
participants into an acute exercise study, and conceal the exercise
portion of the intervention until the last moment. Such a study design
would only be feasible in an acute setting due to the deception
involved.
A factor known to influence expectancy and credibility is knowledge
gained from others (Wilson, Lisle, Kraft, & Wetzel, 1989). It is possible that
women in this study discussed their own personal experiences and
beliefs in relation to the quit smoking aids offered. Such interactions
would potentially be an influencing factor in the change demonstrated
in these variables over time. To control for this, it may have been
prudent to separate women according to their expectancy and
credibility beliefs upon entering into the programme.
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Although the group size of week 14 smokers was small (n = 9), and was
not equal to that of week 14 non-smokers (n = 28), the research was
exploratory in nature, and as such it was deemed acceptable to
compare these two groups. However, these results should be
interpreted with caution. To rectify this, and gain an accurate profile of
smokers who were unsuccessful, it would have been ideal to obtain
questionnaire data by phone or email during missed assessment times.
3.4.4 Future research
Interestingly, no differences were found between EX-EXP and NRT-EXP
or between EX-CRED and NRT-CRED amongst women who were
successfully quit at week 14. Regardless of the accuracy of these
beliefs, stronger positive beliefs would likely increase the use of exercise
as a quit smoking aid and perhaps improve treatment outcomes
(Juliano & Brandon, 2004). Physical activity is a behavioural strategy
that is increasingly advocated by tobacco treatment specialists and
often reportedly used by quitters (Abrams, Niaura, Brown, Emmons,
Goldstein, & Monti, 2003; Everson, Taylor, & Ussher, 2010; O'Connell,
Gerkovich, Cook, Shiffman, Hickcox, & Kakolewski, 1998). Thus, it seems
important to determine the impact clinicians might exert on EX-EXP and
EX-CRED beliefs in the real world, and how such strategies might
influence cessation outcomes (Greenberg et al., 2006).
3.4.5 Conclusions
In general, people who join a novel exercise aided smoking cessation
intervention have some expectation that exercise will help them quit
smoking and believe it to be a credible quit smoking aid. Regardless of
exercise expectancy and credibility, all recently quit smokers received
a significant reduction in craving and withdrawal relief following an
acute bout of moderate intensity exercise. Nevertheless, the results
provide some evidence that expectancy and credibility may have
some influence on treatment outcomes. The aim is not to denigrated
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the value of exercise as an adjunct smoking cessation aid (Kirsch &
Lynn, 1999). Rather, tobacco treatment specialists should be trying to
maximise

expectancy

and

credibility

beliefs

amongst

smokers

attempting to quit and using exercise as a means to control craving
and withdrawal.
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4 CHAPTER FOUR: EXERCISE MAY BE AN EFFECTIVE
BEHAVIOURAL SUPPORT STRATEGY FOR COPING
WITH SMOKING TEMPTATIONS DURING A QUIT
ATTEMPT

4.1

Introduction

Cigarette smoking is the single greatest cause of preventable death
worldwide because it is associated with numerous dire health
consequences; these adverse effects include an increased risk of heart
attack, stroke, chronic obstructive pulmonary disorder, and many
cancers (USDHHS, 2010). Although tobacco use has declined markedly
since the 1960’s, there has been a levelling off of cessation since the
1990’s (Fiore, Jaen, & Baker, 2008). Approximately one quarter of the
North American population currently smoke (Fiore et al., 2008).
Tobacco dependence treatment has improved greatly and there is
now much support available for smokers who want to quit. Despite this,
the likelihood of remaining abstinent, six months post-quit, even with the
most

comprehensive

of

programmes

(pharmacotherapy

plus

cognitive-behavioural support) is only between 25-30% (Fiore et al.,
2008). Smoking relapse rates are also alarmingly high. Between 60%
and 98% of quit attempts will end in relapse within the first year, with the
majority (44%) occurring in the first two weeks (Garvey, Bliss, Hitchcock,
Heinold, & Rosner, 1992).
There are a number of reasons why dependent smokers find it
incredibly difficult to remain smoke-free. Specifically, there are three
distinct constructs known to entice smoking relapse (Brownell et al.,
1986; Velicer et al., 1990), and include: (1) individual factors which
involve affect, in particular negative emotional states (N/A); (2)
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situational factors which involve environmental and social factors (P/S);
and (3) physiological factors which correspond to the subjective
feelings of craving, urges, and withdrawal associated with nicotine
deprivation (H/A) (Brownell, Marlatt, Lichtenstein, & Wilson, 1986).
To reduce relapse and maintain abstinence in high-risk situations
cognitive (e.g., positive self-talk) and behavioural (e.g., exercise)
coping strategies are recommended (Abrams, Niaura, Brown, Emmons,
Goldstein, & Monti, 2003). Self-quitters report the use of behavioural
coping skills more often than cognitive coping strategies (O'Connell,
Gerkovich, Cook, Shiffman, Hickcox, & Kakolewski, 1998). Physical
activity is a behavioural strategy that is increasingly advocated by
tobacco treatment specialists and often reported as beneficial by
quitters (Abrams et al., 2003; Everson, Taylor, & Ussher, 2010; O'Connell
et al., 1998). Abstinent smokers are encouraged by health professionals
to substitute smoking for the alternative health behaviour of exercise to
prevent smoking relapse (TTS, 2010).
Research on relapse has consistently shown that individuals are much
more likely to relapse when they experience negative affect (Zeidner &
Endler, 1996). Smokers turn to cigarettes as a way of managing
negative affect; they learn to rely on cigarettes to cope with situations
that induce feelings of anger, frustration, depression, and anxiety
(Abrams et al., 2003). It is posited that when nicotine deprived
dependent individuals find themselves in stressful situations it activates
nicotine craving, which may lead to relapse if not managed by an
alternative to smoking (i.e., a coping strategy) (Shadel & Mermelstein,
1993). Exercise may be an appropriate coping strategy because it has
been shown to reduce negative affect experienced by individuals
attempting to quit (Bock, Marcus, King, Borrelli, & Roberts, 1999). In
addition, exercise is known to reduce withdrawal symptoms such as
stress, anxiety, tension, and irritability in temporarily abstinent smokers
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(Taylor, Ussher, & Faulkner, 2007). Conversely, smokers also turn to
cigarettes to enhance already pleasurable situations (e.g., at the bar
with friends) (Velicer, DiClemente, Rossi, & Prochaska, 1990). Whether
an alternative behaviour such as exercise might work as a coping
strategy or substitute behaviour in this type of high-risk situation is
unknown.
One of the reasons smokers find it difficult to quit is because smoking
becomes a learned habit through years of repetition (Abrams et al.,
2003). This renders the abstinent smoker susceptible to cue-induced
cravings when in situations previously linked to smoking (e.g., getting up
in the morning). There is evidence to suggest that following moderate
intensity exercise, temporarily abstinent smokers are less likely to
respond to a smoking cue (e.g., lit cigarette or smoking related images)
(Janse Van Rensburg, Taylor, Hodgson, & Benattayallah, 2009; Taylor &
Katomeri, 2007). Therefore, an exercise aided quit smoking programme
may reduce the intensity of cue-induced craving and in turn reduce
the likelihood of relapse (Ferguson & Shiffman, 2009).
Exercise and smoking are two behaviours that do not normally cooccur (Prochaska, 2008). To suggest that smokers will use exercise as a
strategy to cope with temptation implies that these two behaviours can
be concurrently altered. Unfortunately, many exercise and smoking
cessation studies do not report changes in physical activity, which limits
the understanding of whether smokers can simultaneously quit smoking
and adopt exercise. There is however research to suggest that as a
smoker increases in confidence to quit smoking, he/she increases in
confidence to undergo other health behaviour changes, such as
exercise (Prochaska, 2008). Data concerning whether these two
behaviours can be simultaneously modified would provide valuable
information

for

developing cost-effective strategies

for

multiple

behaviour interventions (King, Marcus, Pinto, Emmons, & Abrams, 1996).
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The present study provided an ideal platform to examine co-variation;
defined as two behaviours that do not normally co-occur changing
together.
The exercise and smoking literature supports exercise as a meaningful
coping resource during abstinence to prevent relapse (Taylor,
Katomeri, & Ussher, 2006). Exercise has been proposed as a strategy to
enhance coping ability and confidence to remain smoke free (Ussher,
Taylor, & Faulkner, 2008). However, it is not known if abstaining smokers
would confidently report replacing smoking with exercise when
imagining a relapse-inducing situation. It is also unknown whether the
quitter’s confidence in exercise as a behavioural support strategy is
situation specific. With this in mind, the purpose of the present study
was to determine: (1) if women taking part in a combined nicotine
replacement therapy (NRT) and exercise aided smoking cessation
programme report a temporal progression from smoking to exercising in
high risk situations; (2) whether confidence to use exercise as a coping
strategy is situation dependent; and (3) whether concurrent behaviour
change would occur (e.g., exercise increase and smoking decrease).
It was hypothesised that women engaging in an exercise aided quit
smoking programme would naturally substitute smoking for exercise as
a means of coping with situations that promote the resumption of
smoking. It was also hypothesised that of all high-risk relapse situations
those related to affect, particularly negative affect, would be the most
amenable to exercise as a coping strategy. Finally, it was hypothesised
that women who showed an increase in confidence to quit smoking
would demonstrate a reciprocal increase in exercise confidence.
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4.2

Methods

4.2.1 Participants
Participants included 58 females undertaking the third round of the
Getting Physical on Cigarettes (GPOC) trial (Jung, Fitzgeorge,
Prapavessis, Faulkner, & Maddison, 2010). The inclusion and exclusion
criteria were the same as that outlined in section 2.2.1.
4.2.2 Ethical approval
Ethical approval to amend the GPOC trial to contain the necessary
questionnaires was obtained from the University of Western Ontario
Health Sciences Research Ethics Board (#16306).
4.2.3 Design
4.2.3.1 Getting Physical on Cigarettes
See section 2.2.3.1 for details.
4.2.3.2 The Exercise and Health Psychology Laboratory
See section 2.2.3.2 for details.
4.2.3.3 General procedure
Participants engaged in a 14 week exercise programme at the Exercise
and Health Psychology Laboratory at the University of Western Ontario.
On the fourth week of the exercise programme participants began a
smoking cessation attempt and the 10 week NicoDerm® nicotine
replacement therapy (NRT) transdermal patch programme. Preintervention assessments were completed before week one, at
baseline; post-intervention assessments were completed on a date
after the participants’ last exercise session, when they had finished the
NRT programme, on week 14.
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Questionnaires that were completed during the trial were done
immediately following the first exercise session on the appropriate week
(see

Table

4.1).

To

be

eligible

for

analyses, the

participants

demonstrated smoking abstinence (i.e., breath CO < six ppm),
adhered to the NRT programme, and followed the exercise regime. To
answer the research questions participants completed questionnaires
every week with the exception of week 11 and 13. A flow-chart of the
research design is displayed in Figure 4.1 and a timeline of the
measurements and assessments in Table 4.1.
Table 4.1. Schedule of Assessments

Baseline
Quit Smoking

2 3

Week
4 5 6 7 8

9 10 11 12 13 14

X

Demographics Questionnaire
Smoking Ladder
Exercise Readiness

X
X
X

Temptations Questionnaire

X

X X X X X X X X X

X
X

X X X X X X X X X X X X X

Smoking Variables
Carbon Monoxide Assessment
Fagerström Nicotine
Dependence
Smoking Information
Cessation Self-Efficacy (SE)

X
X

X

X

X

X

Exercise Variables
Actical Exercise Behaviour
X
Godin Leisure Time
X
X
Questionnaire
Peak VO2 Fitness Assessment
X
X
Exercise Task SE
X
X
X
Exercise Scheduling SE
X
X
X
Exercise Barrier SE
X
X
X
Note. Baseline refers to pre-trial and week 14 refers to post-trial. Participants began
their smoking cessation attempt and nicotine replacement therapy on week four.
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4.2.5.2 NicoDerm® two step programme
See section 2.2.5.2 for details. Seven of the 58 participants were on the
two step programme.
4.2.6 Demographic measures
See section 2.2.6 for measurement details. These variables are
described in Table 2.2.
4.2.7 Nicotine dependence and other smoking characteristics
See section 2.2.6.2 for measurement details. These variables are
described in Table 2.2.
4.2.7.1 Smoking ladder scale
See section 3.2.6.4 for details. This variable is described in Table 2.2.
4.2.8 Physical activity behaviour
4.2.8.1 Godin leisure time exercise questionnaire (GLTEQ)
See section 3.2.7.1 for details. These variables are described in Table
2.2.
4.2.8.2 Actical® accelerometer
See section 2.2.7.1 for details. This variable is described in Table 2.2.
4.2.8.3 Peak VO2 fitness assessment
See section 2.2.7.2 for details. These variables are described in Table
2.2.
4.2.8.4 Stage of exercise readiness
See section 3.2.7.4 for details. This variable is described in Table 2.2.
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Table 4.2. Demographic characteristics, exercise and smoking behaviour.
Variable
Demographics:
Age
Language spoken at home (% English)
Married
Yearly household income:
Below $50,000
Between $50,000 and $75,000
Above $75,000
Number of children
Occupation:
Employed
Student
Unemployed
Readiness for Change:
Cessation Readiness:
Pre-contemplation
Contemplation
Preparation
Action
Maintenance
Exercise Readiness:
Pre-contemplation
Contemplation
Preparation
Action
Maintenance
Exercise behaviour:
Objective physical activity (Actical)
Pre-intervention (minutes per week MVPA)
Pre-intervention (number of bouts > 10 minutes)
Self-report physical weekly activity (Godin)
Pre-intervention (metabolic equivalent)
Post-intervention (metabolic equivalent)
Peak VO2 (ml/kg/min):
Pre-intervention
Post-intervention
Carbon monoxide (CO) reading:
Pre intervention (baseline)
Post intervention (14 weeks)
Smoking behaviour:
Cigarettes per day
Number of years smoking
Fagerström test of nicotine dependence
Percentage of family and friends that smoke:
Between 0 and 10%

Mean (SD), %

42.72 (13.43)
96 %
32 %
56 %
11 %
33 %
1.89 (2.35)
73 %
13 %
14 %

0%
0%
53 %
40 %
7%
0%
51 %
35 %
7%
7%

99.50 (73.31)
0.802 (1.545)
18.22 (17.13)
39.69 (21.86)
23.23 (6.32)
31.16 (6.82)
11.96 (9.25)
6.83 (11.07)
17.80 (8.24)
22.54 (12.93)
5.02 (2.16)
32 %
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Between 10 and 20%
Above 20%
Number of previous quit attempts

14 %
54 %
6.49 (14.54)

4.2.9 Primary outcome measures
4.2.9.1 Temptations questionnaire
The temptations questionnaire is a 25 item questionnaire that combined
two questionnaires: The Revised Self-Efficacy Temptations scale long
form (SET) (Velicer et al., 1990) and the Cessation Self-Efficacy
questionnaire (CSE) (DiClemente, 1981). Both of these questionnaires
have shown reliability and validity in terms of assessing smokers’
confidence in their ability to avoid smoking in relapse inducing
situations (DiClemente, 1981; Velicer et al., 1990). The scales of these
two questionnaires were modified such that participants had to choose
how likely they would be to either smoke or to exercise in situations
known to induce smoking urges. Participants were required to choose
between the response of smoking and exercising on a nine point scale
(four points on the exercise side + unsure + four points on the smoking
side). The scale was scored such that a score of -4 = extremely likely to
smoke and -1 = a little likely to smoke, 0 = unsure, 4 = extremely likely to
exercise and 1 = a little likely to exercise.
For the purpose of analysis the scale was separated into four
components, corresponding to: cessation self-efficacy (12 items from
DiClemente, 1981), negative/affect (N/A – six items from Velicer et al.,
1990), positive/social (P/S – six items from Velicer et al., 1990),
habit/addiction (H/A – five items from Velicer et al., 1990). There was
some overlap between questionnaires (i.e., some items appeared on
both questionnaires). The three categories of the SET scale (N/A, P/S,
H/A) were used to determine whether participants in an exercise-aided
smoking cessation programme reported a progression from smoking to
exercising when faced with a relapse inducing situation, and to
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determine whether or not exercise is a situation dependent coping
strategy. The items from the CSE scale were used to determine if
participants may be more or less likely in specific situations to exercise
as a relapse coping strategy. This questionnaire was administered
weekly from baseline to week eight, and at week 10, 12, and 14.
Reliability analyses (Cronbach’s alpha scores) were computed at all
time points for the constructs (P/S, N/A, H/A). All alpha values reflected
an acceptable level of reliability and are presented in Appendix 16
(Kline, 1993). See Appendix 10 for a copy of this questionnaire.
4.2.10 Secondary outcome measures
4.2.10.1

Smoking abstinence

Smoking abstinence was verified post-intervention by self-report, and a
breath carbon monoxide reading of less than six ppm. Participants who
failed to attend the post-intervention assessment appointment, scored
greater than six ppm breath carbon monoxide, and/or self-reported
smoking behaviour were considered a smoker at week 14 (postintervention).
4.2.10.2

Cessation self-efficacy

Participants’ confidence in their ability to avoid smoking was assessed
with the Cessation Self-Efficacy Questionnaire (DiClemente, 1981). This
questionnaire was administered at baseline, week six and week 14 of
the trial. The scale consisted of 12 items on a seven point scale (one =
completely

sure

–

seven

=

completely

unsure).

For

ease

of

interpretation the raw data was reverse scored, such that a higher
score on this questionnaire indicates a higher confidence in ability to
avoid smoking in various situations. Reliability analyses (Cronbach’s
alpha scores) were computed at baseline, week six, and week 14. All
alpha values reflected an acceptable level of reliability and are
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presented in Appendix 16 (Kline, 1993). See Appendix 11 for a copy of
this questionnaire.
4.2.10.3

Exercise task self-efficacy

Participants’ confidence in their ability to engage in increasing
intensities and durations of physical activity was assessed at baseline,
week six and week 14 using the exercise task self-efficacy questionnaire
(McAuley & Mihalko, 1998). Responses to nine items were given on a 0%
to 100% scale ranging from not at all confident (0%) to extremely
confident (100%). The scale consisted of three items pertaining to
light/mild intensity physical activity (e.g., “How confident are you that
you can complete 10 minutes of physical activity at a light intensity
three times next week?”), three items on moderate intensity physical
activity, and three items on hard/vigorous intensity physical activity.
Reliability analyses (Cronbach’s alpha scores) were computed at
baseline, week six, and week 14. All alpha values reflected an
acceptable level of reliability and are presented in Appendix 16 (Kline,
1993). The results of this questionnaire are presented on a 0-10 scale,
where 0 corresponds to 0% confidence and 10 corresponds to 100%
confidence. See Appendix 12 for a copy of this questionnaire.
4.2.10.4

Exercise scheduling self-efficacy

Participants’ confidence in their ability to schedule exercise into their
daily routine was assessed at baseline, week six and week 14 using the
seven item exercise scheduling self-efficacy measure (Woodgate,
Brawley, & Weston, 2005). Responses were given on a 0% to 100% scale
ranging from not at all confident (0%) to extremely confident (100%).
Reliability analyses (Cronbach’s alpha scores) were computed at
baseline, week six, and week 14. All alpha values reflected an
acceptable level of reliability and are presented in Appendix 16 (Kline,
1993). The results of this questionnaire are presented on a 0-10 scale,
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where 0 corresponds to 0% confidence and 10 corresponds to 100%
confidence. See Appendix 14 for a copy of this questionnaire.
4.2.10.5

Exercise barrier self-efficacy

Participants’ confidence in their ability to engage in exercise when
faced with various barriers to do so was assessed using a five item
questionnaire modified from the barrier self-efficacy scale (Garcia &
King, 1991). Participants reported their confidence to participate in 60
minutes of physical activity when faced with situations known as
barriers to exercise. Responses were given on a 0% to 100% scale
ranging from not at all confident (0%) to extremely confident (100%).
Reliability analyses (Cronbach’s alpha scores) were computed at
baseline, week six, and week 14. All alpha values reflected an
acceptable level of reliability and are presented in Appendix 16 (Kline,
1993). The results of this questionnaire are presented on a 0-10 scale,
where 0 corresponds to 0% confidence and 10 corresponds to 100%
confidence. See Appendix 13 for a copy of this questionnaire.
4.2.11 Challenges and considerations
4.2.11.1

Smoking abstinence

See section 2.2.2.1 for details.
4.2.11.2

Physical activity measurement

See section 3.2.9.2 for details.
4.2.11.3

Nicotine replacement therapy

See section 2.2.2.3 for details.
4.2.11.4

Participant retention

See section 2.2.2.4 for details. The number of participants differed
between analyses due to attrition, absenteeism and/or smoking lapses
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(e.g., baseline to week four temptations questionnaire, n = 41; week
five to week eight, n = 33; week 10 to week 14, n = 29) (Figure 4.1). A
total of 12 participants provided continuous, baseline to week 14,
temptation questionnaire data.
4.2.12 Power calculation
Due to the exploratory nature of this study, no power calculation was
computed.
4.2.13 Statistical analyses
Separate repeated ANOVAs were used to analyse differences in the
temptation constructs of the Temptation Questionnaire at different time
points (baseline – week four, week five – week eight, week 10 – week
14), and to determine change over time. Planned comparison t-tests
were used to determine at what time point (week) differences
between the scales occurred. For these analyses Bonferroni correction
set the alpha at .005. Separate repeated ANOVAs were also used to
analyse differences in the self-efficacy scales over time. For the selfefficacy scales that were measured at three time points, planned
comparison t-tests were used to compare baseline to week six and
baseline to week 14 if differences were found. Pearson product
moment correlations were used to examine relationships between
exercise self-efficacy’s and smoking cessation self-efficacy (change
from baseline to week six, CO < six ppm at week 14). A univariate
ANOVA was used to compare baseline exercise self-report behaviour
to week 14 exercise self-report behaviour. A chi-square was used to
determine the relationship between week 14 smoking abstinence and
exercise programme adherence.
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4.3 Results
4.3.1 Baseline to quit week (week four)
A significant change over time (baseline to week four, n = 41) occurred
for

all

three

temptation

constructs

(Positive/Social

[P/S],

Negative/Affect [N/A], Habit/Addictive Qualities [H/A]) (F[3,360] =
94.529, p < .001, η2 = .706) (Figure 4.2). Scores changed from smoking in
relapse provoking situations (at baseline) to being ‘unsure’ or ‘a little
likely’ to exercise in such situations (at week four). Significant
differences in scores over the weeks are presented in Table 4.3. There
were no differences over time (baseline to week four) between the
three categories of temptation 3 (F[6,360] = .898, p = .497, η2 = .015).

Scores on the three temptation constructs over time for women who attended each
assessment time point and were continuously abstinent from week four onwards (n =
12) were no different to those who were continuously abstinent at the distinct time
points (baseline – week four; week five – week eight; week 10 – week 14).
3
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Table 4.3. Baseline to week four change in score over time t-test results. Baseline –
week two, n = 51; week two – week three, n = 44; week three – week four, n = 44.
Construct
Positive
Social

Comparison
Baseline – week two
Week two – week three
Week three – week four

Negative
Affective

Baseline – week two
Week two – week three
Week three – week four

Habit
Addiction

Baseline – week two
Week two – week three
Week three – week four

Mean (sd)
-2.85
-2.81
(1.01)
(1.18)
-2.73
-2.07
(1.17)
(1.12)
-2.14
-0.29
(1.03)
(1.27)
-3.06
-2.38
(1.01)
(1.37)
-2.32
- 2.16
(1.37)
(1.52)
-2.23
- 0.20
(1.53)
(1.69)
-2.15
-1.60
(1.21)
(1.51)
-1.50
-1.32
(1.48)
(1.46)
-1.32
0.56
(1.43)
(1.52)

T
-0.268

Sig.
.789

η2
.001

-7.013

.001

.534

-7.573

.001

.572

-3.915

.005

.235

-1.104

.276

.028

-6.464

.001

.493

-2.937

.005

.147

-1.162

.251

.001

-6.909

.001

.526

4.3.2 Week five to week eight
No significant change over time (week five to week eight, n = 31) was
demonstrated for any of the three temptation constructs (F[3,288] =
.282, p = .838, η2 = .003) (Figure 4.2). Values remained between zero
(unsure) and one (a little likely to exercise). It should be noted that
none of the post quit scores were negative (negative score denotes
likely to smoke). There was no difference in participants scores between
the three categories of temptation during this time period (F[6,288] =
.529, p = .786, η2 = .011).
4.3.3 Week 10 to end of programme (week 14)
No significant change over time (week 10 to week 14, n=29) was shown
for the three temptation constructs (F[2,168] = 3.252, p = .061, η2 = .037)
(Figure 4.2). Similar to mid-intervention scores (week five to eight)
participants scores remained consistently between zero (unsure) and
one (a little likely to exercise). Again, it should be noted that none of
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the post quit date reports leaned towards smoking. There were no
differences between the three categories of temptation during this
time period (week 10 to 14) (F[4,168] = 1.125, p = .346, η2 = .026).

Unsure

Exercise

4

Positive/Social
Negative/Affective
Habit/Addiction

2

0
**

Smoke

**
-2

*
**

*
-4
2

4

6

8

10

12

14

Week of Intervention
Figure 4.2. Scores on the three temptation constructs over time. Minus four =
‘extremely likely to smoke’ vs. four = ‘extremely likely to exercise’. Baseline – week four,
n = 41; week five – week eight, n = 33; week 10 – week 14, n = 29. Week four denotes
quit week; the y-axis reference line denotes a score of zero (unsure).
* p < 0.05 increase in confidence to exercise in relapse inducing situations.
** p < 0.001 increase in confidence to exercise in relapse inducing situations.

4.3.4 Are certain individual temptations more responsive to exercise
behaviour as a coping strategy than others?
The frequencies of each question on the temptations inventory at week
five and week 14 are presented in Appendix 17. Participants answered
that they would be highly likely to exercise in the scenario ‘when I see
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that I am gaining weight’ (question 25 [week five – 40% responded with
three or four out of four; week 14 – 38% responded with three or four out
of four]). They reported being highly likely to smoke at both week five
and 14 in the scenario ‘when I experience an emotional crisis (i.e., an
accident or death in the family)’ (question 24 [week five – 26%
responded with minus three or minus four out of minus four; week 14 –
21% responded with minus three or minus four out of minus four]).

4.3.5

Exercise self-efficacy

Exercise self-efficacy was measured at three time points over the
course of the programme (baseline, week six, week 14). The results
demonstrated that individuals who were considered abstinent (CO < six
ppm) and provided data at each time point showed a significant
difference over time for exercise task self-efficacy (n = 28; F[2,54] =
3.421, p < .05, η2 = .112). Exercise task self-efficacy significantly improved
from baseline to week six (t = -2.150, p < .05, η2 = .146) and from
baseline to week 14 (t = -2.325, p < .05, η2 = .167) (Figure 4.3).
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Exercise Task Self-Efficacy Score (0-10)

10

8

*

6

4

2

0
Baseline

6

14

Week of Intervention
Figure 4.3. Exercise task self-efficacy scores for women considered abstinent (CO < six
ppm at week six and 14) and competed questionnaires at all three time points (n =
28).
* p < 0.05 significant difference between baseline and week six and week 14.

No change over time was found for either exercise scheduling selfefficacy (n = 27; F[2,52] = 7.674, p = .073, η2 = .096 [baseline – M = 7.042
SD = 3.020; week six – M = 6.814, SD = 2.778; week 14 – M = 7.830, SD =
2.249]) or exercise barrier self-efficacy (n = 27; F[2,52] = 1.491, p = .235,
η2 = .054 [baseline – M = 7.725, SD = 2.249; week six – M = 7.377, SD =
2.874; week 14 – M = 7.007, SD = 2.167]).
4.3.6 Cessation self-efficacy
Cessation self-efficacy was measured at three time points over the
course of the programme (baseline, week six, week 14). The results
demonstrated that individuals who were considered abstinent (CO < six
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ppm) and provided data at each time point showed a significant
difference over time for smoking cessation self-efficacy (n = 26; F[2,50]
= 57.859, p = .000, η2 = .698).

Smoking cessation self-efficacy was

significantly greater at week six (t = -10.510, p = < .001, η2 = .804) and
week 14 (t = -7.959, p = < .001, η2 = .701) when compared to baseline
(Figure 4.4).

Cessation Self-Efficacy Score (1-7)

7
6
5
4

*

3
2
1
0
Baseline

6

14

Week of Intervention
Figure 4.4. Cessation self-efficacy scores for women considered abstinent (CO < six
ppm at week six and 14) and competed questionnaires at all three time points (n =
26).
* p < 0.001 significant difference between baseline and week six and week 14.

4.3.7 Exercise behaviour
Self-reported leisure time physical activity behaviour questionnaire
scores significantly increased from pre- to post-exercise for those
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participants that provided data (n = 36; F[1,35] = 44.536, p < .001, η2 =
.560)
4.3.8 Correlations
No significant correlations were found between change in cessation
self-efficacy over time (baseline to week six) and change in any of the
exercise self-efficacy variables over the same time period (task [r = .319,
p = .091]; scheduling [r = -.077, p = .697]; barrier [r = .294, p = .121]).
However, a trend effect for change over time (baseline to week six)
was demonstrated between cessation self-efficacy and task selfefficacy.
4.3.9 Smoking cessation outcomes
48.1 percent (n = 38) of participants were able to abstain from
cigarettes on the week four quit date (CO < six ppm). At the end of the
programme (week 14) 60.3% of participants were considered smoke
free (CO < six ppm). Smoking abstinence was related to attendance to
the exercise programme (x2[2, n=58] = 14.758, p < .001) (Table 3.5).
Table 4.4. Breakdown of participants smoking status at week 14 in relation to
attendance to the exercise portion of the programme (n = 58)
Exercise Programme Attendance
80-100%
60-80%
<60%
Non-smoking at week 14
Number of participants
Percent of total
Smoking at week 14
Number of participants
Percent of total

Total

27
46.6%

2
3.4%

6
10.3%

35
60.3%

6
10.3%

4
6.9%

13
22.4%

23
39.7%

140
4.4

Discussion

Successfully coping with situations that invoke the desire for a cigarette
is essential to quit success. The present study sought to determine
whether women undergoing a NRT and exercise aided quit attempt
would report a temporal progression away from smoking in tempting
situations. It was hypothesised women engaging in 14 weeks of
structured exercise would report incrementally swapping smoking
behaviour for exercise behaviour when faced with relapse provoking
situations. Certainly this was the case from baseline to quit week (week
four). During this time period there was a significant shift in reported
response from smoking to exercise on all three temptation constructs
(positive/social,

negative/affective,

habit/addiction).

This

finding

indicates that smokers engaging in regular exercise could imagine how
exercise might help them cope with the urge to smoke when faced
with a smoking trigger.
An additional hypothesis addressed in the present study was that from
quit week to the end of the programme (week 14) participants who
had successfully quit smoking and continued to take part in the
intervention would report confidence in exercising instead of smoking in
tempting situations. This was not however the case; the results suggest
that women undergoing a quit attempt are not likely to report exercise
as a coping mechanism to deal with future potential smoking urges.
Due to the complexity of quitting smoking the null findings for switching
to exercise post-target quit date are clinically relevant. The exercise
intervention progressed quitters to the point where they did not believe
they would smoke in tempting situations; although, they reported that
they would not exercise either. Considering that quitting smoking is a
process that unfolds over time and that abstinent smokers often
relapse, any quit smoking aid that steers the recent quitter away from
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succumbing to smoking temptation is worthwhile (Shiffman, Kassel,
Gwaltney, & McChargue, 2005).
One of the most commonly reported immediate coping strategies
utilised by self-quitters is informal exercise (O'Connell et al., 1998).
However, coping skills training research shows that in order for a coping
strategy to be reliably utilised when abstinence is threatened it needs
to be well learned, such that it becomes a habitual response (Shiffman
et al., 2005). Perhaps additional intensive exercise coping skills training
was required and simply engaging in exercise on a regular basis was
not sufficient to perceive exercise as a behavioural coping strategy in
high-risk situations. Perhaps, had these women received intensive
training in the use of exercise as a relapse coping strategy they may
have reported more confidence in its use. If this is the case then it
challenges the cost effectiveness and scalability of an intervention
such as this for relapse prevention. However, it should be noted that
recent research in both the United Kingdom and New Zealand have
demonstrated that it is feasible to embed the promotion of physical
activity into existing smoking cessation services (Maddison, Roberts,
Bullen, McRobbie, Jiang, Prapavessis, Glover, Taylor, & Brown, 2010;
Taylor, Everson-Hock, & Ussher, in press).
The preferred coping response inventory was separated into three
distinct constructs known to entice smoking relapse (Velicer et al.,
1990). This allowed for investigation into the perceived utility of exercise
as a strategy for coping with each construct separately. Given the
effects of exercise in the general population, and the acute smoking
and exercise literature, it was hypothesised that participants would be
more likely to report using exercise as a strategy to cope with a
negative emotional state (N/A construct). This was not the case; there
was no difference in perceived likelihood of using exercise to prevent
relapse between the different constructs. These three constructs are
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not only predictors of relapse they are also associated with the
maintenance of smoking behaviour. For example, some people
continue to smoke to reduce negative affect whereas for others
smoking is maintained through the social networks of family and friends
(TTS, 2010). In addition, subjective impressions of craving and
withdrawal are also important; physical nicotine dependence also
varies for individuals and may be a central determinant of smoking
maintenance (Brownell et al., 1986). Perhaps a participant’s response
to the use of exercise as a relapse coping strategy was contingent on
what maintains their smoking behaviour. For example, if an individual
continues to smoke because it is their social norm, they may not be
able to imagine exercising when faced with a temptation (e.g., at a
party).
Previous researchers have posited that exercise is likely to be a less than
practical solution to counter craving in many environments where
abstinence is enforced (e.g., a bar or workplace) (Ussher, Nunziata,
Cropley, & West, 2001). The results from the current study concur with
this notion and suggest that recently quit smokers were unable to
comprehend how exercise would be an appropriate response in many
tempting situations. The relevance of exercise as a coping strategy
may have been undermined by the fact that these women were
engaging in aerobic exercise only; a type of exercise that may not be
a natural coping choice in many situations (e.g., when with friends at a
party). The majority of acute exercise and smoking research has
investigated aerobic exercise but there are an increasing number of
studies researching the effects of isometric exercise on craving and
withdrawal symptoms (Ussher, Cropley, Playle, Mohidin, & West, 2009;
Ussher, West, Doshi, & Sampuran, 2006). The findings from these studies
are promising and short bouts of isometric exercise (five or 10 minutes)
seem to reduce desire to smoke and withdrawal symptoms in
temporarily abstinent smokers. Additionally, individuals engaging in this
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type of exercise believed it to be a credible strategy for dealing with
craving and withdrawal (Ussher et al., 2009). The present study findings
for the week five to week 14 time period would suggest that extensive
training is needed before individuals will confidently use exercise as a
behavioural coping strategy. Imagined future use of exercise to
prevent relapse may have been boosted had participants been
schooled in different types of exercise strategies for different situations
(e.g., at a bar socialising - use isometric contractions; stressed at work go for a walk at lunch time). The results highlight that simply engaging
in exercise does not constitute situation specific relapse prevention
training.
In addition to examining each relapse category and how it may relate
to exercise as a coping strategy, each of the questions on the coping
with temptation inventory was examined individually. Of the 25 items
pooled from the Revised Temptations Inventory and the Cessation SelfEfficacy Questionnaire (DiClemente, 1981; Velicer et al., 1990), two
items stood out as worthy of mention. First, a large number of
participants (40% at week five, 38% at week 14) responded that they
would be highly likely to exercise to avoid relapse ‘when I see that I am
gaining weight’. Nicotine has been found to have powerful effects on
the regulation of body weight. When a smoker quits it can lead to
physiological pressure to gain weight (Grunberg & Bowden, 1985). The
weight

gain

associated

can

have

negative

psychological

consequences for the quitter and result in the resumption of smoking
(Brownell et al., 1986; Schneider & Waters, 2007). Therefore, identifying
adjunct therapies that can assist quitters in avoiding weight gain is
clinically important. A recent review of exercise interventions for
smoking cessation found that such programmes do not consistently
report an end of programme reduction in weight gain (Ussher et al.,
2008). However, the results from the present study suggest that exsmokers consider exercise a useful strategy to deal with post cessation

144
weight gain. This implies that though exercise may not always be
enough to ward off weight gain it may help with the negative affective
portion of this weight gain that drives quitters to relapse (Schneider &
Waters, 2007). The second stand out item was ‘when I would
experience an emotional crisis (i.e., an accident or death in the
family’). In this instance many of the participants (26% at week five, 21%
at week 14) responded that they would be highly likely to go back to
smoking. This result indicates that while exercise might help with daily
stressors, participants require additional cognitive coping strategies to
avoid smoking in an emotional crisis.
Smoking and a sedentary lifestyle are two behaviours that co-occur
(Nagaya, Yoshida, Takahashi, & Kawai, 2007), and the smokers in the
present study were no exception. Nagaya and colleagues (2007)
examined the longitudinal impact of quitting smoking and relapse on
exercise behaviour in a group of Japanese men (n = 750). They found
smoking cessation to be associated with an increase in exercise
behaviour whereas smoking relapse was associated with reduced
exercise behaviour. It may be that these two behaviours are closely
linked and that the process of change in one is similar to the other.
Indeed, it was demonstrated that an abstinent smoker’s increase in
confidence to perform exercise paralleled confidence in her ability to
successfully quit smoking. In addition, although change in task selfefficacy from baseline to week six was not significantly related to
change in cessation self-efficacy over this same time period, a trend
effect was observed. Perhaps, the complex cognitions involved in these
two behaviours share similarities, which may be an underlying factor as
to why these women were unsure of their ability to use exercise as a
temptation coping strategy. That is, imagining urge inducing situations
led them to feel weakness for both behaviours.
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The majority of participants, coming into the programme, were not
meeting the current Canadian Society for Exercise Physiology
guidelines for physical activity (150 minutes of moderate to vigorous
intensity aerobic physical activity per week, in bouts of 10 minutes or
more) (CSEP). Likely, when this group of women began the programme
they did not consider themselves to be exercisers. Although they did
increase their confidence in their ability to exercise, they did not
experience an increase in their confidence to overcome barriers to
being active or to schedule exercise into their lives. It is possible that
after being sedentary, 14 weeks of exercise was not enough time for
them to truly imagine exercise as a coping strategy and believe they
could overcome barriers to its use (Anderson & Cychosz, 1995).
Smoking cessation rates were highest when individuals attended more
than 80% of the programme. Engaging in exercise may have reinforced
participant’s commitment to making healthy lifestyle changes, in
particular giving up smoking (Prochaska, Hall, Humfleet, Munoz, Reus,
Gorecki, & Hu, 2008). It has been reported in the literature that
individuals who believe they can increase their physical activity levels
are also confident about reducing their smoking behaviour and vice
versa (Boudreaux, Francis, Carmack Taylor, Scarinci, & Brantley, 2003;
King et al., 1996; Prochaska et al., 2008). The present study
demonstrated a similar result (i.e., exercise task and cessation selfefficacy increased over time). These findings taken together make it
possible to suggest that female smokers who are confident in their
ability to change their smoking behaviour also have an increased
confidence in their ability to improve their exercise regimen (Prochaska,
Spring, & Nigg, 2008). It is also postulated that developing confidence
to exercise provided quitters with confidence not to give in to the urge
to smoke and resulted in temptation scores staying above zero.
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It should be noted that these results were demonstrated when exercise
behaviour was specifically targeted. Other researchers have found that
targeting a single behaviour for change does not necessarily translate
into healthy changes in other behaviours (Dutton, Napolitano, Whiteley,
& Marcus, 2008). Therefore, changes in physical activity may not simply
occur because the individual quits smoking or vice versa. In addition,
the majority of participants were highly motivated and ready to
change both behaviours entering into the programme. As such, it is not
possible to say that change in one lifestyle behaviour increases an
individual’s

confidence

to

improve

behaviours

that

they

lack

motivation for or are not ready to change.
Interventions

designed

to

concurrently

change

multiple

health

behaviours are often challenged by poor adherence as participants
may find them overwhelming (Prochaska et al., 2008). Indeed, previous
exercise and smoking cessation trials are often limited by a lack of
exercise adherence (Ussher et al., 2008). To improve exercise
adherence rates in the current study the two behaviours were
sequentially introduced (i.e., four weeks of exercise before attempting
to quit smoking) and participants were identified as being ready to
change both their smoking and exercise behaviour (Prochaska et al.,
2008). As previously mentioned, smoking cessation was highest when
individuals attended more than 80% of the programme and almost half
of all participants did so. While this adherence rate is not dismal it is
somewhat

sobering

and

considering

that

exercise

programme

attendance influenced quit status, attendance stands out as one of
the greatest barriers to multiple behaviour change programme
success.
4.4.1 Limitations
All participants received a comprehensive intervention that involved
NRT and exercise in a group setting. Pharmacotherapy and social
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support are considered essential components of any effective quit
smoking programme (Fiore et al., 2008). Therefore, it is possible that the
significant change in the temptation inventory demonstrated between
baseline and quit week was not solely due to exercise. However, this
notion is somewhat mitigated by the fact that exercise task selfefficacy increased from baseline to week six. This increase suggests that
any increase in confidence to exercise in high-risk situations would be
related to the exercise portion of the intervention.
Newly abstinent smokers reported that when confronted with a trigger
they would neither smoke nor exercise. A limitation of this research is
that alternative behavioural (e.g., do something else) or cognitive (e.g.,
positive self-talk) coping strategies were not measured. Asking
participants at an exit interview how they dealt with temptations may
have provided valuable insight into the type of coping strategies being
used over and above exercise.
The study was also limited by the fact that participants had to imagine
whether or not they would exercise when faced with a trigger. A more
ecologically valid way to measure the use of exercise as a relapse
coping strategy would have been through real time reporting with
electronic devices (Shiffman, Paty, Gnys, Kassel, & Hickcox, 1996).
The findings from the present study are only generalisable to female
abstinent smokers who completed the questionnaire assessments. A
large number of individuals were excluded from the analyses because
they were not considered smoke-free at the time of assessment. Future
research should examine the temptation inventory responses of nonabstinent smokers. However, the majority of participants considered to
have relapsed were also those who stopped attending the programme
and as such these data were scant. Similarly, it would have been
advantageous to examine self-efficacy to quit smoking and exercise
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based on adherence to the exercise programme. Unfortunately,
because only a few participants with poor adherence attended the
three self-efficacy assessment time points these comparisons could not
be made. To rectify this it would have been worthwhile to contact
absent participants and have them email or provide their answers over
the phone.
Due to the time frame of the research it was not possible to obtain an
objective measurement of post-intervention physical activity behaviour
for this group of participants. Therefore, in terms of pre- and postintervention physical activity behaviour only self-report data was
available and reported in this study. It has been demonstrated that
people tend to over report their physical activity data when they selfreport, making it a less accurate measurement of physical activity than
when objectively measured (Taber, Stevens, Murray, Elder, Webber,
Jobe, & Lytle, 2009).
Finally, there were many criteria that had to be met (e.g., CO < six
ppm, consistent exercise attendance) before an individual was
included in the dataset. The strict inclusion criteria led to a small sample
size for the self-efficacy data set (n = 25), which resulted in these
analyses being underpowered. Had these analyses been adequately
powered we may have found significant change in the other exercise
self-efficacy variables.
4.4.2 Future research
When planning a relapse prevention intervention psychological and
situational factors that underlie why an individual smokes should be
considered. For example, if an individual smokes to suppress anger and
frustration at work, they will need to be taught alternative anger
management skills to use in preparation for cessation (Abrams et al.,
2003). The point is, in the future it may be beneficial to determine what

149
sustains cigarette use for the individual and determine if exercise proves
to be an effective adjunct under the circumstances.
Multiple health behaviour change interventions may be the future of
preventive medicine. There is a growing body of research to suggest
that concurrently and successfully targeting change in health
behaviours is possible (Prochaska, 2008). However, there is also
evidence to suggest that it is not as simple as a change in one
behaviour translating to a change in another behaviour (Dutton et al.,
2008). Finding that individuals experience a simultaneous increase in
confidence to quit smoking and exercise leads to a number of
important questions worthy of future research: (1) does confidence to
change one behaviour come before confidence to change the other
i.e., increased confidence in changing exercise behaviour leads to
confidence to quit smoking or vice versa?; (2) are smokers who
become regular exercisers likely to spontaneously quit smoking?; (3) in
the interest of cost effectiveness, what is the minimum treatment
required to get these two behaviours to change together?; (4) how
many ex-smokers continue to exercise at six and 12 months post
intervention?; and (5) are there identifiable individual factors that
contribute to success in multiple health behaviour change programmes
involving exercise and smoking cessation?
4.4.3 Conclusions
The findings from the present study highlight the importance of focusing
interventions on behavioural problem solving treatments (e.g., exercise)
leading up to a quit attempt. They also suggest that smokers, who are
preparing to quit, can realise how exercise might be a useful strategy
to help them resist the urge to resume smoking in tempting situations.
However, despite the appeal of exercise as a coping strategy, recently
quit smokers may require intensive behavioural coping skills training
before they accept using exercise in future tempting situations. Finding
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that greater exercise adherence increased smoking cessation, and
that amongst those who remained abstinent, cessation self-efficacy
and exercise self-efficacy both increased provides evidence that it is
possible to successfully change these two incompatible behaviours at
once. Finally, when an individual is confident in her ability to change a
complex behaviour it may be a good time to capitalise on her being in
a time for multiple complex behaviour changes.
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5 CHAPTER FIVE: GENERAL DISCUSSION

The research contained within this dissertation provided valuable
information about the mechanisms underlying how exercise might assist
female smokers deal with the craving and withdrawal symptoms
associated with nicotine deprivation, and how it might help them to
quit. Elucidating the mechanisms behind the beneficial effects of
exercise on smoking cessation outcomes is important for designing
maximally effective interventions. Additionally, identification of such
mechanisms might increase the prescription of exercise as an adjunct
smoking cessation aid by tobacco treatment specialists. Exercise is an
important health behaviour in its own right. Therefore, anything
researchers can do to improve the odds of exercise being accepted
and recommended as a smoking cessation aid is worthwhile.
The studies contained within this dissertation were all based on a
female population. This was done for a number of reasons: (1) women
are able to refrain from smoking for shorter periods and report greater
nicotine withdrawal compared to men (USDHHS, 2001); (2) the
underlying factors for relapse may be different for men and women
(e.g., females specifically site concerns about post-cessation weight
gain as a barrier to quitting) (Marcus, Albrecht, King, Parisi, Pinto,
Roberts, Niaura, & Abrams, 1999); and (3) for the comfort and
satisfaction of the participants, creating a female only exercise
environment was necessary. In line with profiling and tailoring of
interventions it is possible that there may be a difference between
intervention saliency when gender is considered, and the findings may
not be generalisable to male smokers. Future research to determine
whether these results hold for a group of male smokers undergoing a
quit attempt may be warranted.
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The results of the present dissertation were obtained in a design that
overcame some of the limitations of previous acute exercise and
smoking cessation research. For instance, the majority of studies
investigating the acute effects of exercise on smoking involve smokers
undergoing a period of temporary smoking abstinence before
engaging in an acute bout of exercise. It is assumed from these
experimental studies that cigarette craving and nicotine withdrawal
symptom outcomes can be extrapolated to smokers going through a
real quit attempt (Taylor & Katomeri, 2007). Presumably, as these types
of studies involved temporarily abstinent smokers rather than quitters
per se, it was not appropriate to have participants wear the nicotine
patch, and therefore the effects of exercise in conjunction with NRT
were understudied. Additionally, the majority of acute exercise and
smoking research took place in a lab setting, which limited the
ecological validity of the findings. The acute exercise research
conducted in both study one (Chapter two) and study two (Chapter
three) overcame these limitations by: (1) engaging smokers in a serious
quit attempt; (2) participants were using the patch; and (3) the setting
for the exercise bout was more like a gym than a laboratory.
The specific aims of this dissertation were: (1) to determine whether an
acute bout of exercise would further reduce craving and withdrawal
symptoms in a group of female quitters using the nicotine patch; (2) an
exploration of whether the magnitude of withdrawal and craving relief
experienced following an acute bout of exercise would relate to quit
success in this same group of women; (3) to examine whether recently
quit smokers expectancy and credibility beliefs regarding exercise as a
quit smoking treatment had any bearing on self-reported craving and
withdrawal relief following an acute bout of exercise; (4) to compare
smokers expectancy and credibility beliefs regarding a well established
quit smoking aid such as NRT with a novel quit smoking aid such as
exercise; (5) to determine if women taking part in a combined NRT and
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exercise aided smoking cessation programme would report using
exercise as a relapse prevention aid.
Within the limitations of the studies contained within this dissertation the
following conclusions were drawn:
The results of study one indicated that an acute bout of moderate
intensity aerobic exercise reduced symptoms of nicotine withdrawal
and cigarette craving for women on NRT who are attempting to quit.
Three to five days into the quit attempt an acute bout of exercise
reduced craving and withdrawal symptoms (psychological and
sedation) for recently quit smokers using NRT (nicotine patch). The first
few days and weeks of the quit attempt often determine success or
failure (Shiffman, Paty, Gnys, Kassel, & Hickcox, 1996). The results also
demonstrated that the effects of exercise seven to nine weeks into an
NRT assisted quit attempt were still visible though not as large as those
demonstrated during the first week of the quit attempt. These findings
demonstrated that the beneficial effects of a bout of exercise did not
become redundant when combined with NRT. Similarly, in study two,
the week five result shown in study one was replicated. That is, women
in the first week of their quit attempt using the patch showed a
reduction in cigarette craving, psychological withdrawal, and sedation
following an acute bout of moderate intensity exercise. A review of the
acute exercise and smoking literature suggests that a single session of
exercise has the ability to reduce craving and withdrawal amongst
temporarily abstinent smokers (Taylor, Ussher, & Faulkner, 2007). Study
one and two add to this body of research by demonstrating that these
results hold with a group of women who are not only undergoing a real
quit attempt but using NRT as well.
It is well demonstrated that the nicotine patch, which delivers a steady
release of nicotine, does not help quitters manage cue-induced
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craving (Ferguson & Shiffman, 2009). Finding that a bout of exercise
reduced craving amongst quitters using the patch has important
implications for tobacco treatment. Namely, it implies that exercise and
the patch are compatible, and exercise could be an alternative to
nicotine gum or lozenges to manage cue-induced cravings. Being able
to offer quitters an alternative to buying and using NRT (gum and
lozenges) is beneficial because: (1) it will save the consumer money
(i.e., exercise is free and gum and lozenges are not); (2) ultimately
engaging in exercise is a healthier behaviour than using NRT; and (3) it
may reduce the time it takes the ex-smoker to wean off nicotine
altogether.
In study one it was determined that the magnitude of craving and
withdrawal relief experienced did not differ between women who were
successfully quit at week 14 and those who were unsuccessful at week
14. That is, all newly quit smokers at week five experienced a reduction
in craving and withdrawal regardless of what the end of programme
outcome was. This finding highlights the complexity of quit success and
suggests that numerous factors are involved in determining an
individual’s quit status. It also suggests that the benefits of exercise are
not discriminatory, and implies that health practitioners can confidently
recommend exercise as a cessation aid to any woman attempting to
quit and looking for an adjunct therapy to help manage craving and
withdrawal.
Individuals who strongly believed exercise to be a credible quit smoking
aid, and/or expected that they would derive benefit from exercise,
experienced a greater reduction in cigarette craving following an
acute bout of moderate intensity exercise. This contradicted the
findings of Daniel et al. (2007), but is in accordance with the
psychotherapy outcome research that underscores the influence of
these two variables (Smeets, Beelen, Goossens, Schouten, Knottnerus, &
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Vlaeyen, 2008; Newman & Fisher, 2010). However, no significant
differences between high and low expectancy and credibility groups
were found for either psychological withdrawal, or the withdrawal
symptom of sedation, findings that concur with those reported by
Daniel et al. (2007). Nevertheless, the intensity of craving experienced
by an abstinent smoker during the first few days of quitting is often
predictive of his/her success (Ferguson, Shiffman, & Gwaltney, 2006),
which may make this further reduction in craving of clinical
importance. Although, exercise expectancy and credibility beliefs may
not be a major mechanism involved in the acute effects of exercise on
craving and withdrawal amongst temporarily and recently quit smokers
they may play some role.
The concurrent measurement of exercise expectancy and credibility
with NRT expectancy and credibility amongst a group of female
smokers, who were provided with both cessation aids, allowed for a
comparison of actual expectancy and credibility beliefs related to
these two treatments (study two). It was demonstrated that women
who managed to successfully quit smoking by the end of the
programme believed both exercise and NRT had merit as quit smoking
aids. By no means does this imply that exercise and NRT are equally
effective smoking cessation strategies. However, it does imply that
quitters likely attributed some of their success to the exercise portion of
the programme (Kazdin, 1979).
Throughout the programme both NRT and exercise expectancy and
credibility beliefs fluctuated over time and often showed a different
pattern of change depending on participants quit success. One thing
that remained constant is that for all participants who attended the
programme exercise expectancy and credibility beliefs remained high.
Expectancy and credibility are variables common to all smoking
cessation treatment strategies, and research in the field of clinical
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psychology substantiates that these variables exert some influence
over behavioural outcomes, and that this influence should be utilised
(Kirsch & Lynn, 1999). Any quit smoking treatment that smokers can
believe in from pre- to post-quit and beyond has merit. This implies that
exercise may be a cost effective quit smoking aid because it spans the
gamut, from an initial quit smoking treatment to relapse prevention
strategy.
The results of study three (Chapter four) suggested that leading up to a
quit attempt smokers who are regularly engaging in exercise can
envisage how exercise might help them to cope once they quit and
find themselves in relapse provoking situations. Once they actually quit,
and experienced tempting situations either first hand or hypothetically,
they were no more likely to report that they would exercise in such
situations than they were to report that they would smoke. Smoking
relapse rates are alarmingly high (between 60-98% at one year), and
unfortunately a number of women who at first achieve quit success will
be smoking again at 12 months (Garvey, Bliss, Hitchcock, Heinold, &
Rosner, 1992). Considering this, progressing these women to the point
where they did not believe they would smoke in tempting situations
may still be relevant. That is, regardless of whether they chose to use
exercise to cope with temptation, perhaps becoming regular exercisers
helped them to resist the urge to smoke (Shiffman, Kassel, Gwaltney, &
McChargue, 2005). This notion is strengthened by the finding that
abstinent smokers who increased in their confidence to change their
smoking behaviour also showed an increased confidence in their ability
to improve their exercise behaviour and vice versa. It is possible that
simultaneously being confident in changing these two complex
behaviours resulted in participants reporting they would not give in to
the urge to smoke.
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The majority of participants, coming into the programme, were inactive
and not meeting the current Canadian Society for Exercise Physiology
guidelines for physical activity (CSEP). Although they were engaging in
exercise on a regular basis throughout the programme, intensive
exercise coping skills training may be required before they perceive
exercise as a behavioural coping strategy in high-risk situations.
Providing participants with such training would not have been out of
the question. These skills could have been taught weekly at the end of
the first exercise session over a 15-20 minute session. Alternatively, in the
interest of cost and for improved scalability of such an intervention they
could have been administered over the internet or in a take-home
package.
One of the aims of study three was to determine under what
circumstances smokers or abstinent smokers would perceive exercise to
have the greatest utility as a relapse coping strategy. No difference
was observed between the different relapse constructs investigated. It
is possible that imagined future use of exercise to prevent relapse may
have been improved by instructing participants as to different types of
exercise strategies for different situations (e.g., at a bar socialising - use
isometric contractions; stressed at work - go for a walk at lunch time).
Quitting tobacco involves three phases: (1) preparation or getting
ready to quit; (2) cessation or actually quitting; and (3) maintenance or
relapse prevention (TTS, 2010). Any effective treatment plan must
address all three phases. The results of the present dissertation provide
evidence that exercise is an adjunct therapy that covers all three to
varying degrees.
When preparing to quit, smokers are advised to begin the process of
investigating alternative coping behaviours to smoking (TTS, 2010). Both
varenicline and bupropion, pharmacotherapy for smoking cessation,
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were designed to be initiated before the smoker attempts to quit.
Similarly, exercise is a smoking cessation aid that can be effectively
provided to smokers before their quit date. There is evidence in study
three to suggest that sedentary female smokers who successfully
increased their exercise behaviour demonstrated both an increased
confidence to exercise and an increased confidence to quit. Although,
it is not possible to say which change occurred first, it is possible that
exercise helped these women prepare to quit by increasing their
confidence in their ability to change in general.
Cigarette cravings are one of the most often expressed difficulties
related to quitting, and the intensity of craving experienced by an
abstinent smoker over the first few days of quitting often predicts their
success (Ferguson et al., 2006). The results of study one and two showed
that an acute bout of exercise not only relieved nicotine craving and
withdrawal symptoms (psychological and sedation) but it did so for a
group of abstinent smokers supplementing their nicotine with the
patch. These findings provide evidence for exercise supporting the
cessation phase (and the relapse phase) of becoming smoke-free.
Further, study two showed that an acute bout of exercise has the
potential to reduce cigarette craving even further if women
undergoing a quit attempt believe it to be an effective smoking
cessation treatment.
For both cohorts of women who took part in this research (study one,
two, and three) smoking cessation rates were highest when more than
80 percent of the programme was attended. Engaging in exercise may
have reinforced a participant’s commitment to making healthy lifestyle
changes, in particular giving up smoking (Prochaska, Hall, Humfleet,
Munoz, Reus, Gorecki, & Hu, 2008). In addition, these findings support
the notion that exercise and smoking are incompatible behaviours and
as such complement one another other when an individual is going
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through a period of lifestyle change (King, Marcus, Pinto, Emmons, &
Abrams, 1996).
Evidence for exercise as a relapse prevention strategy comes from the
craving and withdrawal relief demonstrated following an acute bout of
exercise in study one and two. In addition, study three also provided
some evidence that exercise can assist with relapse prevention.
Specifically, a large number of participants (40% at week five, 38% at
week 14) responded that they would be highly likely to exercise to
avoid relapse ‘when I see that I am gaining weight’. Nicotine has been
found to have powerful effects on the regulation of body weight. When
a smoker quits it can lead to physiological pressure to gain weight
(Grunberg & Bowden, 1985). The weight gain associated can have
negative psychological consequences for the quitter and result in
resumption of smoking (Brownell, Marlatt, Lichtenstein, & Wilson, 1986;
Schneider & Waters, 2007). Therefore, although study three did not
show quitters to consistently report that they would use exercise to help
them remain abstinent, they did report that they would use exercise to
counter this leading cause of relapse.
The results of the present dissertation also provided some evidence for
exercise as an effective harm reduction strategy. It is presumed that
there will always be a percentage of smokers that find it extremely
difficult to quit. These so called hardened smokers, likely smoke many
cigarettes a day and have been doing so for many years (TTS, 2010).
Although, completely quitting smoking is always best, a harm reduction
strategy may be appropriate for smokers who find it extremely difficult
to quit and are repeatedly unsuccessful (TTS, 2010). In order for a
smoking cessation treatment to be considered an effective harm
reduction strategy it must fulfil a number of criteria (eight criteria in
total) (deRuiter & Faulkner, 2006). Pertaining to this dissertation,
evidence for exercise as a harm reduction strategy was found for the
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following five criteria: (1) the harm-reduction strategy should not
increase or contribute to the individuals level of nicotine dependence;
(2) the strategy should not sabotage the likelihood of eventual
cessation; (3) the strategy should not lead to an increased population
prevalence

of

tobacco

dependence;

(4)

the

strategy

should

eventually allow the smoker to become nicotine free; and (5)
information that might ultimately lead an individual to quit smoking
should be able to be incorporated into the harm-reduction strategy
(Hatsukami, Henningfield, & Kotlyar, 2004; deRuiter & Faulkner, 2006).
Evidence from study one and two suggests that an acute bout of
exercise in a more natural setting (e.g., gym setting) amongst those
who had recently quit had the effect of reducing craving and
withdrawal symptoms. Therefore, as exercise lessens craving and
withdrawal symptoms it is unlikely to increase or contribute to the
individual’s level of nicotine dependence. On the contrary, reducing
craving and withdrawal would likely increase the time between
cigarettes (Taylor & Katomeri, 2007). Additionally, the intensity of
craving and withdrawal symptoms experienced during a quit attempt
are a good indicator of relapse. The ability of an acute bout of exercise
to ameliorate craving and withdrawal symptoms, demonstrated in
study one and two, make it possible that exercise participation would
contribute to the individual eventually becoming nicotine free.
The results of study three indicated that an increase in exercise
behaviour would not lead to an increase in population prevalence of
tobacco

dependence.

Specifically,

it

was

demonstrated

that

participants concurrently increased in both cessation and exercise selfefficacy, and those who maximally attended the exercise sessions were
more likely to quit. These two findings suggest that exercise and
smoking are not compatible behaviours. Therefore, it is unlikely that
exercise would sabotage eventual cessation.
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More and more, tobacco treatment specialists are integrating physical
activity promotion into their smoking cessation programmes (TTS, 2010).
Indeed, exercise and smoking cessation research has shown it is
possible to successfully incorporate exercise as part of a multicomponent cessation strategy (Marcus et al., 1999; Ussher, West,
McEwen, Taylor, & Steptoe, 2003). In study two it was demonstrated
that smokers believed exercise and NRT to be equally as credible and
expected both cessation strategies would help them quit smoking.
Thus, it is likely that the incorporation of smoking cessation and physical
activity messages would be well received by smokers.
However, it should be noted that the promising results in this dissertation
were found when exercise behaviour was specifically targeted, which
challenges the cost effectiveness and scalability of an exercise aided
intervention such as this. Nevertheless, exercise as a smoking cessation
adjunct has great potential as both a harm reduction strategy and as a
multi-phase treatment. For these reasons, finding a way to incorporate
exercise into cessation treatment such that it becomes widely available
and easily accessible has great public health potential (Fiore, Jaen, &
Baker, 2008; Maddison, Roberts, Bullen, McRobbie, Jiang, Prapavessis,
Glover, Taylor, & Brown, 2010). In study three of this dissertation
evidence was garnered to suggest that it is possible to concurrently
change these two behaviours (smoking behaviour and physical activity
behaviour). Research in New Zealand is currently underway to
determine the feasibility of incorporating two national services (Quitline
and Green Prescription) (Maddison et al., 2010). Similarly, a group of
researchers in the United Kingdom have investigated the feasibility of
embedding physical activity promotion into existing smoking cessation
services (Taylor, Everson-Hock, & Ussher, in press). The results of these
two trials are eagerly awaited and will pave the way for future exercise
and smoking cessation work. As an alternative to incorporating exercise
into smoking programmes, smoking cessation treatment could be
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incorporated into exercise environments such as in gyms or in
community centres.
Overall, the present dissertation addressed the need for research on
the mechanisms responsible for exercise effects on smoking cessation. It
did so in a more natural environment with women undergoing a real
quit attempt and using NRT. In addition, evidence was provided that
exercise may be a smoking cessation strategy that can help a smoker
quit and resist relapse. Finally, evidence is provided to further the cause
for exercise as a potential harm reduction strategy. Ultimately it is
hoped that the information contained within this dissertation will assist
researchers and clinicians to improve cessation rates.
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Appendix 1. Sociodemographic questionnaire

CONTACT INFORMATION:
First Name:_________________________

Last Name:________________________

Address:___________________________________________________________________
STREET ADDRESS, CITY, POSTAL CODE
Home Phone: ________- _________-_________
Email Address: __________________________________________@_____________________
Date of Birth: ________/________/___________
DD
MM
YYYY
Section A
1.

Age:_________ (in years)

2.

What language do you speak most often at home?
(Please check one)

 English
 French
 Cantonese
 Mandarin
 Italian
 German
 Punjabi
 Spanish
 Polish
 Portugese
 Arabic
 Other (specify:____________ )

3.

Were you born in Canada? (Please check one)

 Yes

 No

4.

Marital status: (Please check one)
 single
 separated
 divorced
 widowed

 married
 common law

Section B – Children
Please complete the following questions about any children you may have.
5. Do you have any children? (Please check one)
 Yes
 No
6.

If yes, please list their ages, separated by commas:
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Section C – Education & Employment
7.

What is the highest grade (or year) of regular school have you completed?
(please check one)
Elementary
 01
 02
 03
 04
 05
 06
 07
 08

High school
 09
 10
 11
 12 +

College/University
 01
 02
 03
 04 +

Graduate school
 01
 02
 03
 04

8.

What is the highest degree you earned?
(Please check one)
 High school diploma
 College certificate
 Bachelor’s degree
 Masters degree
 Doctorate
 Professional (MD, LLB, DDS, etc.)
 Other (specify: ______________________ )
 None of the above

9.

Which of the following best describes your main daily activities and/or
responsibilities?
(Please check one)
 Working full-time
 Working part-time
 Unemployed or laid-off
 Looking for work
 Student
 Keeping house or raising children full-time

10. Are you currently working?
(Please check one)
 Yes
 No
If YES, approximately how many hours/week are you working?______________
11. Which of these categories best describes your total combined family income for
the past 12 months? This should include income (before taxes) from all sources,
wages, rent from properties, social security, disability and/or veteran’s benefits,
unemployment benefits, workman’s compensation, help from relatives (including
child payments and alimony), and so on.
(Please check one)
 Less than $5 000
 $5 000 - $11 999
 $12 000 - $15 999
 $16 000 - $24 999

 $25 000 - $34 999
 $35 000 - $49 999
 $50 000 - $74 999
 $75 000 - $99 999

 $100 000 +
 don’t know
 no response
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Section D – Smoking History & Current Practices
12. What is the approximate date and time of the last cigarette you have smoked?
Date: ______________ Time: ________________
13. Does anyone in your household currently smoke?
(Please check one)
 Yes
 No
14. In your best estimate, what percentage of your friends and family smoke?
(Please check one)
 0 – 10%
 11 – 20%
 21 - 30%
 31 - 40%
 41 - 50%
 51% +
Section E – Medical Information
To the best of your knowledge, do you have: Please list your current drugs & medications (i.e.,
blood pressure pills, prescribed medicine):
Yes
No


High blood pressure


High blood cholesterol


High blood sugar


Diabetes (Type II)

Do you drink Alcohol?

 Yes

 No

If yes, number of drinks per week? _______
_______
________
(Beer)
(Wine) (Hard Liquor)
Section F
How did you hear about our programme?
 UWO Staff email
 UWO Student email
 Your place of work (please name workplace) ________________
 The Londoner Newspaper
 The London Free Press
 Smokers’ Helpline
 The Canadian Cancer Society
 The Health Unit
 Other (please specify) _____________________________
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Appendix 2. Fagerström nicotine dependence

1. How many cigarettes per day do you usually smoke?

_______________

2. How soon after you wake up do you smoke your first
cigarette?
(circle one response)

Within 5 minutes
6-30 minutes
31 or more

3. Do you find it difficult to refrain from smoking in places
where it is forbidden (e.g. in the mall, at the library, in
the cinema?)
(circle one response)

No

4. Which cigarette would you most hate to give up?
(circle one response)

The
first
morning

Yes

Other

5. Do you smoke more frequently in the first hours after
waking than during the rest of the day? (circle one
response)

No

6. Do you smoke if you are so ill that you are in bed most
of the day?
(circle one response)

No

Yes

Yes

of

the
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Appendix 3. Motivation to quit smoking and smoking and physical activity history

1. Do you want to quit smoking for good?
a. Yes
b. No
c. Unsure

2. Do you intend to make a serious attempt to stop smoking for good?
a. Yes
b. No
c. Unsure

3. How many cigarettes do you smoke, on average, per day?
___________ cigarettes/day

4. How many years have you been smoking the above number of cigarettes per
day?
___________ years

5. How many years ago did you begin to smoke regularly?
___________ years

6. Have you tried to quit smoking in the past?
a. Yes
b. No

7. If you have attempted to quit smoking in the past, how many times have you
tried?
_________ times

8. Think about your physical activity behaviour in the past month. On average, how
many times per week have you engaged in 30 minutes or more of regular
moderate (e.g., jogging, playing tennis, riding your bike) to vigorous (e.g., running,
spin classes, high impact aerobics classes) physical activity during your spare
time?
_________ times per week

9. How many months have you been exercising at the above frequency per week?
_________ months
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Appendix 4. Shiffman-Jarvik withdrawal scale

INSTRUCTIONS: Please CIRCLE the number to the right of each question that most
accurately reflects how you feel at this moment.

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.

If you could smoke freely, would you like a
cigarette right now?
Is your heart beating faster than usual?
Do you feel more calm than usual?
Are you able to concentrate as well as usual?
Do you feel wide awake?
Do you feel content?
Are you thinking of cigarettes more than
usual?
Do you have fluttery feelings in your chest?
Do you feel hungrier than usual for this time of
day?
If you were permitted to smoke, would you
refuse a cigarette right now?
Do you feel more tense than usual?
Do you miss a cigarette?
Do you have an urge to smoke a cigarette
right now?
Are you feeling irritable?
Are your hands shaky?

Definitely not
1
2
3

4

5

Definitely
6
7

1
1
1
1
1
1

2
2
2
2
2
2

3
3
3
3
3
3

4
4
4
4
4
4

5
5
5
5
5
5

6
6
6
6
6
6

7
7
7
7
7
7

1
1

2
2

3
3

4
4

5
5

6
6

7
7

1

2

3

4

5

6

7

1
1
1

2
2
2

3
3
3

4
4
4

5
5
5

6
6
6

7
7
7

1
1

2
2

3
3

4
4

5
5

6
6

7
7

Scoring:
Craving – 1, 7, 10 reversed, 12,13
Physical – 2, 8, 15
Sedation – 5 reversed
Psychological – 3 reversed, 4 reversed, 6 reversed, 11,14
Appetite – 9
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Appendix 5. Smoking ladder

Below are some thoughts that smokers have about quitting. On this ladder, circle the
one number that shows what you think about quitting. Please read each sentence
carefully before deciding.

10

I have quit smoking and I will never smoke again.

9

I have quit smoking, but I still worry about slipping back, so I need to keep
working on living smoke free.

8

I still smoke, but I have begun to change, like cutting back on the number
of cigarettes I smoke. I am ready to set a quit date.

7
6
5
4
3
2
1

I definitely plan to quit smoking with the next 30 days.
I definitely plan to quit smoking in the next 6 months.
I often think about quitting smoking, but I have no plans to quit.
I sometimes think about quitting smoking, but I have no plans to quit.
I rarely think about quitting smoking, and I have no plans to quit.
I never think about quitting smoking, and I have no plans to quit.
I enjoy smoking and have decided not to quit smoking for my lifetime. I
have no interest in quitting.
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Appendix 6. Godin leisure-time exercise questionnaire
During the last 7 days, how many times did you do the following kinds of exercise for
more than 15 minutes during your free time (write on each line the appropriate
number)?
Times Per Week

a) STRENUOUS EXERCISE (heart beats rapidly)
(e.g., running, jogging, hockey, football, soccer,
squash, basketball, cross country skiing, judo,
roller skating, vigorous swimming,
vigorous long distance bicycling).

______ times

b) MODERATE EXERCISE (not exhausting)
(e.g., fast walking, baseball, tennis, easy bicycling,
volleyball, badminton, easy swimming, alpine skiing,
popular and folk dancing).

______ times

c) MILD EXERCISE (minimal effort)
(e.g., yoga, archery, fishing from river bank, bowling,
horseshoes, golf, snow-mobiling, easy walking).

______ times

During the last 7-Day period (week), in your leisure time, how often did you engage in
any regular activity long enough that your heart would beat rapidly (work up a
sweat)?
1. Often _______

2. Sometimes _______ 3. Rarely/Never _______
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Appendix 7. Stage of exercise readiness

Please place a tick (√) next to the statement that best applies to you. Only tick one
statement.
___

I do not currently exercise and am not seriously thinking about changing in the
next 6 months.

___

I do not currently exercise but I am seriously thinking about changing in the
next 6 months.

___

I exercise sometimes but not regularly.

___

I have started to exercise regularly (most days of the week for at least 45
minutes each time) in the last 6 months.

___

I exercise regularly (most days of the week for at least 45 minutes each time)
and have done so for longer than 6 months.
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Appendix 8. Previous patch experience form

ID Number: _______________________
The questions below ask about your previous experience with the patch (nicotine
replacement therapy e.g. NicoDerm, Nicorette). Please answer the questions as
honestly as possible there are no right or wrong answers.
1. Have you ever tried to quit smoking using the patch before?
a. Yes
b. No
2. If you have, how many times have you used the patch?
_______________
3. How would you rate your previous experience with using the patch?
Extremely poor
1
2

Unsure
4

3

5

6

Extremely good
7

4. If you have managed to quit using the patch before, how much of your quit
success do you attribute to the patch?
0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%
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Appendix 9. Expectancy and credibility questionnaire

INSTRUCTIONS: We would like you to indicate how much you believe, right now, that
the two quit smoking aids [NicoDerm® patch (NRT) and EXERCISE] you receive during
this programme will help you to quit. Belief usually has two aspects to it: (1) what you
think will happen; and (2) what you feel will happen. Sometimes these are similar,
sometimes they are different. Please answer the questions below. In the first set,
answer in terms of what you think. In the second set answer in terms of what you really
and truly feel.
Set I
1. At this point, how logical do the quit smoking aids offered to you seem?
Not at all
1
2
1
2

NRT
EXERCISE

3
3

4
4

Somewhat
5
5

6
6

Extremely
8
9
8
9

7
7

2. At this point, how successfully do you think these treatments will manage your
craving and withdrawal symptoms?
Not at all
1
2
1
2

NRT
EXERCISE

3
3

4
4

Somewhat
5
5

6
6

Extremely
8
9
8
9

7
7

3. How confident would you be in recommending these treatments to a friend who
wants to quit smoking?
Not at all
1
2
1
2

NRT
EXERCISE

3
3

4
4

Somewhat
5
5

6
6

Extremely
8
9
8
9

7
7

4. By the end of the programme how much of your success do you think will be
attributed to each of the quit smoking aids offered?
None
1
1

NRT
EXERCISE

2
2

3
3

4
4

Some
5
5

All
6
6

7
7

8
8

5. How important is quitting smoking to you?
Not at all
1

2

3

4

Somewhat
5

6

7

8

Extremely
9

9
9
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Set II
For the next two questions, close your eyes for a few moments, and try to identify
what you really feel about the quit smoking aids offered. Then answer the following
questions.

1. At this point, how much do you really feel that the quit smoking aids offered will
help you to manage your craving and withdrawal symptoms?

NRT
EXERCISE

Not at all
1
2
1
2

3
3

4
4

Somewhat
5
5

6
6

7
7

8
8

Extremely
9
9

2. By the end of the programme, how much of your quit success do you really feel
will be related to the quit smoking aids offered?

NRT
EXERCISE

None
1
1

2
2

3
3

4
4

Some
5
5

All
6
6

7
7

8
8

9
9

Questionnaire adapted from the Credibility/Expectancy Questionnaire (Devilly and
Borkovec, 2000).
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Appendix 10. Temptations questionnaire
INSTRUCTIONS: Listed below are situations that lead some people to smoke. We would like to
know HOW LIKELY you would be to SMOKE OR EXERCISE in each situation.
Please answer the questions using the four point scale with 1 = A LITTLE LIKELY and 4 =
EXTREMELY LIKELY. You may choose to respond by either SMOKING OR EXERCISE. Please circle
ONLY ONE RESPONSE.
REMEMBER: Circle the answer that best reflects how you would respond. There is no right or
wrong answer. It is very important that you are honest.
HOW LIKELY ARE YOU TO SMOKE?
Extremely Very Somewhat A little
likely
likely
likely
likely
4
3
2
1

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.

Unsure
0

HOW LIKELY ARE YOU TO EXERCISE?
A little Somewhat Very Extremely
likely
likely
likely
likely
1
2
3
4

When I am desiring a cigarette
When things are just not going the way I want and I am
frustrated
With my spouse or close friend who is smoking
When there are arguments and conflicts with my family
When I am very angry about something or someone
When I see someone smoking and enjoying it
When I realise that quitting smoking is a difficult task for me
When I am craving a cigarette
When I first get up in the morning
When I feel I need a lift
When I begin to let down on my concern about my health
When I am depressed
When I am anxious and stressed
When I realise I haven’t smoked for a while
When alone and feeling depressed
When I am nervous
With friends at a party
Over coffee while talking and relaxing
At work when I am experiencing some pressure in my job
At a bar or cocktail lounge having a drink
When I wake up in the morning and face a tough day
When I am happy and celebrating
When I am bored and have nothing to do
When I would experience an emotional crisis (i.e. an accident or
death in the family)
When I see that I am gaining weight

SMOKE
EXERCISE
4 3 2 1 0 1 2 3 4
4 3 2 1 0 1 2 3 4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4

3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3

2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3

4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4

4 3 2 1 0 1 2 3 4

Velicer, W. F., DiClemente, C. C., Rossi, J. S., & Prochaska, J. O. (1990). Relapse situations and selfefficacy an integrative model. Addictive Behaviors, 15, 271-283
DiClemente, C. C. (1981). Self-efficacy and smoking cessation maintenance: a preliminary report.
Cognitive Therapy and Research, 5(2), 175-187.
Negative/affective questions – 2, 4, 5, 12, 13, 24
Habit/addictive questions – 7, 9, 10, 11, 14

Positive/social questions – 3, 6, 17, 18, 20, 22
Cessation self-efficacy questions – 3, 15-25
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Appendix 11. Cessation self-efficacy
For each the items below, please rate your degree of certainty that you could avoid
smoking in each of the situations.
Completely
sure
1.
2.

When alone and feeling depressed
When I am nervous

3.

With friends at a party

4.
5.

Over coffee while talking and relaxing
With my spouse or a close friend who is
smoking
At work when I am experiencing some
pressure in my job
At a bar or cocktail lounge having a
drink
When I wake up in the morning and
face a tough day
When I am happy and celebrating
When I am bored and have nothing to
do
When I would experience an
emotional crisis (i.e. an accident or
death in the family)
When I see that I am gaining weight

6.
7.
8.
9.
10.
11.
12.

Completely
unsure

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7
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Appendix 12. Exercise task self-efficacy
The next questions ask how confident you are that you can participate in physical
activities classified as “light”, “moderate” and “hard”. The word “confident” refers to
the belief that you have in yourself that you can do something well. Please circle the
number that best represents your confidence level to do the following:
1. How confident are you that you can complete 10 minutes of physical activity at a
light intensity level three times next week?

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
extremely
confident

2. How confident are you that you can complete 30 minutes of physical activity at a
light intensity level three times next week?

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
extremely
confident

3. How confident are you that you can complete 60 minutes of physical activity at a
light intensity level three times next week?

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
extremely
confident

4. How confident are you that you can complete 10 minutes of physical activity at a
moderate intensity level three times next week?

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
extremely
confident

5. How confident are you that you can complete 30 minutes of physical activity at a
moderate intensity level three times next week?

0

10

not at all
confident

20

30

40

50

60

somewhat
confident

70

80

90

100
extremely
confident
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6. How confident are you that you can complete 60 minutes of physical activity at a
moderate intensity level three times next week?

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
extremely
confident

7. How confident are you that you can complete 10 minutes of physical activity at a
hard intensity level three times next week?

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
extremely
confident

8. How confident are you that you can complete 30 minutes of physical activity at a
hard intensity level three times next week?

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
extremely
confident

9. How confident are you that you can complete 60 minutes of physical activity at a
hard intensity level three times next week?

0

10

not at all
confident

20

30

40

50

60

somewhat
confident

70

80

90

100
extremely
confident
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Appendix 13. Exercise barrier self-efficacy
How confident (from 0% - 100%) are you that when faced with one of the situations
below, you will still be able to participate in 60 minutes of physical activity most days
next week?
10. If it is bad weather?

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
extremely
confident

11. If I am tired?

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
extremely
confident

12. If I am sore?

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
extremely
confident

13. If I have work to do?

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
extremely
confident

14. If I have family obligations?

0

10

not at all
confident

20

30

40

50

60

somewhat
confident

70

80

90

100
extremely
confident
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Appendix 14. Exercise scheduling self-efficacy
The following is a list of behaviours associated with participating in INDEPENDENT
exercise for the next week. Please consider each specific behaviour as it applies to
you.
In addition to attending your weekly exercise program sessions, how confident are
you that you can …
1. Participate in independent exercise three times per week next week.

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
completely
confident

2. Plan for participation in my independent exercise sessions in my daily activities
next week.

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
completely
confident

3. Arrange my schedule to do independent exercise regularly no matter what next
week.

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
completely
confident

4. Maintain a definite plan to restart my independent exercise if I should miss any
sessions next week.

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
completely
confident

5. Make up times when I miss my regular independent exercise sessions next week.

0

10

not at all
confident

20

30

40

50

60

somewhat
confident

70

80

90

100
completely
confident
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6. Make sure that I do not miss more than one day of independent exercise due to
other obligations next week.

0

10

20

30

40

not at all
confident

50

60

70

80

90

somewhat
confident

100
completely
confident

7. Organize next week’s time and responsibilities around each of my independent
exercise sessions no matter what.

0

10

not at all
confident

20

30

40

50

60

somewhat
confident

70

80

90

100
completely
confident
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Appendix 15. Physical activity readiness questionnaire

1. Has your doctor ever said that you have a heart condition and that you should
only do physical activity recommended by a doctor?
[ ] Yes
[ ] No
2. Do you feel pain in your chest when you do physical activity?
[ ] Yes
[ ] No
3. In the past month, have you had chest pain when you were not doing physical
activity?
[ ] Yes
[ ] No
4. Do you lose your balance because of dizziness or do you ever lose consciousness?
[ ] Yes
[ ] No
5. Do you have a bone or joint problem that could be made worse by a change in
your physical activity?
[ ] Yes
[ ] No
6. Is your doctor currently prescribing drugs (for example, water pills) for your blood
pressure or heart?
[ ] Yes
[ ] No
7. Do you know of any other reason why you should not do physical activity?
[ ] Yes
[ ] No

___________________________________
Name
___________________________________
Date

_____________________________________
Signature
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To be completed by Physician:

Patient is fit to start an exercise programme
 Recommended/Approved

 Contraindicated

Patient is fit to use NicoDerm patch
 Recommended/Approved

___________________________________
Physician’s Name

___________________________________
Date

 Contraindicated

________________________________
Signature
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Appendix 16. Cronbach’s alphas

Chapter Two
Shiffman-Jarvik withdrawal scale
Time
Craving
Week 5
.834
Week 11
.770
Week 13
.854

Psychological
.817
.790
.833

Physical
.680
.779
.669

Chapter Three
Temptation questionnaire
Time
EX-EXP
Baseline
.709
Week 5
.891
Week 14
.923

EX-CRED
.829
.891
.857

Shiffman-Jarvik withdrawal scale
Time
Craving
Week 5
.875
(question 10 removed)

NRT-EX
.781
.930
.932

NRT-CRED
.824
.886
.722
(question 2
removed)

Psychological
.767

Chapter Four
Temptation scale
Time
Positive/Social
Baseline
.799
Week 2
.798
Week 3
.802
Week 4
.785
Week 5
.864
Week 6
.861
Week 7
.909
Week 8
.928
Week 10
.891
Week 12
.881
Week 14
.874
Exercise and cessation self-efficacy
Time
Barrier
Baseline
.940
Week 6
.921
Week 14
.965

Negative/Affective
.759
.837
.926
.913
.882
.859
.772
.924
.922
.909
.876

Task
.954
.921
.959

Scheduling
.977
.961
.985

Habit/Addiciton
.669
.734
.775
.846
.785
.825
.813
.862
.826
.840
.772

Cessation
.842
.880
.849
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Appendix 17. Temptations questionnaire frequencies

Question
Number
1

2

3

4

5

Response
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00

Week 5
Frequency
1

Percent
2.1

2
8
9
17
5
3
2

4.3
17.0
14.8
36.2
10.6
6.4
4.3

4
5
3
8
17
4
6

8.5
10.6
6.4
17.0
36.2
8.5
12.8

1
2
3
12
13
8
4
3
1
2
2
2
12
15
7
3
3
1
2
1
4
10
6
11
66
5

2.1
4.3
6.4
25.5
27.7
17.0
8.5
6.4
2.1
4.3
4.3
4.3
25.5
31.9
14.1
6.4
6.4
2.1
4.3
2.1
8.5
21.3
12.8
23.4
12.8
10.6

Response
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00

Week 14
Frequency
1
3
2
6
10
9
5
4

Percent
2.5
7.5
5.0
15.0
25.0
22.5
12.5
10.0

4
2
6
12
8
7
1

10.0
5.0
15.0
30.0
20.0
17.5
2.5

3
1
9
19
5
2

7.5
2.5
22.5
47.5
12.5
5.0

1

2.5

4
1
7
13
7
6

10.0
2.5
17.5
32.5
17.5
15.0

2

5.0

3

7.5

4
13
6
9
3

10.0
32.5
15.0
22.5
7.5

192

6

7

8

9

10

11

4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00

2
2

4.3
4.3

1
11
19
7
1
5
1
2

2.1
23.4
40.4
14.9
2.1
10.6
2.1
4.3

2
5
12
12
8
3
3

4.3
10.6
25.5
25.5
17.0
6.4
6.4

2
3
5
13
13
6
3
2
1
2
2
6
12
14
3
5
2
1

4.3
6.4
10.6
27.7
27.7
12.8
6.4
4.3
2.1
4.3
4.3
12.8
25.5
29.8
6.4
10.6
4.3
2.1

1
2
10
13
11
6
3

2.1
4.3
21.3
27.7
23.4
12.8
6.4

2
1

4.3
2.1

4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00

2

5.0

2
8
17
6
4
1
2

5.0
20.0
42.5
15.0
10.0
2.5
5.0

6
16
8
6
3
1
1

15.0
40.0
20.0
15.0
7.5
2.5
2.5

3
8
8
10
6
3
1
1

7.5
20.0
20.0
25.0
15.0
7.5
2.5
2.5

1
7
16
4
3
7
1

2.5
17.5
40.0
10.0
7.5
17.5
2.5

1
3
11
7
9
7
2
1

2.5
7.5
27.5
17.5
22.5
17.5
5.0
2.5

1

2.5
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12

13

14

15

16

-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00

7
9
11
7
9
1
1
3
3
1
15
10
8
4
2
1
1
7
5
7
13
5
5
3

14.9
19.1
23.4
14.9
19.1
2.1
2.1
6.4
6.4
2.1
31.9
21.3
17.0
8.5
4.3
2.1
6.4
6.4
2.1
31.9
21.3
17.0
8.5
4.3

2
1
2
16
15
5
4
2
1
2
4
7
14
9
6
3
1
1
1
5
7
16
8
5

4.3
2.1
4.3
34.0
31.9
10.6
8.5
4.3
2.1
4.3
8.5
14.9
29.8
19.1
12.8
6.4
2.1
2.1
2.1
10.6
14.9
34.0
17.0
10.6

-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00

3
11
5
7
8
4
1
1
1
5
11
9
5
4
3
1
2
1
5
11
6
9
3
2

7.5
27.5
12.5
17.5
20.0
10.0
2.5
2.5
2.5
12.5
27.5
22.5
12.5
10.0
7.5
2.5
5.0
2.5
12.5
27.5
15.0
22.5
7.5
5.0

1

2.5

5
21
5
6
1
1
1

12.5
52.5
12.5
15.0
2.5
2.5
2.5

6
14
6
7
3
3
1
1

15.0
35.0
15.0
17.5
7.5
7.5
1.5
1.5

5
17
3
10

12.5
42.5
7.5
25.0
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17

18

19

20

21

22

3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00

3
1
3
1
3
7
24
6
1
2

6.4
2.1
6.4
2.1
6.4
14.9
51.1
12.8
2.1
4.3

2
4
4
24
9
4

4.3
8.5
8.5
51.1
19.1
8.5

1
1
4
6
19
8
3
5

2.1
2.1
8.5
12.8
40.4
17.0
6.4
10.6

1
1
6
8
19
9
1
1
1
1
4
4
2
14
11
7
3
1
1

2.1
2.1
12.8
17.0
40.4
19.1
2.1
2.1
2.1
2.1
8.5
8.5
4.3
29.8
23.4
14.9
6.4
2.1
2.1

3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00

1
2
1
1
2
12
20
1
3

2.5
5.0
2.5
2.5
5.0
30.0
50.0
2.5
7.5

1
7
27
2
3

2.5
17.5
67.5
5.0
7.5

1
4
22
5
3
5

2.5
10.0
55.0
12.5
7.5
12.5

1
1
3
8
23
1
3

2.5
2.5
7.5
20.0
57.5
2.5
7.5

2

5.0

7
14
5
7
3
2

17.5
35.0
12.5
17.5
7.5
5.0

2

5.0
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23

24

25

-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00

1
5
16
13
4
5
2
2
4
4
6
15
5
9
2
47
7
5
2
5
19
5
1
2
1
1

11
9
7
9
10

2.1
10.6
34.0
27.7
8.5
10.6
4.3
4.3
8.5
8.5
12.8
31.9
10.6
19.1
4.3
14.9
10.6
4.3
10.6
40.4
10.6
2.1
4.3
2.1
2.1

23.4
19.1
14.9
19.1
21.3

-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00
-4.00
-3.00
-2.00
-1.00
.00
1.00
2.00
3.00
4.00

2
5
17
6
7
1

5.0
12.5
42.5
15.0
17.5
2.5

1

2.5

6
13
5
6
5
4
7
1
3
3
16
3
5

15.0
32.5
12.5
15.0
12.5
10.0
17.5
2.5
7.5
7.5
40.0
7.5
12.5

2

5.0

4
4
9
4
4
6
9

10.0
10.0
22.5
10.0
10.0
15.0
22.5
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Appendix 18. Letter of information and consent
Study Title:

Getting Physical on Cigarettes

Principal Study Investigator:
Harry Prapavessis, Ph.D. (School of Kinesiology, The University of Western Ontario)
519-xxx-xxxx extension: xxxxx
Co-Investigators:
Guy Faulkner, Ph.D. (Faculty of Physical Education and Health, University of Toronto)
Ralph Maddison, Ph.D. (Clinical Trials Research Unit, University of Auckland)
Lyndsay Fitzgeorge, Ph.D. (School of Kinesiology, The University of Western Ontario)
Therese Harper MSc. (School of Kinesiology, The University of Western Ontario)
Kevin Shoemaker, Ph.D. (School of Kinesiology, The University of Western Ontario)
You are being invited to participate in a research study looking at the long-term
effects of exercise on helping women quit smoking. This is a clinical trial (a type of
research study) which includes eligible volunteers who choose to take part. Please
take your time to make a decision, and discuss this proposal with your personal
doctor, family members and friends as you feel inclined. The purpose of this letter is to
provide you with the information you require to make an informed decision on
participating in this research and to help us talk to you about smoking cessation
(quitting). This letter contains information to help you decide whether or not to
participate in this research study. It is important for you to understand why the study is
being conducted and what it will involve. Please take the time to read this carefully
and feel free to ask questions if anything is unclear or there are words or phrases you
do not understand. We are asking you to take part because you are a woman who
smokes and wishes to quit. We hope to recruit a total of 420 women and help them
quit smoking and remain smoke-free over a total of 13 months, as well as examine the
effect of exercise on maintaining a healthy body weight.
Invitation to Participate in Research and Eligibility Criteria
You are being invited to take part in this research study because you:
(a) are between the ages of 18 and 65
(b) smoke 10 or more cigarettes per day for the past 2 years or more and want to quit
(c) engage in 2 or less 30-minute bouts of moderate (e.g., jogging, playing tennis) or
vigorous (e.g., running, spin classes, high impact aerobics) intensity exercise over
the past 6 months
(d) do not have a medical condition that prevents you from exercising
(e) are not pregnant or intending on being pregnant over the next 13 months
(f) are able to read and write in English
(g) have a telephone or an email account that we can reach you at over the next 13
months
Please note that if you are pregnant, or wish to become pregnant during the
course of the study, you are NOT eligible to participate. If you become pregnant
during the course of the study, you must notify the study researchers immediately.
This is because low doses of radiation will be administered during one of the tests of
the study, and this could cause harm to a foetus or breast-fed baby.
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What is the purpose of this study?
This study is intended to evaluate how useful an exercise program, nicotine
replacement therapy (e.g., Nicoderm®), and support and advice from an exercise
counselor, is at helping women who smoke become smoke-free and remain
physically active for 13 months. We will also examine the effects of this program on
body composition (e.g., your weight, the ratio between your body fat and your body
muscle mass), your physical fitness, and your confidence to perform certain activities.
It has been shown in past research that exercising can help women quit smoking by
alleviating smoking withdrawal symptoms. Unfortunately, if the exercise program is
stopped, women often resume smoking. Our goal in this study is to help women learn
how to stick with an exercise program in their own homes, maintain their health and
weight through exercise, and subsequently stay motivated to remain smoke-free. The
information we gather will help guide the development of future programs to help
women like you who wish to quit.
Specific questions we hope to answer by conducting this study are:
1) Does the type of information and support given by the exercise counsellor make a
difference in terms of how long women who have recently quit smoking can
remain smoke-free?
2) Does the type of information and support given by the exercise counsellor make a
difference in terms of how long women who have recently quit smoking can
continue with their exercise program?
WHAT YOU ARE ASKED TO DO IN THIS STUDY?
1) Participate in a lab-based exercise program
Time involvement = 3 x 45 minutes each week for 14 weeks
If you choose to participate in this study, you will be asked to take part in an exercise
program three times per week for a total of 14 weeks. These exercise sessions will be
supervised by a trained exercise counselor, and will all take place in the Exercise and
Health Psychology Laboratory (EHPL) at the University of Western Ontario in the Arthur
and Sonia Labatt Health Sciences building. Each exercise session will last 45 minutes,
and will consist of a warm-up, cardiovascular work-out, and cool-down on pieces of
equipment such as the treadmill, stationary bike, stepper, and rower. You will be
asked to wear a heart rate monitor so that your efforts can be monitored to ensure
that you are working at an effective and safe exercise intensity, based on your fitness
level. A trained councilor will be there at all times to assist you. If you miss an exercise
session, you will be asked to make up for the missed session on the weekend at a
scheduled time.
2) Quit smoking
Time involvement = 0 minutes
After 4 weeks of this exercise program, we will ask you to stop smoking cigarettes
completely. To assist you in doing this, we will be providing you with commerciallyavailable nicotine replacement therapy (NICODERM®) in the form of daily patches
that adhere to your skin like a small band-aid. This will be dispersed to you in weekly
allotments each week from week 4 through 14 at the EHPL after your exercise sessions.
The dose that you will receive from this patch depends on your current level of
smoking, but will most likely result in you following the recommended guidelines of:
A) Wearing a 21mg patch each day for 6 weeks (weeks 4 through 10 of the
study)
B) Wearing a 14 mg patch each day for 2 weeks (weeks 11 and 12 of the study)
C) Wearing a 7 mg patch each day for 2 weeks (weeks 13 and 14 of the study)
In total, you will wear these daily patches for 10 weeks while you continue to exercise
at our exercise facility.
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3) Participate in support group that you are randomly assigned to
Time involvement = 3 x 15 minutes for a total of 3 weeks
You will also be provided with group counseling and support information during weeks
12 through to week 14 of the program. The type of support information you will
receive during these weeks depends on which group you are randomized to. In other
words, the participants in the study will be assigned at random (like a flip of a coin),
that is, by a method of chance, to one of 4 groups. You will have a 1 in 4 chance of
being in any one of the support groups. The four support groups are as follows:
1. Lifestyle Exercise Maintenance Group
2. Relapse Prevention Group
3. Health and Nutrition Maintenance Group
4. Lifestyle Exercise Maintenance and Relapse Prevention Group
ALL support groups will receive information related to health for women from the
trained exercise counselor you have been working with in a group format (e.g., with
the other women you have been exercising with). This information will be delivered for
15 minutes at the end of each exercise session in the EHPL during weeks 12 through 14
of the study.
The trained exercise counselor you have been working with will also follow-up with
you via either phone or email (it is your choice which mode of communication you
would like to be contacted through) to provide support and encourage you to
remain physically active and remain smoke free after the program has ended for 10
additional months.
4) Perform tests
There are a number of tests that you will be asked to do if you choose to participate
in this study. ALL tests will be performed within the EHPL under trained research staff.
These tests provide the study researchers with evidence that will help us answer the
research questions. At baseline testing (before the exercise program begins), we will
ask you to perform a number of these tests so that we may measure how you are
doing before you quit smoking and before you begin to exercise.
i)
Baseline Testing
Time involvement = 3 hours
For baseline testing, you will be asked to visit our exercise facility (the Exercise and
Health Psychology Laboratory; EHPL) at the University of Western Ontario. Baseline
testing will begin after you have provided the study researchers with written consent
from your family physician indicating that he or she supports your involvement in this
study. Baseline testing will take approximately 4 hours and will include completing a
number of questionnaires, or surveys, as well as some physical tests.
The surveys will ask you about:
• Your motivation to quit smoking (“How motivated are you to quit smoking in the
next 7 days?”)
• Physical activity (“In the past week, how often did you do light activities, such as
yoga or slow walking?”, “Has your doctor ever advised you NOT to engage in
physical activity?”)
• Your personal goals for quitting smoking (“Please identify your most important
smoking cessation goal”)
• Your personal goals for engaging in exercise (“Please identify your most important
exercise goal”)
• Smoking history (“In the past week, how many cigarettes did you consume?”)
• A demographic questionnaire (which asks you about information such as your
age, education, martial status, income)
• Your satisfaction with your weight (“How satisfied, or content, are you with your
current body weight?”)
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•

Your confidence in your abilities to do activities related to exercise and quitting
smoking (“How confident are you in your ability to exercise for 30min continuously,
once per week?”)
• Your smoking cravings (“How irritable do you feel right now?”)
• Your dependence on nicotine (“How soon after you first wake up do you have a
cigarette?”)
• Your sleeping patterns (“In the past week, how often did you have trouble falling
asleep?”)
• Your mood (“How often during the past week did you feel full of pep?”)
It is important to note that there are no correct or incorrect answers to these
questions, and you may choose to skip any questions you do not feel comfortable in
answering.
The physical tests will consist of:
• An aerobic fitness test on a treadmill (often called a maximal oxygen uptake
treadmill test). A trained research technician will be performing the test on you,
making sure you are safe and comfortable at all times. This test is performed
regularly in our laboratory. Length of the treadmill test varies from 9 to 18 minutes,
depending on your level of physical fitness. The test begins by having you walk at
an easy pace on a treadmill (e.g., the pace you walk when you walk down the
street). The speed and incline of the treadmill will then be gradually increased
every 3 minutes until you indicate to us that you do not wish to continue, or you
reach your age-predicted maximum heart rate, as determined by a trained
research technician. During this test you will breath through a mouthpiece
connected to a computer that will measure your oxygen consumption. By doing
this test, we will be able to assess your aerobic fitness and also determine the level
of training intensity that is safe for you to exercise at during the exercise program.
The test will end with a cool-down, where you will walk at an easy, self-selected
pace for 5 minutes.
•

A non-invasive body composition test. The body composition test uses a machine
called Dual-Energy X-Ray Absorptiometry (DXA; GE Lunar). This machine measures
the amount of fat and muscle you have in your body without touching you. We
will want to measure your body composition throughout the study, so that we may
look for any changes that may occur due to exercise. Although this machine does
use an X-ray, the amount of radiation is very minimal. The amount of radiation
used in one test is extremely small (0.01 mSv). Each day, you receive
approximately 0.01 mSv of natural background radiation from the earth. In
comparison, flying on a commercial airplane exposes humans to approximately
0.03 mSv per trip. All that is required of you is that you lie down on the bed surface
of the DXA for approximately 5 minutes, while the monitoring arm scans the length
of your body. You will be asked to take off any metals you may be wearing, such
as earrings, as they could alter the results of the test. You will feel absolutely no
pain or discomfort.

•

Measures of your smoking status. We will measure your smoking status using
physical tests in two separate ways. First, we will ask you to breath into a machine
called the Bedfont Smokerlyzer. This machine measures the amount of carbon
monoxide (CO) as you breathe out. It does not cause any harm or discomfort to
you. This smokerlyzer measures how much you have smoked in the past several
hours. Second, we will ask you to provide us with a saliva sample by spitting
approximately 10mL into a special test tube. If you have difficulties producing that
much saliva, you will be given parafilm (an odourless, tasteless product) to chew
on. From this saliva sample, we will measure cotinine, which tells us about your
smoking behaviour in the past several days, and 3-hyrdroxycotinine: cotinine ratio,
which tells us about the rate at which your body metabolizes (breaks down)
nicotine.
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•

A measure of your lung health, using a device called spirometry. To complete this
test, you will take your deepest possible breath and then let all of the air out
(exhale) into the sensor on the device. You will breathe out as hard as you possibly
can, and for as long as you possibly can.

•

Measures of your vascular (blood vessel) health. Smoking could cause damage to
your blood vessels, which is a leading cause for cardiovascular disease. In order to
measure your vascular health, a trained research technician will perform a total of
5 non-invasive measures on you. The first is a measure of blood pressure. First, a
small cuff will be placed around one finger. Second, a cuff will be placed around
your upper arm and inflated periodically in the same manner as blood pressure
measurements made by your family physician. An additional cuff will be placed
around one of your toes to measure the blood pressure changes in your feet. In
addition, a small cuff will be placed around one of your toes in order to measure
the blood pressure pulse wave in that region. An electrocardiogram will also be
conducted by placing 3 sticky buttons (electrodes) on your chest in order to
measure the electrical activity of your heart. The third measure of vascular health
that will be measured is images of your heart and blood vessels. Specifically, your
heart and blood vessels in your leg, arm and neck will be measured with an
ultrasound system. For these tests you will be placed in the supine (lying down)
position, where you will relax as a “flash-light” sized probe is held gently on your
skin over your heart and blood vessels and applied for up to 10-15 minutes at
each site. The fourth measurement of vascular health is similar to the third: a 3-D
ultrasound measurement of carotid artery and plaque volume. This will measure
the extent of plaque buildup in the arteries of your neck using ultrasound. The
same probe used for blood vessel imaging (above) will be mounted in a special
device that moves the probe in precise, stepped movements along the neck. This
procedure should take approximately 45 minutes, which includes setup time and
verification of the data. Finally, we will measure forearm endothelial function. The
size of the brachial artery in your arm will be measured by the ultrasound in this
test. You will be asked to lie quietly while a blood pressure cuff is inflated around
your forearm to prevent blood flow into your hand for 5 minutes. When this cuff is
released and blood flow to your hand is restored, you will be asked to lie quietly
for an additional 5 minutes.

•

Wearing an accelerometer. At the end of baseline testing, we will give you an
accelerometer (motion detector) to wear around your waist at all times except
for when sleeping and bathing, for 7 days. This device is small and unobtrusive.
After one week, you will be asked to return the device to the study researchers.
We will then download the data from the device you wore onto our computer
programs.

ii)
Post-Testing
Time involvement = 3 hours
The same number of tests will be performed again after the study ends, 13 months
after baseline, so that we may measure the effects of the program.
iii)
Testing throughout the study
Time involvement = approximately 15 minutes each week
There will also be periodic testing that you will be asked to do throughout the study (in
between baseline and post-testing). These tests will consist of tests that you already
did at baseline, so you will be familiar with the procedures. The table that follows
shows which tests you will be asked to do, and at what times. Please do not hesitate
to ask for clarification – we realize there is a lot of information in this table.
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What are the risks associated with my involvement in this study?
While in the study, you may experience side effects. Known side effects are listed
below, but other effects may occur that we cannot predict.
Exercise: There are some inherent risks of injury associated with exercise participation,
particularly among people who are not used to exercising. You may, for example,
feel mild muscle “tightness” or soreness that lasts for a couple of days after their first
few bouts of exercise. The possible benefits associated with exercise may outweigh
the potential minor discomfort of beginning a supervised, laboratory-based exercise
program. To minimize the physical risks of exercise, proper warm-up/cool-down and
stretching protocols will be performed, with each exercise session being supervised by
a trained exercise counsellor. Additionally, the exercise program delivered will be
tailored to your individual fitness level, and modified according to your comfort level.
You will gradually, under the supervision of a trained exercise facilitator, work up to a
moderate intensity for your aerobic exercise training bouts. Furthermore, you will only
be allowed to participate in this exercise program if you provide medical clearance
from your physician, and complete the PAR-Q (Physical Activity Readiness
Questionnaire) forms to ensure that it is safe for you to begin an exercise program.
The exercise facilitator will be both CPR and First Aid trained, and experienced in
working with previously inactive populations. Throughout, if any physical or mental risks
arise, you will be referred to the Middlesex London Health Unit if issues arise that fall
outside of the scope of the study.
Quitting Smoking: You may experience withdrawal symptoms during the first few days
after you quit smoking in this program. Such symptoms may include feeling edgy and
nervous, dizzy, sweaty, having trouble concentrating, headaches, difficulty sleeping,
increased appetite and weight gain, muscular pain, constipation, fatigue, or having
an upset stomach. All of these symptoms are common for those who quit smoking so
you should not be alarmed, as these symptoms will go away within a few days. It
should be noted, however, that this program provides you with tools that we believe
will help counter these withdrawal symptoms. Specifically, moderate intensity exercise
has been shown to reduce smoking withdrawal symptoms. The nicotine replacement
therapy we provide you with should also eliminate or reduce the smoking withdrawal
symptoms. Another common side effect of quitting smoking is that your “smoker’s
cough” gets worse for the first few days after you quit. This is your body’s way of
attempting to rid the lungs of excess toxins. This may not be alleviated by exercise or
nicotine replacement therapy. Your smoker’s cough will improve to a great extent
after you have become smoke-free for a number of days.
Nicotine Replacement Therapy (NICODERM®): It is important to note that while this
product does contain nicotine, it is considered safer and healthier than smoking. We
are providing you with this medication as a tool to help you become completely free
of your addiction to cigarettes. Some individuals who wear the patch experience
redness, swelling, or a rash on their where the patch is placed. This is due to the
adhesive material on the patch. Contact your family physician if this occurs. You
should also contact your family physician if you develop an irregular heart beat, or if
you get symptoms of nicotine overdose such as nausea, vomiting, dizziness, weakness
and a rapid heartbeat. These are all potential side effects of taking nicotine
replacement therapy; however, the chance of you developing one of these side
effects is minimal.
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Nicoderm should not be used by people who:
- Are allergic to nicotine
- Are non-smokers or occasional smokers
- Are under 18 years of age
- Are pregnant or breast-feeding
- Have just had a heart attack
- Have life-threatening abnormal heart rhythm
- Have severe or worsening chest pain
- Have recently had a stroke
- Have a generalized skin disorder
Electrocardiogram: The only potential side effect known is a rash that may develop
due to the adhesive of the ECG electrodes. Should you develop this rash, it will
disappear over the next 2-3 days.
Forearm Circulatory Occlusion: When blood flow to your hand is stopped, you may
experience pins and needles or numbness in your forearm. These sensations will be
followed by a sensation of warmth in the hand once the cuff is released and blood
flow to the hand resumes. All of these sensations will resolve within 45 seconds of cuff
release.
Blood Pressure Measures: The blood pressure monitoring cuffs used to measure blood
pressure may cause some mild discomfort, bruising or red blood spots on the arm to
which it is applied. There is some discomfort when the cuff is inflated around your arm
but this feeling goes away when the cuff is deflated.
Dual-Energy X-Ray Absorptiometry (DXA; GE Lunar): This test uses a small dosage of
radiation to conduct a non-invasive x-ray on your body. The amount of radiation is
very minimal, and no known side effects are associated with this minimal amount of
radiation. The amount of radiation used in one test is extremely small (0.01 mSv). Each
day, you receive approximately 0.01 mSv of natural background radiation from the
earth. In comparison, flying on a commercial airplane exposes humans to
approximately 0.03 mSv per trip. The DXA machine used in the EHPL is tested and
calibrated daily to ensure it is working optimally at all times. A trained and certified
research technician will always perform this test on you.
Risk to your foetus or baby: If you are pregnant or breastfeeding, there are also side
effects that could harm your foetus or baby. Use of nicotine replacement therapy is
not recommended while pregnant or breastfeeding. Use of this product could cause
harm to your foetus or baby. You are not eligible to participate in this study if you are
pregnant or planning on becoming pregnant over the course of this study. If you
become pregnant, it is important that you tell one of the study researchers
immediately. It should be noted that pregnant women are advised to limit their
exposure to radiation due to potential harm to the foetus. As such, women in this
study who become pregnant, or who have any reason to believe they may be
pregnant at all will not undergo DXA testing.
Do I have to take part?
Participation in this study is voluntary. You may refuse to participate, refuse to answer
any questions or withdraw from the study at any time with no effect on your future
care. If you decide to take part you will be given this Letter of Information to keep
and be asked to sign the consent form. If you withdraw from the study, you maintain
the right to request that any data collected from you not be used in the study. If you
make such a request, all of the data collected from you will be destroyed. Please
contact the Principal Investigator if you wish to withdraw from the study.
Participation in other studies
If you are participating in another study at this time, please inform the study
researchers right away to determine if it is appropriate for you to participate in this
study.
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Biological specimens given by you for use in this study
The sample we are asking of you during the course of this study is saliva. This saliva
sample will be used for the current study only. Specifically, this saliva will be frozen in
our laboratory freezer, then shipped and analyzed at the Salimetrics® Laboratory in
the United States of America for markers of smoking abstinence (cotinine). The saliva
taken at the baseline measurement time point only will be frozen in our laboratory
freezer, then shipped and analyzed at the University of Toronto in Canada for an
indication of how quickly you metabolize (break down) nicotine in your body (3hydroxycotinine: cotinine ratio). Bar codes will be used to label your saliva samples, so
the laboratory technicians analyzing your saliva will have no information as to who
provided the saliva sample. The samples will be stored for a minimum of 3 years.
Usage and potential research value will be reviewed annually thereafter. It is typical
to keep the samples collected from a research study for 6 years after the study has
been conducted. Once the research value is deemed lower than sufficient to justify
storage costs, the samples will be destroyed by standard disposal of biohazardous
waste laboratory policies and procedures.
Any specimen(s) obtained for the purposes of this study will become the property of
the study researchers and once you have provided the specimens you will not have
access to them. The specimen(s) will be discarded or destroyed once they have
been used for the purposes described in the protocol. The specimen(s) will be used
for research and such use may result in inventions or discoveries that could become
the basis for new products or diagnostic or therapeutic agents. In some instances,
these inventions and discoveries may be of potential commercial value and may be
patented and licensed by the researcher. It is not the purpose of this study to use
specimens for any inventions or patents, so it is very unlikely that this will occur as an
outcome of a sample you provide us with. You will not receive any money or other
benefits derived from any commercial or other products that may be developed
form use of the specimens.
New findings
If, during the course of this study, new information becomes available that may relate
to your willingness to continue to participate, this information will be provided to you
by the investigator.
What are the benefits of my involvement?
Involvement in this study could help you to increase your levels of physical activity in a
safe and supportive setting, and may assist you in remaining smoke free. It may also
help you manage your weight and ease weight concerns, and teach you how to
maintain your levels of physical activity. Ultimately, to be physically active and to quit
smoking is good for your health, and may prevent you from developing co morbidities
associated with long-term smoking and from an inactive lifestyle (e.g., cardiovascular
disease). Furthermore, your participation will help to inform the development of other
programs in the future.
Are there any costs associated with participation?
The study medication (NICODERM ®) will be given to you at no cost. You will not be
paid to take part in the study; however, you will be reimbursed for your expenses such
as parking for visits required as part of this study.
If you have private medical or life insurance, you should check with your insurance
company before you agree to take part in the study to confirm your participation in
this study will not affect your insurance coverage and/or access to benefits.
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This study is covered by an insurance policy and if during the course of the study any
injury should occur to you as a result of the administration of the study medication, not
due to your fault or negligence, all medical expenses necessary to treat such injury
will be paid provided: a) you comply at all times with the study researcher’s
instructions b) you promptly report any such injury to the study researchers conducting
the study, and c) the expenses are not otherwise covered by your provincial health
care. Financial compensation for such things as lost wages, disability or discomfort
due to this type of injury is not routinely available. You do not waive any legal rights by
signing the consent form.
Will information obtained in the study be confidential?
All the information you provide to the researcher will be kept in the strictest
confidence. You will be assigned an identification number and all data collected
from you will be recorded and stored under this number only, so study researchers will
have any way of connecting your data to you. All data will be stored in coded form
on computers accessible only to research staff in a secure office. You will not be
identified in any documents relating to the research. No information obtained during
the study will be discussed with anyone outside of the research team. If the results of
the study are published, your name will not be used.
Representatives of the University of Western Ontario Health Sciences Research
Ethics Board and regulatory bodies (Health Canada) may contact you or require
access to your study-related records to monitor the conduct of the research. If we
find information we are required by law to disclose, we cannot guarantee
confidentiality. We will strive to ensure the confidentiality of your research-related
records. Absolute confidentiality cannot be guaranteed as we may have to
disclose certain information under certain laws.
Alternative treatments
An alternative to participating in this study would be to see your family physician for
advice on how to quit smoking. You could also choose to not participate in the study
and continue on just as you do now.
Questions?
If you have any questions about your rights as a research participant or the conduct
of the study you may contact the Office of Research Ethics (Phone: 519-xxx-xxxx;
Email:).
If you have any questions about the study, please contact the principal investigator,
Dr. Harry Prapavessis (Phone: 519-xxx-xxxx ext. xxxxx; Email:.
This letter is for you to keep. You will be given a copy of this letter of information and
consent form once it has been signed. If you have any concerns, please feel free to
contact one of the researchers below. You may request the general findings of this
research study from the researchers after the study is complete. Again, if you have
any questions about the conduct of this study, or your rights as a participant, you may
contact the Office of Research Ethics, The University of Western Ontario, 519-xxx-xxxx.
Dr. Lyndsay Fitzgeorge
Postdoctoral Fellow
School of Kinesiology
UWO

Dr. Harry Prapavessis
Professor
School of Kinesiology
UWO

Therese Harper
Ph.D. Student
School of Kinesiology
UWO
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Informed Consent
Study Title: Getting Physical on Cigarettes
I have read the Letter of Information, had the nature of the study explained to me
and I agree to participate. All questions have been answered to my satisfaction. I will
be given a copy of the Letter of Information and consent form once it has been
signed.

Consenting Signature:
Participant: ________________________________________________________
Please Print Name

Participant: ________________________________________________________
Please Sign Name

Date: ___________________
Please send me the overall conclusions from this trial:

Yes □ No □

Researcher Signature:

Person obtaining informed consent:

_______________________________________
Please Print Name

Person obtaining informed consent:

_______________________________________
Please Sign Name

Date: ____________________
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